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Behavioral and Neuroanatomical Consequences of Neonatal Hypoxic Ischemic 
Injury, and the Therapeutic Effects of Neuroprotectants: An Animal Model 
Michelle Alexander Curtis 
University of Connecticut, 2013 
Children born prematurely or at very low birth weight (VLBW) are at increased risk for 
sustained brain injury, including hypoxic ischemic (HI) injury that can arise from blood 
and/or oxygen deprivation.  Additionally, HI injury can arise in term infants suffering 
from birth complications (e.g., cord prolapse, placental disruptions).  The location and 
type of HI injury is dependent on the time at which injury is sustained.  Premature infants 
diagnosed with HI injury more often show white matter fiber tract damage, where-as term 
infants with HI typically show gray matter damage.  Furthermore, studies on the neuro-
inflammatory profile following neonatal HI injury in rodent models have demonstrated 
an exaggerated expression of inflammatory factors in P12 (term model) as compared to 
P1 (preterm) rodents.  Given this background the first study presented here was desgined 
to investigate the differences in behavioral deficits and neuropathology characterizing P3 
(preterm model) and P7 (term model) HI injured rodents.  Results indicated wide-spread 
behavioral deficits and neuropathology in P7 HI injured rodents, and more specific 
behavioral deficits with no apparent neuropathology in P3 HI rodents.  Based on the more 
severe behavioral and neuropathological outcomes seen following P7 HI injury, 
subsequent studies went on to explore the use of the putative neuroprotectants 
erythropoietin (Epo) and caffeine in this model.  Results show that Epo can be used to 
prevent neuroanatomical alterations following neonatal HI injury, as well as resulting 
behavioral deficits. Additionally, data presented here further show that caffeine may only 
 ii 
be effective in ameliorating task-specific behavioral deficits.  Finally, results suggest that 
both of these compounds need to be administered as soon as possible following the 
induction of HI injury in order to obtain an optimal outcome.  Our cummlative results 
have implications for future research investigating the effects of preterm versus term HI 
injury, as well as for th development of neuroprotective strategies following HI injury. 
Thuss, our results could be applied to human neonatal HI injured populations in order to 
optimaize treatment strategies.    
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Chapter 1  
Introduction 
I. Neonatal Hypoxia Ischemia in human populations:  
Hypoxic ischemic (HI) injuries can occur because of compromised blood and/or 
oxygen delivery to the brain.  HI injuries can be a major cause of mortality, as well as 
long-term neurological morbidity, in both premature (< 37 weeks gestational age)/very 
low birth weight (<1500 grams/VLBW) infants (Annibale & Hill, 2008; Volpe, 2001; 
Volpe, 2009), and in term infants suffering from birth complications (Fatemi et al., 2009; 
Volpe, 2001).  Resulting injuries can lead to major complications in neuropathology, as 
well as disruptions to cognitive behaviors later in life.  In fact, 25% of premature/VLBW 
infants show brain abnormalities that likely contribute to subsequent cognitive, 
behavioral, attention and social deficits (Volpe et al., 2009).  In a similar manner, 25% of 
term HI survivors go on to show major motor and/or cognitive deficits later in life 
(Armstrong et al., 2010).   
Neuropathology: In premature/VLBW infants, brain injury can arise due to fragile 
cerebral vascular systems as well as poor autoregulation.  Thus blood pressure 
fluctuations can lead to ruptures, which in turn can result in intraventricular hemorrhage 
(IVH; bleeding within the ventricles) or periventricular hemorrhage (PVH; bleeding 
surrounding the ventricles; Volpe, 1997; Volpe, 2009).  Hemorrhages are often unilateral, 
and typically affect the germinal matrix and overlaying cerebral white matter including 
pre-oligodendrocytes (pre-OLs; Volpe et al., 2009).  Additionally, thalamo-cortical 
connectivity development can be compromised (Volpe et al., 2009).  Drops in blood 
pressure can also lead to ischemic reperfusion failure (vascular collapse), often leading in 
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turn to non-hemorrhagic HI injury (e.g., periventricular leukomalacia or PVL; Volpe, 
2001).  PVL is commonly seen in severely injured premature infants, and is associated 
with cyst formation (cystic PVL) and a loss of white matter fiber tracts surrounding the 
ventricles.  Cystic PVL is characterized by localized necrosis deep in the periventricular 
white matter (Volpe et al., 2009).  In non-cystic PVL, focal necrosis typically evolves 
into glial scars characterized by marked astrogliosis, microgliosis, and decreases in pre-
OLs (Volpe et al., 2009).  Similarly, HI injuries can also arise in term infants, typically 
following birth complications such as cord prolapse, placental disruptions/failure, and/or 
cord asphyxia (de Vries & Cowan, 2009; Johnston, et al., 2001; Lai & Yang, 2011; 
Volpe, 2001).  Due to the more global nature of these insults, full term injured infants are 
more commonly diagnosed with hypoxic ischemic encephalopathy (HIE). These infants 
show damage in predominantly gray matter areas such as cortex, hippocampus, basal 
ganglia, and thalamus (Huang & Castillo, 2008; Martinez-Biarge, et al., 2011).  
Cognitive/behavioral deficits following neonatal HI: Given these neuroanatomical 
alterations following neonatal HI, it is not surprising that both populations (preterm and term 
HI) exhibit increased incidence of neuropsychological dysfunction, including deficits in 
language abilities (Jansson-Verkasalo et al., 2004; Steinman et al., 2009), memory deficits 
(Briscoe et al., 2001; Gimenez et al., 2004; Luu et al., 2011; Luu, et al., 2011; Vicari, et al., 
2004), visual attention modulation (Fazzi et al., 2009), and motor coordination abilities (Cho et 
al., 2012; Martinez-Biarge et al., 2011; Mercuri & Barnett, 2003; Mercuri et al., 2004; Kono et 
al., 2011; van Haastert et al., 2008).  
With specific regard to language abilities, children born very prematurely are at elevated 
risk for early delays in language development (Foster-Cohen et al., 2007). Also, children born 
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prematurely were found to require more support in spelling, reading and writing skills, and 
showed deficits in receptive and expressive language, as well as spelling and reading skills (Luu 
et al., 2009; Ortiz-Mantilla, et al., 2008; Van Lierde et al., 2009).  Gestational age and language 
development have also been found to be negatively correlated, where the earlier in gestational 
age an infant is born, the greater the risk for language delays (Foster-Cohen et al., 2007). At two 
years old, premature/VLBW infants showed significantly lower scores on language 
comprehension tasks, and at four years old scores correlated with later performance on language 
comprehension, naming, and auditory discrimination tasks  (Jansson-Verkassaio et al., 2004).  
Furthermore, at age 6, these same subjects showed alterations on mismatched negativity during 
naming tasks and showed difficulty in pre-attentively discriminating changes in syllables 
(Jansson-Verkassaio et al., 2004).  Similarly, full term injured infants diagnosed with moderate 
to severe HIE showed receptive language, reading and spelling scores in childhood that were 
significantly lower than scores from healthy full term control children (Badawi, et al., 2001). 
Additionally, verbal IQ scores correlated with the degree of “water shed” brain injury 
(measured by MRI) in HIE infants, where greater degree of injury was associated with lower 
verbal IQ scores (Steinman et al., 2009). Given the various language deficits in both 
populations, one common proposed underlying mechanism may involve more basic deficits in 
rapid auditory processing (RAP) - - that is, the ability to discriminate differences between 
rapidly presented auditory cues, such as /ba/ and /da/ sounds, and to discriminate stop constants 
as well as non-verbal acoustic stimuli.  Studies have demonstrated that children diagnosed with 
severe PVL lesions at birth show deficits on RAP tasks later in childhood (Downie, et al., 
2002).  Furthermore, deficits in RAP early in life correlated with, and are predictive of, later 
language impairments in children (Benasich & Tallal, 2002; Choudhury, et al., 2007). 
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 With specific regard to memory deficits, neonates suffering from HI show later 
impairments on a variety of behavioral/memory tasks. For example, children born extremely 
prematurely showed deficits on short-term non-word and digit span memory tasks as compared 
to healthy term controls (Lubsen et al., 2011).  Furthermore, children diagnosed with PVL 
injury also showed deficits on working memory and sentence comprehension (Briscoe et al., 
1998), and showed lower than expected memory quotient scores based on verbal IQ (using the 
Wechsler Memory Scale in childhood; Gadian et al., 2000).  Decreased activation of the caudate 
nucleus as measured by fMRI, as well as poorer performance on a spatial memory tasks, have 
also been seen in children born prematurely (Curtis et al., 2006).  In term infants with severe HI 
injury (diagnosed at birth) who were tested at 7 years of age, deficits on various memory tasks - 
- - including memory for names, narrative memory sentence repetition, and “everyday memory 
tasks” - - have been reported when compared to children diagnosed with mild to moderate insult 
(Marlow et al., 2005).   
 Deficits in visual attention are also seen in HI injured infants.  Visual attention allows 
for the ability to survey a scene, locate and recognize an object of interest and decide on an 
appropriate plan for that object.  Children diagnosed with PVL were tested on a variety of 
cognitive visual perceptual tasks.  Specific impairments were seen in visual memory, visual 
recognition, and visual spatial tasks, but these were not related to general attention deficits (e.g., 
attention deficit disorder; Fazzi et al., 2009).  In another study, premature children who did 
show deficits in attention processes also showed dorsal stream alterations as revealed by a 
fMRI, and these deficits correlated with severity of injury (Atkinson et al., 2008).  In term 
injured children diagnosed with HI, and later tested at two years old, abnormalities on a fixation 
task, along with wide-spread brain injury, were seen.  Diffuse involvement of cortical and 
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subcortical areas was also found in this sample using fMRI during the fixation shift task 
(Mercuri et al., 1997; Mercuri, 1999).  Deficits revealed here suggest that higher order complex 
visual circuitry (i.e., presumably involved in the fixation shift task) is affected by HIE in term 
injured infants. 
Finally, motor impairments are also seen in children suffering from HI brain 
injury.  In children born prematurely, white matter fiber tract damage seems to lead to 
motor deficits (Nanba et al., 2007; van Haastert et al., 2008).  Among children born 
prematurely and diagnosed with PVL who also developed cerebral palsy, it was found 
that the severity of their lesions in white matter areas correlated with gross motor abilities 
later in life (van Haastert et al., 2008).  In fact, children diagnosed with Grade 3 or 4 
(severe) injuries could not walk on their own in childhood (van Haastert et al., 2008).  
Correlations between white matter injury and cerebral palsy were found to be persistent 
into later childhood as well.  For example, severity of cystic PVL and IVH diagnosed at 
birth later correlated with the severity of cerebral palsy (three years of age; Kono et al., 
2011).  Furthermore, in children diagnosed with PVL, diffusion tensor imagining (DTI) 
showed that hemiplegic complications were associated with disruptions of the integrity of 
specific cerebral spinal tracts but sparing of others, while diplegia was associated with 
symmetric disruptions of both left and right cerebral spinal tracts (Cho et al., 2012).  In 
term born infants diagnosed with HI, motor impairments appeared to be associated with 
basal ganglia and thalamic damage (Martinez-Biarge et al., 2011).  Studies have also 
shown that when assessed at 5-6 years old, severity of early basal ganglia damage 
associated with more severe later outcomes, including quadriplegia (Mercuri & Barnett, 
2003), and hemiplegia (Mercuri et al., 2004).  Furthermore, HIE children showed 
 6 
asymmetry on neuromotor assessments and poorer scores on tasks assessing neuromotor 
functions (Mercuri et al., 2004).  Involvement of thalamic regions also plays a role in 
motor impairments.  For example, severity of damage to basal ganglia and thalamic 
regions was strongly correlated with severity of motor impairment at one year old 
(Martinez-Biarge et al., 2011).  Additionally, degree of damage to the posterior limb of 
the internal capsule correlated with later inability to walk independently in HIE children 
(Martinez-Biarge et al., 2011). 
Together, these data demonstrate a wide variety of behavioral deficits following 
neonatal HI injury.  To better understand resulting deficits and neuroanatomical 
alterations in these populations, animal models can be employed.  
 
II. Neonatal Hypoxia Ischemia in rodent models:  
Animal models can provide further insight into the neuroanatomical and 
behavioral features of neonatal HI injury, for example using the Rice-Vannucci method 
(Vannucci & Vannucci, 2005).  This model entails cauterization of the right common 
carotid artery followed by exposure to a less than normal oxygen environment for a 
period of time (typically 8% oxygen; Vannucci & Vannucci, 2005).  Induction of HI 
injury using this method in rodents between P1-5 can produce injuries that correspond 
roughly to those seen in premature/VLBW infants with HI, including ventriculomegaly 
and predominantly white matter damage (much like human PVL; Scafidi et al., 2009).  
Conversely, injury induced between P7-10 leads to neural anomalies that appear to 
correspond to term birth HI injury, with gray matter damage predominating (as in the 
case of HIE; Vannucci & Vannucci, 2005).  Furthermore, there appears to be a sex 
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difference following HI injury in both human populations and rodents, with males 
seeming to be more affected (both behaviorally and neuroanatomically) as compared to 
females (Hill et al., 2012).  For this reason, the studies described and discussed here will 
focus on male rodents.   
Behavioral Deficits: In regards to behavioral deficits following the induction of HI, male 
rats that received an HI injury on P7 showed subsequent deficits on RAP tasks during both 
juvenile and adult periods, which could possibly reflect outcomes related to language deficits in 
human populations (Hill et al., 2011; McClure et al., 2005; McClure et al., 2005; McClure et al., 
2006; Alexander et al., 2013).  These P7 HI injured rats also showed gray matter damage, 
particularly in the cortex and hippocampus, along with increased ventricular size as measured 
by post mortem histological analysis (McClure et al., 2005; McClure et al., 2005; McClure et 
al., 2006; Alexander et al., 2013).  Rats with neonatal HI have also been found to show memory 
deficits.  For example, utilizing the Morris Water Maze (MWM; a test of spatial navigation and 
learning), studies have shown poorer performance in P7 HI injured animals as compared to 
sham animals (Arteni et al., 2003; Delcour et al., 2012; Ikeda et al., 2001; McClure et al., 2005; 
McClure, et al., 2007).  Along with spatial memory deficits, P7 HI injured animals also showed 
deficits in choice reaction time tasks (Ikeda et al., 2001), place learning tasks (Arteni et al., 
2003), and spatial working memory tasks (Arteni et al., 2003; Ikeda et al., 2001).  Subjects from 
these studies also showed reductions in hippocampal volume in post mortem histological 
analysis (McClure et al., 2006; McClure et al., 2007).   
 Studies have further demonstrated sensorimotor deficits in neonatal HI injured rodents.  
For example bilateral artery occlusions on P4 resulted in a decrease in mature oligodendrocytes 
and impaired myelination later in life (Fan et al., 2005). These same animals showed deficits on 
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righting reflexes, wire hanging, cliff avoidance, and locomotor activity as compared to shams 
(Fan et al., 2005).  Studies using P3 HI injured rodents also revealed disorganized barrel 
patterns in the somatosensory cortex (Quairiaux et al., 2010).  At P10, these HI animals showed 
no somatosensory evoked potentials on the side ipsilateral to the injury, and by P21, evoked 
potentials were apparent but were reduced compared to the contralateral hemisphere (Quairiaux 
et al., 2010).  Authors interpreted these findings as evidence of “large-scale” network plasticity 
of somatosensory networks following neonatal HI injury (Quairiaux et al., 2010).  In related 
studies, animals with HI induced on P7 showed deficits on fine motor control tests at 3 months 
old (P90), and also showed less activation of the sensorimotor cortex in response to left and 
right forepaw stimulation as measured by fMRI (Tuor et al., 2001).  Other studies report that P7 
HI injured animals showed deficits in righting reflex, gait reflex, muscle power, motor 
coordination, and limb placing as compared to shams (Lubics et al., 2005; Pazaiti et al., 2009).  
These HI animals also showed loss of volume in the cortex, thalamus, and striatum (Pazaiti et 
al., 2009). 
 The literature on visual attention processing in HI injured rodents is limited.  One 
study has shown deficits in P7 HI injured male rats on a choice reaction time task, where 
animals were required to press one of two levels paired with a light stimulus for a food 
reward.  P7 HI injured animals showed deficits on the choice reaction time task, with 
decreased percent correct choices but increased reaction time, as well as increased lever 
presses compared to sham animals (Ikeda et al., 2001).  This suggests P7 HI animals 
show deficits in selective attention of information processes including arousal, decision-
making, and motivation (Ikeda et al., 2001).  Another commonly used test to assess visual 
attention in other rodent models of related pathologies is a 5-choice serial reaction time 
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(5SCRT) task.  In an operant chamber, animals are trained to poke their nose in a hole 
associated with visual stimulus cue (typically a light), and are rewarded with a food pellet 
when the correct association is made (Bari et al., 2008).  This paradigm is more 
challenging than the paradigm described in Ikeda et al (2001) because animals are 
required to attend to five stimulus cues rather than just two.  This paradigm could also be 
used to assess attention modulation deficits follow neonatal HI injury in the rodent.  
Overall these data demonstrate similar behavioral deficits in HI injured rodents as 
compared to those in human HI injured populations.    
 
III. Mechanisms of Cell Death 
 Cellular death following neonatal HI is believed to occur in two phases: necrosis 
and apoptosis.  Depending on the severity of the insult, both necrosis and apoptosis 
appear to play roles of differing magnitude.  In cases where reduction in blood flow leads 
to HI injury (such as PVL or HIE), subsequent reductions in nutrient delivery (i.e., 
glucose) to the cells might trigger the cascade.  In situation of IVH-PVH, bleeding in the 
brain predisposes infants to secondary ischemic damage that can trigger cell death 
cascades (Cahill et al., 2006).    
 Necrotic cell death is initiated by the direct and immediate effects of HI (drops in 
blood and oxygen).  Necrosis occurs in a passive manner, and is characterized by cell 
swelling, membrane fragmentation, and inflammation (Volpe et al., 2001).  Within 
minutes of the initial oxygen/blood deprivation, cellular energy (adenosine triphosphate 
or ATP) decreases dramatically.  The decrease in ATP leads to a failure of sodium 
(Na+)/potassium (K+) pump, which typically regulates intracellular voltage 
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concentrations and ionic integrity.  Dysfunction here leads to a dramatic influx of Na+ 
into the cell, resulting in depolarization of the cells, and thus eliciting action potentials 
(Distefano & Pratico, 2010; Gill & Perez-Polo, 2008; J. J. Volpe, 2001a).  Additionally, 
failure of energy-dependent glutamate uptake mechanisms in local astrocytes occurs, 
leading to an excess of glutamate in the synapses (Distefano & Pratico, 2010; Gill & 
Perez-Polo, 2008; J. J. Volpe, 2001a).   This excess glutamate binds to its local receptors 
(NMDA and AMPA), leading to an increase in cytosolic calcium (Ca2+).  Furthermore, 
additional Ca2+ release can occur due to a failure in the energy-dependent Ca2+ pumps, as 
well as a failure to open voltage-dependent Ca2+ channels (Distefano & Pratico, 2010; 
Gill & Perez-Polo, 2008; J. J. Volpe, 2001a).  This cascade of events contributes to the 
release of excessive glutamate and activation of ionotropic glutamate receptors.  
Excessive glutamate thus results in a net influx of Na+, Ca2+, and chloride (Cl-), which in 
turn leads to water accumulation and cell swelling, followed by lysis.  These events are 
followed by an inflammatory reaction, as well as cytokine release (e.g., interleukin (IL-
1β) and tumor necrosis factor (TNF-α; Sun et al., 2005).  Increases in intra-neuronal Ca2+ 
also mediate the generation of nitric oxide synthase (NOS), which in turn produces the 
free radical gas nitric oxide (NO).  These events alone can have toxic effects on neurons 
and glia cells, specifically targeting mitochondria (Johnston et al., 2001).  In severe cases 
of HI, these events can lead to mitochondrial failure promptly, resulting in immediate cell 
death, whereas in less severe cases, free radical formation can lead to delayed 
programmed cell death (apoptosis). Additionally, the massive intra-cellular entry of Ca2+ 
activates the endocellular enzymes protease and phospholipase.  Protease in turn degrades 
neurofillaments, including the cytoskeleton, leading to rupture and disarrangement of the 
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cell body.   Phospholipase further hydrolyzes phospholipids, and thus can also damage 
the cellular membrane (Distefano & Pratico, 2010).  
 The more delayed apoptotic cascade (programmed cell death) following neonatal 
HI is triggered in part by the initial glutotoxicity, calcium influx, and oxidative stress 
resulting from the necrotic cell death cascade.  Apoptosis is characterized as a longer 
lasting form of cell death, and occurs in an active manner.  Specifically, HI-induced 
apoptosis occurs 2-6 hours post insult and can last up to 7 days post injury (Gill & Perez-
Polo, 2008; Johnston et al., 2001; Nakajima et al., 2000; J. J. Volpe, 2001).  Apoptosis is 
characterized by DNA fragmentation and chromatin condensation, decoupling of the 
cytoskeleton, and shrinkage of dying cells (Gill & Perez-Polo, 2008; J. J. Volpe, 2001).   
 Within the general apoptotic death cascade, there are two distinct pathways – the 
extrinsic and intrinsic pathways.  The extrinsic “death receptor” pathway is also called 
receptor mediated apoptosis.  In this pathway Fas-L (a part of the TNF-α family) binds to 
the Fas receptors on the cell membrane.  This binding recruits cytoplasmic adaptor 
protein Fas – associated with the death domain protein (FADD), which in turn, binds 
procaspase-8.  This complex - - Fas-L, Fas, FADD, and procaspase-8 - - serves as the 
death inducing signaling complex (DISC).  DISC in turn cleaves procaspase-8 into 
caspase-8, an effector caspase.  Caspase-8 cleaves caspase-3, which then cleaves and 
deactivates poly-ADP ribose polymerase (PARP-1).  With the inactivation of PARP-1, 
apoptosis inducing factor (AIF) is activated from the mitochondria and translocates the 
cell’s nucleus.  This causes large-scale DNA fragmentation and condensation of 
peripheral chromatin.  This DNA fragmentation is mediated by phosphorylation and 
activation of p53, a DNA damage-sensing transcription factor.  Specifically, p53 
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regulates the cell cycle progression, DNA repair mechanisms, and initiates cell death 
signaling - - all of which occur in proportion to the degree of insult.  Phosphorylation of 
p53 then promotes the pro-cell death genes PUMA, NOXA, and BAX - - leading to DNA 
fragmentation, and ultimately, cell death (Bonde et al, 2005; Broughton et al., 2009; 
Gibson et al., 2001; J. J. Volpe, 2001).  Additionally, in a parallel extrinsic apoptotic 
pathway, TNF-α binds to its receptor (TNFR-1) and activates TRADD.  TRADD cleaves 
procaspase-10 into caspase-10 and activates the RAIDD/CRADD complex.  This 
complex then cleaves procaspase-2 into caspase-2.  Both caspase-2 and caspase-10 
activate BID (Bcl-2 interacting domain).  BID is a cystolic member of the Bcl-2 family of 
proapaptotic proteins that translocate the mitochondria when the death signal is received.  
This first target is the outer mitochondrial membrane pores (MTP), which induce 
conformational changes in the proapoptotic proteins such as Bax, Bak, and Bad in the 
mitochondria.  In one study, two groups of postnatal day (P) 7 HI injured mice were 
assessed - - one group with the gene for the Bax protein (Bax +/+), and one group 
missing the gene for the Bax protein (Bax-/-).  Both groups were sacrificed one week 
after injury.  Bax +/+ mice were found to show significantly more damage than the Bax -
/- mice, indicating that: 1) the cascade can extend for up to week in the brain; and 2) that 
Bax plays an important role in brain injury following HI damage and cell death (Gibson 
et al., 2001). These factors together open MTP, which then releases apoptogenic factors.  
The first factor group includes a cluster of cytochrome c, Smac/DIABLO, and protease 
HtrA3/Omi molecules.  Little is known about the two latter factors, but cytochrome c 
binds to procaspase-9 and apoptotic protein activating factor-1 (Apaf-1) to form an 
apoptosome.  The apoptosome in turn cleaves procaspase-9 to form caspase-9, which 
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activates caspase-3. From here, the intrinsic apoptosis cascade carries on much like the 
extrinsic pathway, where caspase-3 inactivates PARP-1, activating AIF, in an ongoing 
feedback chain.  Notably, in the above study, P7 HI injured Bax -/- mice still showed 
some evidence of caspase-3 and cytochrome c activation, indicating that Bax and other 
proapoptotic family members might not be the sole moderators of this cascade (Gibson et 
al., 2001).  For example, there is evidence that Smac/DIABLO proteins deactivate the 
anti-apoptotic protein family (IAP), which typically prevents the cell from going into a 
cycle of programmed death (Gill & Perez-Polo, 2008; J. J. Volpe, 2001a, Cahill et al., 
2006). 
 Intrinsic apoptosis, in contrast, is characterized mitochondrial apoptosis.  Here 
cell death mechanisms first target the mitochondria of the cell before leading to DNA 
fragmentation in the nucleus. Events are initiated by post-ischemic Ca2+ entry (via 
AMPM and NMDA channels) into the intracellular space, which triggers the intrinsic 
pathway.  Ca++ then activates calpains (a protein belongs to the cysteine protease 
family), which cleaves the Bcl-2 interacting domain (BID).  From here, BID translocates 
the mitochondria and activates Bax, Bak, and Bad (as in the extrinsic pathway) and 
carries out the same mechanisms that lead to cell death (Gill & Perez-Polo, 2008; J. J. 
Volpe, 2001, Cahill et al., 2006). 
 
IV. Neuroprotective Strategies following neonatal HI:  
Given the various behavioral deficits and neuroanatomical alterations following 
neonatal HI injuries, various neuroprotective strategies have been explored as a means to 
improve long-term outcomes.  
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Erythropoietin: Erythropoietin (Epo) is one proposed intervention to reduce 
deleterious outcomes following neonatal HI.  Epo is a cytokine hormone expressed 
endogenously in the brain, kidney, and liver (Buemi et al., 2002; Ghezzi & Brines, 2004).   
Epo has been shown to readily cross the blood brain barrier, and within the central 
nervous system Epo binds to the Epo receptor (EpoR).  Epo and EpoR are in turn highly 
expressed in gray matter areas like the cortex and hippocampus, which are particularly 
vulnerable to HI damage in term infants (Buemi et al., 2002). 
Epo in human neonatal populations: In humans, Epo has been used to help treat 
anemia in premature infants, but retrospective studies have also shown unexpected 
neuroprotective properties (Bierer et al., 2006; Buemi et al., 2002; McAdams et al., 2012; 
McPherson & Juul, 2010; Zhu et al., 2009).  For example, in a study of VLBW infants, 
those treated with 400 U/kg three times per week and who showed high Epo plasma 
concentrations had better Mental Development Index (MDI) Scores at 18-22 months as 
compared to treated infants with lower Epo plasma concentrations (Bierer et al., 2006).  
Furthermore, preterm infants who were treated with multiple doses of Epo at birth 
showed improved gross motor, fine motor and language abilities at 6-12 months when 
compared to age matched controls (reviewed in McPherson & Juul, 2010).  High doses of 
Epo treatment in VLBW infants in the first three days of life also positively correlated 
with cognitive and motor scores at 4-36 months (McAdams et al., 2012).  In term injured 
infants diagnosed with moderate HIE and treated with repeated doses of Epo, subjects 
showed improved MDI scores and lower incidence of disability as compared to control 
groups at 18 months (Zhu et al., 2009).  Furthermore, term injured infants treated with 
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multiple doses of Epo at birth also showed fewer incidences of seizures, improved EEG 
scores, and improved neurological scores at six months of age (Elmahdy et al., 2010). 
Epo in rodent HI models: The use of Epo in animal models of HI has also revealed 
promising effects.  Behaviorally, treatment with Epo following P7 HI injury has been found to 
ameliorate later sensory and motor deficits (Fan et al., 2011; Kim et al., 2008), as well as spatial 
memory deficits (Kumral et al., 2004; McClure et al., 2006; McClure et al., 2007) in P7 injured 
rats.  Additionally, Epo has been shown to help prevent later RAP deficits in P7 HI injured rats 
as measured in both juvenile and adult periods (McClure et al., 2006; McClure et al., 2007).  
Neuroanatomically, treatment with Epo immediately following HI injury in P7 rat pups has 
been shown to reduce infarct size in the cortex (Aydin et al., 2003; Chang et al., 2005; Fan et 
al., 2011; Kumral et al., 2003; Kumral et al., 2004; McClure et al., 2006; McClure et al., 2007), 
and hippocampus (Aydin et al., 2003; McClure et al., 2007), as well as to reduce the volume of 
the lateral ventricles (McClure et al., 2006; McClure et al., 2007).  These data suggest that Epo 
is a promising candidate for neuroprotection against HI brain injury in neonates.       
Epo Mechanisms of Action 
Epo has anti-apoptotic effects and promotes neurogenesis and angiogenesis (Juul 
et al., 2012).  Epo crosses the blood brain barrier readily and binds to its endogenous 
receptor (EpoR).  The EpoR is highly expressed in gray matter structures such as the 
cortex and hippocampus (Buemi et al., 2002).   When Epo binds to EpoR, the Janus 
Kinase 2 (JAK2) pathway is initiated and phosphorylates several proteins including 
STAT5 (an antiapoptotic erythrooid precursor).  STAT5 mediates the induction of Bcl-xL 
(an anti-apoptotic protein; Ghezzi et al., 2004; Sola et al., 2005).   JAK 2 also activates 
phosphatidy linositol – 3 kinase (PI3K).  This recruits Akt protein and decreases the 
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amount of Bad (pro-apoptotic) protein.  This decreases the probability of mitochondrial 
leakage and prevents later DNA fragmentation (Ghezzi et al., 2004; Kumal et al., 2003; 
Spandou et al., 2004).  Furthermore, Epo regulates Ca2+ by decreasing the dramatic influx 
of intracellular Ca2+ that normally results from the decreased oxygen supply (Ghezzi et 
al., 2004).  With this, neurotransmitter release is better regulated, thus preventing the 
excessive glutamate expression in the synapse (Ghezzi et al., 2004).  One study found 
that P7 HI injured rodents treated with 2000 U/kg of Epo showed a decrease in TUNNEL 
(dying) positive cells and dramatically minimized DNA fragmentation in both the 
cerebral cortex and hippocampus (Spandou et al., 2004).  In another study, P7-8 HI pups 
treated with 30,000 U/kg of Epo had 40% smaller lesion size (measured by MRI) as 
compared to non-treated pups, as well as a decrease in apoptotic markers like caspase 3 
(Brissaud et al., 2010).  Furthermore, in vitro studies have shown that P7 oxygen 
deprived hippocampal slices treated with Epo showed increased neurogenesis, as well as 
and increased number of proliferating cells, 4-5 days after oxygen deprivation (Osredkar 
et al., 2010).  Additionally, Epo treatment following HI also seems to prevent early 
neuroinflammatory injury.  For example, P7 HI injured animals treated with three doses 
of 5,000 U/kg of Epo showed significantly attenuated brain injury as well as a delayed 
rise in interleukins (IL-1β) and decreased infiltration of leukocytes (Sun et al., 2005).        
Caffeine: Caffeine is another promising and novel candidate for neuroprotection 
following neonatal HI injuries.  Caffeine is a non-selective adenosine antagonist currently 
used to increase respiratory drive and thus wean premature infants off ventilation. 
Caffeine in human neonatal populations: Along with improved respiration, 
previous research has shown that premature infants treated with caffeine have an 
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increased rate of survival without long-term disability, along with a decreased incidence 
of cerebral palsy and neurodevelopmental delay (Benitz, 2008; Gray et al., 2011; Schmidt 
et al., 2006; Schmidt et al., 2007; Stevenson, 2007).  Additionally, preterm infants treated 
with caffeine for respiratory stimulation (two hours via intravenous injection) showed 
unexpected increased cortical activity as later measured by EEG (Supcun et al., 2010).  
Also, in caffeine treated premature infants, serum caffeine levels correlated with a 
positive change in pro-inflammatory and anti-inflammatory cytokine levels in the 
peripheral blood (Chaves-Valdez et al., 2011).  Specifically, caffeine treated children 
showed decreases in IL-6 and TNF-α (pro-inflammatory) and increases in IL-10 (anti-
inflammatory), and greater concentrations of anti-inflammatory markers correlated with 
increase caffeine levels (Chaves-Valdez et al., 2011).  Finally, in HIE children, caffeine 
treatment down-regulated TNF-α, as well as the release of lipopolysaccharides (an 
endotoxin that elicits a large inflammatory response following HI; Chavez-Valdez et al., 
2009).   
Caffeine in rodent HI models: In a handful of studies, caffeine has also shown 
beneficial effects in rodent models of neonatal HI.  Neonatal mice reared in a hypoxic 
environment from P3-P14 with a dam provided caffeine in drinking water ad lib later 
showed increased myelination, more normally arranged axons, increased proportions of 
oligodendrocytes, and decreased ventricular volume (reduced ventriculomegaly) as 
compared to non-treated hypoxic pups (Back et al., 2006).   Additionally, in P7 animals 
where early life convulsions were induced (via kinate), animals showed later memory 
deficits and a loss of presynaptic glutamate terminals (Cognato et al., 2010).  However, 
concurrent caffeine treatment prevented these memory deficits and induced a 
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preservation of nerve terminals in the hippocampus (Cognato et al., 2010).  Finally, 
premature baboons treated with caffeine showed more myelination as compared to non-
treated animals (Rivkees et al., 2011).  Although, data is limited on this topic, existing 
human and animal research do indicate that caffeine also shows promise as a possible 
therapeutic agent following neonatal HI.   
Caffeine Mechanisms of Action: Caffeine’s effects appear to be mediated via the 
adenosine receptor.  Adenosine receptors are widely expressed throughout the brain, with 
A1 receptors expressed in gray matter areas including the cortex and hippocampus, and 
A2A receptors in the basal ganglia (Rivkees et al., 2011).  Specifically regarding the A1 
receptor, during development there is an increase in density between P9-P15, with the 
highest density seen in the cortex and hippocampus by adulthood (Cunha et al., 2005). 
The neuroprotective effects of caffeine further appear to be mediated primarily via the A1 
receptor (Riveeks et al., 2011), and antagonism affects transmitter release and neuronal 
firing under typical conditions (Fredholm et al., 2000).  Adenosine is generated as ATP is 
catabolized, and this process is heightened during hypoxia.  Endogenous adenosine levels 
are around 50 nM under normal conditions but under hypoxic conditions increase to 
upwards of 1000 nM in neonates.  When adenosine binds to its receptor, there is 
increased binding with coupled extracellular G proteins that leads to activation of 
hypoxia inducing factor (HIF; Riveeks et al., 2011).  This activates the necrotic 
inflammatory pathway traditionally seen in ischemia (described above; Rivkees et al., 
2011; Ryzhov et al., 2001). Moreover, adenosine accumulation following hypoxia is 
thought to be responsible for electrical suppression in the brain, where the release of 
adenosine is directly related to depression of excitatory synaptic transmission in 
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hippocampal slices at P10-24 (Dale et al., 2000; Frenguelli et al., 2003).  By antagonizing 
the adenosine (A1) receptor with caffeine, the downstream effects leading to cell death 
appear to be prevented, thus preserving cellular integrity.   
V. Dissertation Purpose 
 Based on the convergent evidence described above, the current series of studies 
was designed to evaluate the therapeutic potential of both Epo and caffeine as 
neuroprotective strategies following neonatal HI in a rodent model.  Additionally, we 
focused on the age of HI injury as well as the timing of therapeutic intervention following 
injury.  Specifically, we first characterized the differences in deleterious outcomes for 
early (P3) versus late (P7) HI injury, using various behavioral tasks as well as 
neuropathological measures (Chapter 2).  Based on the RAP data collected from the study 
in Chapter 2 as well as previous data supporting the magnocellular theory (purporting 
that RAP deficits in language disordered populations might arise due to cell size 
abnormalities in the medial geniculate nucleus (MGN) of the thalamus) we next 
measured and analyzed the differences in cell size in the MGN (Chapter 3).  Based on 
these results, we selected the P7 HI model as the most robust platform to explore 
neuroprotection.  We then evaluated the therapeutic effectiveness of Epo administration 
at various delayed intervals following P7 HI injury on behavior and neuropathology 
(Chapter 4).  Given the paucity of data evaluating caffeine following P7 HI injury, we 
then sought to investigate the therapeutic effectiveness of caffeine on various behavioral 
tasks and neuropathology (Chapter 5).  Finally, we sought to characterize the therapeutic 
potential of delayed caffeine administration following P7 HI (Chapter 6) and also the 
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effectiveness of combined Epo and caffeine treatment following P7 HI injury (but see 
Addendum II).   
 Previous evidence has shown a difference between early and late HI injury in 
rodent models (McClure et al., 2006; Brochu et al., 2011), where animals with HI injury 
induced earlier in life show protection on both behavior and neuropathology as compared 
to animals with late injury.  In Chapter 2, we sought to further characterize the difference 
between early (P3) and late (P7) HI injury in rodent models.  Results showed that, first, 
both P3 and P7 HI injured animals showed deficits on RAP tasks in juvenile periods, but 
only P7 HI injured animals showed deficits on the same RAP task in adulthood, 
replicating previous evidence (McClure et al., 2006).  Second, P7 HI injured animals 
showed deficits on motor learning tasks as well as spatial memory and non-spatial 
memory tasks compared to sham and P3 HI animals.  Interestingly, in adulthood, P3 HI 
injured animals showed deficits on a visual attention tasks as compared to shams and P7 
HI animals.  Furthermore, P3 HI animals showed no alterations in neuropathology where 
P7 HI animals showed global volume loss.   Results from this study show that late HI 
injured animals show a variety of deficits across the life span as well as larger reductions 
in brain volume.  Results also demonstrate a novel finding that P3 HI injured animals 
show deficits on early RAP tasks as well as on a visual attention tasks in adulthood, 
despite a lack of reduction in brain volume.  Additionally, results from Chapter 3 showed 
alterations in cell size in the right MGN (in the same subjects described in Chapter 2).  
Specifically, P7 HI injured rodents showed a shift towards smaller cells in the right MGN 
compared to both P3 HI and shams, suggesting that reductions in cell size in the MGN 
might lead to RAP deficits later in life in HI injured rodents.  Given the results from these 
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two studies, we sought to focus on P7 HI injury for our subsequent studies investigating 
the neuroprotective effectiveness of Epo and caffeine, based on the variety of deficits 
seen in these animals.  Future studies will be needed to explore neuroprotection in the P3 
(preterm) model.   
 Previous evidence from our lab has demonstrated that P7 HI injured animals 
treated with Epo immediately following the induction of injury show preservation of 
cortical volume as well as better performance on RAP tasks, both in juvenile and adult 
periods (McClure et al., 2006, McClure et al., 2007).  In Chapter 4 we sought to expand 
this finding by evaluating the therapeutic potential of Epo when initiation of treatment 
was delayed either 60 or 180 minutes.  This design was based on real-world clinical 
delays in initiation treatment due to any number of factors.  Results from this study first 
replicated previous evidence of a protective effect of immediate Epo treatment following 
HI injury, both for RAP tasks and neuropathology.  Second, results indicated a partial 
protection of 60 minute delayed Epo injection on RAP tasks compared to sham animals.  
Finally, we found no protective effect of 180 minute delayed Epo administration on 
juvenile and adult RAP tasks, nor for neuropathology.  Results from this study suggest 
that Epo treatment following neonatal HI injury is most effective when administered 
immediately.   
 As far as we are aware, there are no data directly characterizing the therapeutic 
effect of caffeine following P7 HI injury in rodents (using this model).  In Chapter 5, we 
sought to characterize the therapeutic effectiveness of caffeine immediately following P7 
HI injury in rodent models.  Results showed that HI animals without caffeine treatment 
showed significant deficits on spatial learning/memory tasks as compared to shams, 
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replicating previous evidence (Arteni et al., 2003; Delcour et al., 2012; Ikeda et al., 2001; 
McClure et al., 2005; McClure, et al., 2007).  However, caffeine treated HI animals 
showed preservation of behavior as compared to non-treated HI animals.  These results 
support previous evidence suggesting caffeine is a viable therapeutic option following 
neonatal HI injury.  Furthermore, in Chapter 6, we sought to investigate the therapeutic 
effect of delayed caffeine treatment following neonatal HI injury.  Results showed that 
treatment with caffeine immediately following P7 HI in rodents preferentially protected 
against learning/memory deficits (largely replicating our prior findings), but not RAP 
deficits when subjects were compared to shams.  In addition, P7 HI injured animals 
treated with a delayed injection of caffeine (60 minutes post hypoxia) showed no 
significant preservation of RAP or learning/memory scores as compared to sham animals.  
These results suggest that caffeine might be better at protecting against deficits in specific 
types of cognitive abilities (such as learning/memory tasks) as opposed to other abilities 
(such as language related tasks).  Results also suggest that delaying caffeine treatment by 
as little as 60 minutes following hypoxia leads to no therapeutic benefit following 
neonatal HI injury.   
 Finally we sought to evaluate the therapeutic potential of a combination treatment 
of Epo and caffeine following P7 HI injury.  Unfortunately, there were no obtainable 
results for this study (see Addendum II).  We believe significant prenatal stress due to 
building construction aberrantly affected all of our animals, (including shams), thus 
making it difficult to obtain or interpret any meaningful results.   
 Together, the data presented here address the difference in brain injury and 
resulting behavioral deficits for preterm versus term HI injury rodent models, as well as 
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the efficacy of various neuroprotective strategies following neonatal HI.  We believe our 
results have important clinical applications.  For example, findings could be applied to 
human neonatal populations to better understand the differences in brain injury and 
behavioral outcomes between preterm and term HI injured infants.  Additionally, results 
could be applied to human HI populations to better understand optimal therapeutic 
strategies to prevent brain injury and resulting behavioral deficits.   
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Abstract 
 Hypoxia-ischemia (HI) occurs when blood and/or oxygen delivery to the brain is 
compromised.  HI injuries can occur in infants born prematurely (<37 weeks gestational 
age) or at very low birth weight (<1500 grams), as well as in term infants with birth 
complications.  In both preterm and term HI populations, a heightened incidence of brain 
injury and later behavioral deficits are seen.  Neonatal HI injury can be modeled in 
rodents using the Rice-Vannucci method, where the right common carotid artery is 
cauterized followed by exposure to reduced oxygen air.  When injury is induced early in 
life (between postnatal (P)1-5) neuropathologies typical of premature birth are modeled.  
When injury is induced later in the neonatal period (between P7-12) neuropathologies 
typical of those seen in term injured infants are modeled.   The current study sought to 
characterize the similarities/differences between outcomes following early (P3) and late 
(P7) HI injury in rats.  Male rats with both types of HI injuries, as well as controls, were 
tested on a variety of behavioral tasks in both juvenile and adult periods.  Results showed 
that P7 HI animals displayed deficits on motor learning, rapid auditory processing, and 
learning/memory tasks, as well as a reduction in volume of various neuroanatomical 
structures, when compared to P3 HI and sham animals.  Interestingly, P3 HI animals 
showed only transient deficits on RAP tasks in the juvenile period (but not in adulthood) 
yet robust deficits on a visual attention task in adulthood as compared to P7 HI animals or 
shams. Also, P3 HI animals did not show any significant reductions in brain volume that 
we could detect.  Combined data suggest that: 1) behavioral deficits following neonatal 
HI are task specific depending on timing of injury; 2) P3 HI injured animals showed 
initial deficits, but then recovery of function on RAP tasks; 3) more widespread 
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behavioral deficits following P7 HI injury co-occur with substantial global tissue loss; 
and 4) deficits in attentional processes in P3 HI subjects might be linked to neural 
connectivity disturbances rather than a global loss of brain volume.  These combined 
findings can be applied to our understanding and follow-up to the differing outcomes for 
neonatal HI injury in premature versus term infants.   
Introduction 
 Hypoxic Ischemic (HI) brain injury can lead to major behavioral and 
neuroantomical morbidity in both premature (born < 37 week gestational age)/very low 
birth weight infants (VLBW; born < 1500 grams; Annibale & Hill, 2008; Volpe, 1997; 
Volpe 2009) as well as term infants suffering from birth complications (Vannucci, 2000).  
In premature/VLBW infants, HI injury can arise following intraventricular-
periventricular hemorrhage (IVH-PVH) due to blood/oxygen loss and tissue compression 
(Volpe, 1997). Other cardiovascular injuries to the preterm brain, such as reperfusion 
failure, can cause ischemia and lead to periventricular leukomalacia (PVL; Volpe, 2001).  
Hypoxic ischemic encephalopathy (HIE) is more commonly diagnosed in term injured 
infants following birth complications that occlude global oxygen delivery to the brain 
(e.g., placental disruptions, cord prolapse, or cord asphyxia; Vannucci 2000).  HI injury 
in preterm infants tends to be more focal, following vascular insult to specific regions 
(Volpe, 2009).  HI injury in premature/VLBW infants also more commonly results in 
white matter tract damage (Volpe, 2009), whereas full-term HI injured infants typically 
show gray matter damage in the cortex, hippocampus, basal ganglia, and/or thalamus 
(Huang & Costilla, 2008; Martinez-Biarge et al., 2011). These differences likely reflect 
the heightened vulnerability of these particular regions at the time of injury.    
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 Although the cause and location of injury can differ between premature and full-
term injured infants, both populations show a wide variety of subsequent behavioral and 
cognitive deficits. For example both populations exhibit deficits in language (Jansson-
Verkasalo et al., 2004; Steinman et al., 2009), learning and memory (Briscoe et al., 1998; 
Gimenez et al., 2004; Luu et al., 2011; Luu et al., 2009; Vicari et al., 2004), visual 
attention (Fazzi et al., 2009; Mercuri et al., 1997; Mercuri et al., 1999), and motor 
coordination tasks (Cho et al., 2013; Kono et la., 2011; Mercuri et al., 2003; Mercuri et 
al., 2004; van Haastert et al., 2004).  
 With specific regard to language abilities, VLBW children show deficits on 
standardized language tasks (Ortiz-Mantilla et al., 2008) as well as sustained deficits on 
language comprehension and language production at 4 years old (Jansson-Verkasalo et 
al., 2004).  Furthermore, at age 6 these same subjects showed alterations in mismatched 
negativity during a naming task and showed difficulty in preattentively discriminating 
changes in syllables  (Jansson-Verkasalo et al., 2004).  Additionally, meta-analysis 
revealed that premature/VLBW infants display poorer performance on spelling, reading, 
and verbal fluency tasks compared to healthy term control children (Aarnoudse-Moens et 
al., 2009). In related work, term infants diagnosed with HIE at birth showed verbal IQ 
deficits at 4 years old, and lower scores were associated with increased degree of injury 
(Steinman et al., 2009).  Additionally, full-term injured infants diagnosed with moderate 
HIE showed receptive language, reading and spelling deficits in childhood as compared 
to healthy full term controls (Badawi et al., 2001).  Furthermore, the degree of watershed 
(global) brain injury at birth (measured by MRI) negatively correlated with verbal IQ 
scores in HIE children tested at 4 years old (Steinman et al., 2009).  Although many 
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different processes are involved in language development, one proposed mechanism that 
might lead to later language deficits is an underlying impairment in rapid auditory 
processing (RAP).  RAP references the ability to discriminate differences between 
rapidly presented auditory cues, such as formant transitions (e.g., /ba/ versus /da/) or stop 
constants with short duration cues. Deficits are typically not restricted to the verbal 
domain, and can also be seen using non-verbal acoustic stimuli (thus making tasks 
amenable to pre-lingual infants).  In fact, studies have demonstrated that infants with 
severe PVL lesions (diagnosed at birth) showed deficits on RAP tasks later in childhood 
(Downie et al., 2002).  Furthermore, deficits in RAP early in life correlated with and were 
predictive of later language impairments in children at risk for language disorders, as well 
as in controls (Benasich et al., 2002; Choudhury et al., 2007).   
 With regard to memory abilities, children with HI injury also show a variety of 
deficits.  Children born extremely prematurely showed deficits on short term, non-word 
and digit span memory tasks as compared to healthy full term controls (Lubsen et al., 
2011).  Furthermore, children diagnosed with PVL also showed deficits on short term 
memory tasks (Briscoe et al., 1998), working memory tasks (Vicari et al., 2004), and 
showed lower scores on the Weschler Memory Scale in childhood  (Gadian et al., 2000).   
Additionally, children born prematurely and who showed poorer performance on a spatial 
memory task also exhibited decreased activation in the caudate nucleus as measured by 
fMRI (Curtis et al., 2006).  Term injured populations with severe HI injury (diagnosed at 
birth and tested later at 7 years old) further demonstrated deficits on various memory 
tasks, including memory for names, narrative memory, sentence repetition, and 
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“everyday memory tasks,” when compared to children diagnosed with only mild to 
moderate insults (Marlow et al., 2005).  
 Regarding visual attention (i.e., the ability to survey a scene, locate, and recognize 
an object of interest, and decide an appropriate plan for that object), HI injured children 
also show a variety of deficits.  For example, children diagnosed with PVL and tested on 
a variety of visual perception tasks in childhood showed impairments on visual memory, 
visual recognition and visual spatial tasks (Fazzi et al., 2009). In a related study, 
premature children who showed attention deficits also showed dorsal stream alterations 
on an fMRI, and these deficits correlated with the severity of injury (Atkinson et al., 
2008).  With regards to term injury, children diagnosed with HIE and tested at two years 
old showed abnormalities on a fixation task, as well as wide-spread brain injury (Mercuri 
et al., 1997; Mercuri et al., 1999).  
    Finally, motor impairments are also seen in children with HI injury.  For 
example, premature children diagnosed with PVL at birth who went on to develop 
cerebral palsy also showed gross motor impairments that correlated with the severity of 
white matter lesions (Cho et al., 2013). Cystic PVL and IVH (diagnosed at birth) was also 
found to correlate with the severity of cerebral palsy at three years of age (Kono et al., 
2011).  In term born children suffering from HI, studies have demonstrated that at 5-6 
years old, the severity of basal ganglia damage is associated with more severe motor 
outcomes (including quadriplegia and hemiplegia; Mercuri et al., 2003; Mercuri et al., 
2004; van Haastert et al., 2004)  Furthermore, HIE diagnosed children showed behavioral 
asymmetry on neurological examinations and poorer scores on tasks assessing 
neuromotor functions (Mercuri et al., 2004).   
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 Given the wide range of behavioral deficits following neonatal HI injury in 
premature and full term injured infants, animal models can provide a mechanism for 
insight into variables related to behavioral and anatomical outcomes. Using the Rice-
Vannucci method (Vannucci & Vannucci, 2005), the induction of HI in rat pups between 
postnatal day (P) 1-5 has been found to lead to patterns of brain injury comparable to that 
seen in premature infants (Scafidi et al., 2009).  When HI is induced between P7-10, 
however, resulting injury resembles that associated with term birth HIE (Vannucci & 
Vannucci, 2005) - - specifically, with animals showing more gray matter damage.  Like 
HI injured infants, neonatal HI injured rodents show variety of behavioral deficits and 
neuroanatomical pathology.  For example, in regards to RAP, male rodents that had HI 
injury induced on P7 showed deficits on RAP tasks in both juvenile and adult periods. 
These findings could possibly reflect outcomes related to language deficits in human 
neonatal HI populations (Alexander et al., 2013; Hill et al., 2011; McClure et al., 2005; 
McClure et al., 2005; McClure et al., 2006).  These animals also showed gray matter 
damage, particularly in the cortex and hippocampus, along with enlarged ventricular size 
as compared to non-injured animals in post mortem histological analysis (Alexander et 
al., 2013; McClure et al., 2005; McClure et al., 2005; McClure et al., 2006).  In addition 
to RAP deficits, P7 HI injured rodents also show deficits on a variety of learning and 
memory tasks.  On the Morris Water Maze (MWM) task (a measure of spatial memory), 
previous studies have demonstrated poorer performance for P7 HI injured animals 
compared to shams (McClure et al., 2006; Alexander et al., 2013; Arteni et al., 2003l 
Declour et al., 2012; Ikeda et al., 2001; McClure et al., 2007).  P7 HI injured animals also 
show deficits on a choice reaction time task (Ikeda et al., 2001), on a place learning task 
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(Arteni et al., 2003), and on a spatial working memory task (Arteni et al., 2003; Ikeda et 
al., 2001).  Furthermore, P7 HI injured animals showed reductions in hippocampal 
volume in post mortem histological analysis (McClure et al., 2006; McClure et al., 2007).   
Sensorimotor deficits are also seen following HI injury.  Rodents with induced bi-
lateral artery occlusion on P4 showed deficits on righting reflex, wire hanging, and 
locomotor activity (Fan et al., 2005).  Animals also showed a decrease in mature 
oligodendrocytes and impaired myelination (Fan et al., 2005).  In a P3 HI rodent model, 
injured animals showed disorganized barrel patterns in the somatosensory cortex, and by 
P10, HI animals showed no somatosensory evoked potentials on the ipsilateral side of 
injury (Quairiaux et al., 2010).  By P21, evoked potentials were apparent but were 
reduced compared to the contralateral hemisphere (Tuor et al., 2001).  Additionally, 
following P7 HI, injured animals showed deficits on fine motor control tasks at 3 months 
old, and fMRI showed less activation of the sensory motor cortex in response to left and 
right forepaw stimulation (Tuor et al., 2001).  Furthermore, P7 HI injured animals 
showed deficits on the righting reflex, gait reflex, muscle power, motor coordination, and 
limb placing compared to shams (Lubics et al., 2005; Pazaiti et al., 2009), along with a 
loss of volume in the cortex, thalamus, and striatum (Pazaiti et al., 2009).   
There is limited data investigating visual attention deficits following neonatal HI 
injury.  One study showed animals with a P7 HI injury showed deficits on percent correct 
responses, choice reaction time, and the number of lever presses compared to sham 
treated animals (Ikeda et al., 2005).  However, these animals were tested using an operant 
paradigm where animals were required to press one of two levers associated with a light 
stimulus (Ikeda et al., 2005).  Another commonly used task to assess visual attention 
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abilities in rodents is a 5-choice serial reaction time (5-CSRT) task, where animals are 
trained to respond to a light stimulus with a nose poke for a food reward when the correct 
association is made (Bari et al., 2008).  This paradigm could also be applied to assess 
possible visual attention deficits in neonatal HI injured rodent models.  
 Although there are a wide variety of animal studies demonstrating the effects of 
neonatal HI injury (both in premature and term injured models (separately)), there are 
few studies that have directly compared “premature” (P1-3) versus “full-term” (P7-10) 
HI injury as a function of resulting behavioral deficits and neuropathology.  In one study, 
investigators did find a difference in the neuro-inflammatory profile following early and 
late neonatal HI injury in rats.  Specifically, when HI injury was induced on P1, the 
resulting inflammatory profile was “limited,” that is, inflammatory responses were absent 
or down regulated, but if a response was present (such as interleukin (IL)-1β and MCP-
1), profiles were typically more prominent in white matter (Brochu et al., 2011).  In 
contrast, animals that had HI injury induced on P12 (corresponding to term) showed a 
much stronger neuro-inflammatory profile, with inflammatory mediators such as IL-1β 
increased eight fold (as compared to TNF-α).  Additionally, this dramatic increase in 
inflammatory response was associated with blood brain barrier leakage and massive 
neurophil infiltration (Brochu et al., 2011), which could relate to a heightened incidence 
of bleeds.  In a related study investigating the effects of P1 and P7 HI injury in rodents, 
animals that had HI induced on P1 showed deficits on a RAP task only juvenile periods, 
but not in adulthood, where-as P7 HI injured animals showed persistent RAP deficits 
across both juvenile and adult periods (McClure et al., 2006).  Furthermore, P1 HI 
injured animals showed no observed neuroanatomical alterations as compared to shams, 
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where-as P7 HI subjects showed significant decrements in right cortical, hippocampal, 
and corpus callosum volume (McClure et al., 2006).  The current study sought to explore 
in greater detail the differences between a P3 HI and P7 HI injured rodent model on a 
variety of behavioral (RAP, learning/memory, motor, and visual attention), tasks as well 
as neuroanatomical pathology.  We chose P3 rather than P1 because it is sill within the 
window of a human premature model, yet surgical outcomes are improved.  We 
hypothesized (based on prior findings) that P7 HI injured animals would continue to 
show persistent deficits on behavioral tasks across the lifespan, as well as substantial 
neuroanatomical pathology, but that the P3 HI injured animals would show only 
“moderate” and possibly transient behavioral deficits as compared to P7 HI animals. We 
also predicted a preservation of neuroanatomical volumes in P3 as compared to P7 HI 
animals.    
Methods 
 Time-mated female Wistar rats were ordered from Charles River Laboratories and 
were shipped to the University of Connecticut on embryonic day (E) 8 to minimize 
prenatal stress effects on the feti.  Upon birth (P1), pups were culled into litters of 10 (8 
males and 2 females).  Only males were used in the current study because of known sex-
specific differences in the neonatal HI model that are evident at both the behavioral and 
nauroanatomical levels (Hill et al., 2012).  In brief, deleterious effects of HI are 
consistently found to be more robust in males.     
 HI injury was induced on either P3 or P7, and this was assigned within litter.  HI 
selected pups were anesthetized with isoflurane (2.5%) and a longitudinal mid-line 
incision was made in the neck.  The right common carotid artery was located, separated 
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from surrounding tissue, and completely cauterized.  The incision was then sutured and 
animals were given a footpad injection indicating their specific treatment condition.  
Sham selected animals (also assigned within litter) were treated in the same manner, 
however there was no manipulation of the carotid artery.  Approximately two hours after 
surgery (allowing for recovery and for the pups to feed), HI assigned animals were placed 
in an airtight chamber (sitting on a heating pad and under a warming lamp) containing 
8% humidified oxygen (balanced with nitrogen) for 120 minutes.  Sham animals were 
placed in a similar container exposed to normal room air. All treatment conditions were 
balanced across litters.  All pups were then returned to the dam, and remained there until 
weaning.  At P21, pups were weaned from their mother and double housed with like-
treated animals.  On P55, animals were single housed for the duration of testing.  Final 
N’s included: P3 HI, n=14; P7 HI, n=14; P3 sham, n=6; P7 sham, n=6 (the n in each 
sham group was smaller due to an assumption the two groups would be pooled for 
analysis).   
 Behavioral Testing 
 Motor Coordination and Learning (P28-P32): 
  Rota-Rod: To assess motor coordination and learning in the juvenile 
period, animals were tested on a Rota-Rod task where they were required to remain stable 
on a rotating drum.  Animals were placed on the rotating drum which was set to 
accelerate from 4 rotations per minute (rpm) to 44 rpm over the span of 5 minutes.  
Subjects were given two trials per day for 5 days, and the latency for the subject to fall 
from the rotating drum was recorded for each trial (in seconds).  Average latency was 
used for analysis.  
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 Auditory Discrimination Testing (P34-38; P60)  
   Startle Reduction:  The startle reduction paradigm utilizes the subject’s 
acoustic startle reflex (ASR).  An ASR is a relatively large motor response to a startle 
eliciting stimulus (SES; or as implemented here, a 105 dB white noise burst).  When the 
SES is coupled with a benign acoustic stimulus presented just prior to the burst, the 
animal exhibits what is commonly known as pre-pulse inhibition.  This procedure 
provides a measure of the animal’s ability to detect the cue based on the magnitude of the 
startle attenuation elicited by the prepulse cue (see Fitch et al., 2008 for review).  The 
magnitude of the animal’s startle response on cued versus uncued trials (as a function of 
cue properties) can thus provide an index of detection of the pre-SES cue (and thus 
discrimination thresholds).     
  Apparatus:  During auditory testing each subject was placed on a Med 
Associates PHM-225B load cell platform in a black polypropylene cage in a quiet testing 
room.  Output voltage from each platform was sent through the PHM-250-60 linear load 
cell amplifier and into a Biopac MP 100A-CE Acquisition system.  This system was 
connected to a Power Macintosh G3 computer, which records the amplitude of each 
subject’s startle reflex using Acknowledge Software.  Auditory stimuli were generated on 
a Pentium III Dell PC with custom programmed software and a Tucker Davis 
Technologies (RP2) real time processor, amplified by a Niles SI-1260 System 
Integrations Amplifier.  The sound programs were delivered through 10 calibrated 
Cambridge Soundworks MC 100 loudspeakers placed 53 cm above the platforms, and 
adjusted to provide acoustic comparability at each station (as measured by dB SLP).  
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  Single Tone PPI Procedures: The single tone task consisted of 103 cued or 
uncued trails.  Trials were presented in random order, and animals were tested for two 
sessions (once in the juvenile period (P33) and once in adulthood (P57)).  The single tone 
procedure was used to assess any underlying hearing or pre-pulse inhibition (gating) 
deficits that might confound further testing results.  Uncued trials consisted of a silent 
background followed by the SES.  On cued trials, a 75-dB, 7-ms, 2300-Hz tone was 
presented 50 ms before the SES.   
  Silent Gap (SG) 0-100 PPI Procedures: The SG 0-100 procedure 
consisted of 299 cued or uncued trials per session.  All animals were tested on one 
session/day for 4 consecutive days in the juvenile period (4 days), and only one day in 
adulthood (1 day).  For all trials, a continuous background broadband white noise (75 dB) 
was played.  On uncued trials, the SES was embedded in the background white noise.  On 
cued trials, a gap in the white noise varying in duration from 2-100 ms was presented 50 
ms before the SES.  Attenuation score (Att) for each subject and for each gap were used 
for analysis.  
 Learning and Memory Testing 
 Prior to maze testing, animals were assessed on a one-day water escape task to 
screen for general motor deficits that might confound subsequent results.  The water 
escape task involved the use of an oval tub (40.5 in x 21.5 in) filled with room 
temperature water, and a visible escape platform at one end.  Animals were placed in the 
water at the opposite end of the tub from the platform, and were timed until they swam 
and climbed onto the platform.  Latency to escape was recorded for each animal. All 
maze testing took place in adulthood.   
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 Morris Water Maze (MWM; P83-87):  Spatial learning/memory was evaluated 
using the MWM.  Maze testing took place for 5 consecutive days in a 48-inch diameter 
hard black plastic tub, with a six-inch diameter escape platform submerged right below 
the water line (so that is was not visible to the subjects).  On each trial, the escape 
platform was located in the same quadrant of the tub, and the tub was surrounded by 
various extra-maze cues in the room (painted shapes on the wall, lights, the 
experimenter).  There were no intra-maze cues, forcing subjects to use a spatial strategy. 
Each testing day consisted of four trials in which the animal’s start position (north, south, 
east, west) was varied.  The start position never repeated in the same day, and the order 
varied randomly between testing days.  The animal’s trajectory was recorded with a Sony 
Digital 8 video camera, which was connected to a Dell Dimensions E21 computer. 
SMART Version 2.5 tracking software was used to record the animal’s latency 
(measured in sec) to the platform, as well as average velocity (measured in cm/sec).  For 
each trial, the animal was given 45s to locate and climb onto the submerged platform. If 
the animal failed to reach the platform it was gently guided to the platform and allowed to 
sit for 5s before being removed.  Total latency to reach the platform (across all four trials 
per day) was used for analysis.  
  Non-Spatial Water Maze (NSM; P91-95): NSM testing took place in the same 
48-inch diameter hard plastic tub, with the same six-inch diameter invisible escape 
platform.  However in this paradigm, cues directing the animal to the escape platform 
were located intra-maze rather than in the outside room (and in fact the platform was 
moved to dissociate it from extra-maze cues).  The four different cues consisted of a 
background with black and white vertical lines, horizontal lines, diagonal lines to the left, 
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or diagonal lines to the right.  Each cue was attached in a different quadrant in the maze 
via velcro.  The order of the intra-maze cues was changed randomly at the beginning of 
each testing day.   On each trial, the escape platform was located in a different quadrant 
adjacent to a single positively associated intra-maze cue (always the black and white 
vertical lines).  Thus, the internal maze cues were shifted relative to the room across 
trials, but the target cue indexing the platform remained constant.  The start position of 
the animal for each trial also remained constant.  The animal’s trajectory was again 
recorded via video camera, and latencies/velocities were ascertained with SMART 
version 2.5 computer software.  For each trial, the animal was given 45s to locate and 
climb onto the platform.  If the animal did not reach the platform in the allotted amount 
of time they were gently guided to it and allowed to sit on the platform for 5s before 
being removed.  Total latency to reach the platform (across all four trials per day) was 
used for analysis.  
 Visual Attention (P100-140): Animals were tested on a 5-choice serial reaction 
time task in order to assess visual attention.  For a week prior to testing, animals were 
placed on a restricted diet (5 grams/100 grams of body weight per day).  The testing 
chamber consisted of 5-square holes on a curved wall of the operant box, and a pellet 
dispenser located on the opposite wall.  While in the testing chamber, animals were 
required to attend to all five holes and correctly identify the illuminated hole with a nose 
poke.  If correctly identified, the animal was rewarded with a sugar pellet (45 mg, 
BioServe).   
 Animals were gradually trained on progressively harder tasks, and training began 
with a day of habituation training followed by a day of nose-poke training.  Visual 
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attention training tasks included (listed in order of difficulty): 60s-stimulus duration (light 
on); 30s-stimulus duration; 10s-stimulus duration; and 5s-stimulus duration.  All animals 
were moved on to the next training task together when all group averages reached 70% 
correct responses (Schneider et al., 2011).  For all training tasks, the inter-trial interval 
was held constant at 5s, but the position of the light for each trial varied.  Following the 
completion of training, animals were tested for 5 days on a variable inter-trial interval 
(VITI) task.  In the VITI task, the position of the illuminated hole and the inter-trial 
interval (duration) varied randomly with a fixed stimulus duration of 10s (light on).  This 
was considered the most difficult phase because the lack of a fixed interval made the 
illumination (targets) more unpredictable. Response latencies to the correct choice and 
percent correct responses were measured (recorded) and analyzed.    
 Histological Preparation: Upon the completion of behavioral testing, all animals 
were transcardially perfused.  Animals were weighed and deeply anesthetized with an 
intraperitoneal (i.p.) injection of ketamine (100 mg/kg) and xylazine (15 mg/kg).  
Animals were perfused with .9% saline followed by 10% buffered formalin.  Brain were 
removed from the skull and post-fixed in 10% buffered formalin.   
 At least 24 hours after fixation, brains were placed in 30% sucrose (mixed with 
distilled water) solution for 24 hours for cryoprotection prior to slicing.  Brain tissue was 
sliced at 60 µm on a cryostat.  Every third slice was saved and mounted on a slide in 
sequential coronal sections through the whole brain.  Cresyl Violet staining procedures 
were used to prepare brain tissue for volumetric analysis.   
 Volumetric/Area Analysis: Using StereoInvestigator software, volumes of the 
right and left cortex, hippocampus, lateral ventricles, and striatum (the caudate and 
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nucleus accumbens) were collected.  Volumes were calculated using the Cavaleri’s 
Estimator.  Additionally, mid-sagittal area of the corpus callosum was reconstructed 
using the same StereoInvestigator software.  Every other mounted section was counted, 
resulting in 16-18 representative sections throughout the brain.  All measurements were 
performed blind to Treatment group.  
 Statistical Analysis: All statistical analyses were performed using SPSS 15.0 
software and an alpha criterion of 0.05.  Two-tailed analyses were used unless otherwise 
stated. Preliminary analyses compared scores for the two sham groups (P3 and P7 sham) 
on a variety of measures, and no significant differences were seen.  Therefore, these 
groups were pooled for all analyses to create a sham group of n=12 for all analyses.  For 
each task, the three groups were compared using analysis of variance (ANOVAs) with 
multiple levels of Treatment.  Additionally, based on specific a priori hypotheses, 
planned comparisons were also performed (as a function of Treatment) between paired 
groups.  The following specific comparisons were made: P3 HI versus sham, P7 HI 
versus sham, and P3 HI versus P7 HI.   
 Repeated measures ANOVA were used to analyze behavioral data for each task.  
For Rota-Rod, variables included Treatment (3 levels) and Day (5 levels).  For the RAP 
task, variables included Treatment (3 levels), Day (4 levels for juvenile testing; Day was 
not a variable for adult silent gap since only one day was performed), and Gap (9 levels).  
For maze testing (both MWM and NSM) variables included Treatment (3 levels) and Day 
(5 levels).  For the visual attention task, variables included Treatment (3 levels) and Day 
(6 levels for the 5s stimulus duration task and 4 levels for the VITI task).  Univariate 
ANOVA was used to analyze histology, specifically to compare right hemisphere and left 
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hemisphere volumes between groups.  For the corpus callosum, total area is reported as 
measured using StereoInvestigator software.  Graphs presented in the results section 
show average scores for each Treatment condition.  It should be noted that on the RAP 
task, lower ATT score indicate better performance and higher scores indicate poorer 
performance, as well as the Rota Rod task where longer latencies reflect better motor 
skills.  On the MWM & NMS, lower scores are better (reflecting faster location of the 
platform.   
Results 
 Rota-Rod (P28-32): A 5 (Day) x 3 (Treatment) repeated measures ANOVA 
revealed a significant overall Treatment effect [F(2,37) = 5.247, p<.05].  Additionally, a 
significant Day x Treatment interaction was found [F(8,148) = 2.718, p<.05] (Figure 1), 
reflecting delayed learning in P7 HI on days 3 and 4.  Follow-up analyses revealed no 
significant Treatment effect between P3 HI and shams [F(1,24) = .007, p>.05].  There 
was, however, a significant Treatment effect found between P7 HI and shams [F(1,24) = 
12.776, p<.01], with P7 HI performing worse.  Independent samples t-tests revealed 
specific differences on Day 3 [t(24) = 2.461, p<.05] and Day 4 [t(24) = 3.199, p<.05], 
with P7 HI performing worse than shams.  Finally, a 5 (Day) x 2 (Treatment) repeated 
measures ANOVA revealed a significant Treatment effect between P3 HI and P7 HI 
[F(1,26) = 7.261, p<.05] again with P7 HI performing worse.  Follow up independent t-
tests revealed differences on Day 2 [t(26)=2.334, p<.05], on Day 3 [t(26)=2.132, p<.05] 
and Day 4 [t(26) = 2.985, p<.05].   
  Rapid Auditory Processing:  
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 Normal Single Tone (P30 & P58): On the normal single tone task, there was a 
significant Treatment effect found in both juveniles [F(2,37) = 3.753, p<.05] and adults 
[F(2,39) = 3.812, p<.05].  This could be due to a difference in body weight between the 
three groups, with HI P7 animals showing lower average body weights than the two other 
treatment groups.  Nonetheless all further RAP analyses used the normal single tone Att 
score as a covariate to remove any confounds due to this difference.  
  Silent Gap 0-100 Juvenile (P34-38): On the SG 0-100 task, a 4 (Day) x 9 (Gap) x 
3 (Treatment) repeated measures ANOVA revealed a significant overall Treatment effect 
[F(2,14) = 7.482, p<.05]1 (Figure 2a). One tailed tests were used in some of the 
subsequently analyses based on prior reports of directionality in results for specific 
treatments on this task from prior research (McClure et al., 2006).  Follow up repeated 
measures ANOVA also revealed a significant difference between P3 HI and shams 
[F(1,9) = 3.935, p<.05, one-tailed], with P3 HI performing worse than shams.  
Additionally, a highly significant difference was seen between P7 HI and shams [F(1,9) = 
14.785, p<.05] with P7 HI performing worse. There was no significant difference 
between P3 HI and P7 HI groups [F(1,9) = 4.405, p>.05]. 
  Silent Gap 0-100 Adulthood (P60): A 9 (Gap) x 3 (Treatment) repeated measures 
ANOVA revealed an overall Treatment effect [F(2,36) = 5.799, p<.05]2 (Figure 2b).  
Interestingly, in adulthood, there was no longer a significant difference seen between P3 
HI and shams [F(1,23) = .201, p>.05].  A 9 (Gap) x 2 (Treatment) repeated measures 
                                                
1 It should be noted that on one day of testing, computer malfunctioning resulting in a 
loss of data for some animals, thus lead to differences in degrees of freedom for juvenile 
RAP.  
2 The difference in degrees of freedom for adult SG 0-100 analysis reflects the use of 
NST adult ATT score as a covariate. 
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ANOVA did however show a significant difference between P7 HI and shams [F(1,23) = 
3.699, p<.05, one tailed), and between P3 HI and P7 HI groups [F(1,25) = 10.085, p<.05], 
with P7 HI performing worse compared to both groups.    
  Learning/Memory 
  Water Escape (P80):  A Univariate ANOVA revealed no differences between 
groups on the water escape task [F(2,37) = 2.024, p>.05], indicating a lack of underlying 
differences in ability to locate the visible escape platform, or in swimming.   
  Morris Water Maze (P83-87): For the MWM a 5 (Day) x 3 (Treatment) repeated 
measures ANOVA showed no significant differences in swim speed [F(2,37) = .502, 
p>.05] between the three groups.  This again suggests there were no underlying 
swimming deficits in either HI group that might confound results.  For total latency to the 
platform, a 5 (Day) x 3 (Treatment) repeated measures ANOVA revealed a significant 
Treatment effect [F(2,37) = 9.959, p<.05] (Figure 3a).  Follow up repeated measures 
ANOVA revealed no differences between P3 HI and shams [F(1,24) = .00003, p>.05].  
There was, however, a significant difference found between P7 HI and shams [F(1,24) = 
10.098, p<.01] with P7 performing worse. We also found a differences between P3 HI 
and P7 HI groups [F(1,26) = 10.985, p<.05], again with P7 HI performing worse than 
both groups.   
 Non-Spatial Maze (P91-95): For the NSM a 5 (Day) x 3 (Treatment), repeated 
measures ANOVA revealed no differences in swim speed between groups [F(2,37) = 
2.223, p<.05].  For total latency to reach the platform, a 5 (Day) x 3 (Treatment) repeated 
measures ANOVA revealed a significant overall Treatment effect [F(2,37) = 12.048, 
p<.01] (Figure 3b).  Follow up repeated measures ANOVAs revealed no difference 
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between P3 HI and shams [F(1,24) = 3.385, p>.05].  However, a 5 (Day) x 2 (Treatment) 
repeated measures ANOVA revealed a significant difference between P7 HI and shams 
[F(1,24) = 9.232, p<.01] with P7 HI performing worse than shams.  There was also a 
significant Treatment effect between P3 HI and P7 HI [F(1,26) = 16.835, p<.01], again 
with P7 HI performing worse.   
Visual Attention (P100-140):3 
  5-second stimulus duration: On the 5-second stimulus duration task, a 6 (Day) x 
3 (Treatment) repeated measures ANOVA revealed a significant overall effect of 
Treatment [F(2,36) = 3.122, p<.05] (Figure 4a).  Follow up repeated measures ANOVAs 
revealed a significant difference between P3 HI and shams [F(1,23) = 5.845, p<.05] with 
P3 HI performing worse.  There was no significant difference between P7 HI and shams 
[F(1,22) = .570, p>.05] or between P3 HI and P7 HI [F(1,25) = 2.64, p>.05] although 
measures were in the expected direction (P7 HI worse).  There was also no significant 
difference in average latency to make a correct response [F(2,36) = 2.596, p>.05].  
 Variable Inter-Trial Interval (VITI): A 4 (Day) x 3 (Treatment) repeated measures 
ANOVA revealed a trend towards an overall Treatment effect [F(2,29) = 2.569, p=.09]4. 
Additionally, there was a significant Day x Treatment interaction [F(6,87) = 2.287, 
p<.05] (Figure 4b), suggesting that over days, higher performing Treatment groups 
improved more dramatically than poorer performing groups. Follow up repeated 
measures ANOVAs revealed a significant Treatment effect between P3 HI and shams 
[F(1,18) = 5.49, p<.05], and a significant Day x Treatment interaction [F(2,54) = 3.056, 
                                                
3 For visual attention analysis, differences in degrees of freedom reflect one subject 
dropped from testing due to the time constraints during a testing day  
4 Differences in degrees of freedom in the inter-trial interval task were due to the fact that 
on one day of testing there was a computer malfunction resulting in a loss of data.   
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p<.05] with P3 HI performing worse.  Independent samples t-test revealed significant 
differences on Day 1 [t(23) = -2.562, p<.01], Day 2 [t(23) = -3.010, p<.01] and Day 3 
[t(23) = -2.431, p<.05].  Additionally, repeated measures ANOVA revealed a trend for a  
Day x Treatment interaction between P3 HI and P7 HI groups [F(3,66) = 2.68, p=.053].  
Follow up independent samples t-tests revealed significant differences on Day 1 [t(26) = -
2.199, p<.05] and a trend on Day 2 [t(22) = -1.780, p=.08] with P3 HI performing worse.  
There was no significant difference between P7 HI and shams [F(1,18) = 1.169, p>.05], 
though means were in the expected direction (P7 worse).  There was no also significant 
difference in average latency to make a correct response [F(2,36) = 2.135, p>.05].    
 Histology 
 Ventricular Volume: A Univariate ANOVA revealed a significant Treatment 
effect for right ventricular volume [F(2,39) = 18.77, p<.001], but no Treatment 
differences for left ventricular volume [F(2,39) = 2.20, p>.05] (Figure 5a).  Follow-up 
independent sample t-tests revealed a significant difference specifically between P3 HI 
and P7 HI [t(26) = -4.529, p<.001] and between P7 HI and shams [t(24) = -4.137, 
p<.001], with P7 HI animals showing a higher rate of right ventriculomegaly.  There was 
no significant difference between P3 HI and shams in right ventricular volume.   
 Cortical Volume: A Univariate ANOVA revealed a significant Treatment effect 
for right cortical volume [F(2,39) = 33.9, p<.001] but no effect on left cortical volume 
[F(2,39) = .923, p>.05] (Figure 5b).  Follow-up independent sample t-test revealed a 
significant difference between P3 HI and P7 HI [t(26) = 6.089, p<.001], and between P7 
HI and shams [t(24) = 6.063, p<.001], with P7 HI animals showing significantly smaller 
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right cortical volume than both other groups.  There was no difference between P3 HI and 
shams. 
 Hippocampal Volume: A Univariate ANOVA revealed a significant Treatment 
effect for right hippocampal volume [F(2,39) = 25.58, p<.001] but no effect on left 
hippocampal volume [F(2,39) = 1.83, p>.05] (Figure 5c).  Follow-up independent 
samples t-tests revealed a significant difference between P3 HI and P7 HI [t(26) = 6.531, 
p<.001], and between P7 HI and shams [t(24) = 4.675, p<.001], with P7 HI showing 
significantly smaller right hippocampal volume than both other groups.  There was no 
difference seen between P3 HI and shams.   
 Striatal Volume: A Univariate ANOVA revealed a significant Treatment effect in 
right striatal volume [F(2,39) = 34.08, p<.001], but no significant effect on left striatal 
volume [F(2,39) = 1.19, p>.05] (Figure 5d).  Follow-up independent sample t-tests 
revealed a significant difference between P3 HI and P7 HI [t(26) = 6.021, p<.001], and 
between P7 HI and shams [t(24) = 7.084, p<.001], with P7 HI showing smaller right 
striatal volumes as compared to both other groups.  There was no difference between P3 
HI and shams.    
 Corpus Callosum Area: A Univariate ANOVA revealed a significant Treatment 
effect on corpus callosum area [F(2,39) = 32.364, p<.001] (Figure 5e).  Follow-up 
independent sample t-tests revealed a significant difference between P3 HI and P7 HI [(t) 
= 6.357, p<.001], as well as a difference between P7 HI and shams [t(24) = 6.372, 
p<.001], with P7 HI animals showing smaller area compared to both groups.  Again, 
there was no difference between P3 HI and shams.    
   
 47 
Discussion 
 In the current study, we have replicated prior data (McClure et al., 2006) showing 
that animals with an “early” (preterm equivalent) HI injury show a recovery of function 
on an RAP task compared to animals that received a “late” (term equivalent) injury 
(McClure et al., 2006).  Specifically, animals that had HI injury induced on P3 showed 
deficits on the RAP task in juvenile periods but not in adulthood, whereas P7 HI injured 
animals showed persistent deficits throughout early life and adulthood on the RAP task.  
Furthermore, P7 HI injured animals showed deficits on learning/memory tasks in 
adulthood and a motor learning task in the juvenile period.  These findings also replicate 
previous data showing P7 HI deficits on a variety of learning and memory tasks in male 
rats (McClure et al., 2005; Alexander et al., 2013; Arteni et al., 2003l Declour et al., 
2012; Ikeda et al., 2001; McClure et al., 2007) as well as on sensorimotor tasks (Lubics et 
al., 2005; Pazaiti et al., 2009).  Additionally, we report that P7 HI animals showed a 
reduction in right cortical, hippocampal, and striatal volume along with a reduction in 
corpus callosum area, as compared to P3 HI and shams as well as increases in right 
ventricular size.  Moreover, we report novel findings that, although P3 HI animals show 
transient RAP deficits and no learning/memory or motor learning deficits, they do show 
highly robust deficits on a visual attention task as compared to P7 HI rats.   
 Motor Learning deficits 
 With regards to our motor learning task, P7 HI animals exhibited a clear deficit.  
Specifically, on Days 2, 3, and 4 of testing, P7 HI injured animals spent a significantly 
shorter time on the rotating beam as compared to both P3 HI and sham animals.  
However, there were no differences seen on Days 1 or 5 of testing between the three 
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groups.  This indicates that P7 HI injured animals were able to eventually learn the task, 
but took significantly longer to do so compared to both P3 HI and shams.  This finding is 
important as many experiments use only one day of rotarod testing to assess coordination 
deficits, and our findings suggest that although P7 HI animals are equivalent to shams in 
regard to baseline (naïve) coordination, they do show a delay in motor learning 
(performance improvement) when the task is administered over multiple trials.  In 
clinical literature, infants diagnosed with HIE also show motor impairments, and these 
impairments are believed to reflect to basal ganglia, cortical and/or cerebellum damage 
(Martinez-Biarge et al., 2011; Mercuri et al., 2003; Mercuri et al., 2004).  Specifically, 
HIE children (diagnosed with encephalopathy following term insult) showed significant 
reductions in basal ganglia and thalamic structures, as well as in the internal capsule, as 
measured by MRI. Moreover, these reductions were associated with deficits on 
neuromotor tasks (Martinez-Biarge et al., 2011; Mercuri et al., 2003; Mercuri et al., 
2004).  The current study revealed a similar pattern of brain injury in the P7 HI injured 
group, with evidence of significant reductions in striatal and cortical volume as well as a 
reduction in corpus callosum area.  This extends previous research showing sensorimotor 
deficits in P7 HI injured animals along with cortical, thalamic, and striatal injury (Pazaiti 
et al., 2009).  Interestingly, P3 HI injured animals did not show any deficits on the 
rotarod task, nor any significant reductions in brain volume, even though premature birth 
in human infants is often associated with motor deficits such as cerebral palsy (van 
Haastert et al., 2004).  It may be that due to the relatively small degree of myelination and 
white matter in the small rodent as compared to larger models (e.g., sheep) it is much 
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harder to induce a white matter injury and associated motor deficits comparable to those 
seen in preterm human neonates (Silbereis et al., 2010).  
 Rapid Auditory Processing Deficits 
 With regards to rapid auditory processing deficits, the current study replicated 
previous work showing a recovery of function following early (P1-P3) neonatal HI injury 
(McClure et al., 2006).  That is, while P7 HI injured animals showed persistent deficits 
on the SG 0-100 RAP task in juvenile and adult periods, P3 HI injured animals only 
showed deficits during juvenile RAP testing - - not in adulthood.  Taken together, these 
data show that animals with very early HI injuries (simulating preterm) are more able to 
recover from early RAP deficits compared to HI injuries induced later in life (near term).  
This suggests that neural-reorganization and plasticity following early HI injury may lead 
to more optimal brain re-organization and functional recovery, as well as suggesting that 
neural systems critical to RAP may be less vulnerable to damage following early HI 
insult.  Conversely, P7 HI animals showed widespread brain injury, including volumetric 
reductions in the right cortex, hippocampus, striatum, and increases in right ventricular 
volume, in parallel with persistent behavioral deficits.  Importantly, although the neural 
substrates underlying rapid auditory processing are not as well delineated as the role of 
the hippocampus in spatial memory, these is some evidence that anatomic alterations to 
the medial geniculate nucleus may index RAP deficits (in both humans and animal 
models (Stein, 2001; Alexander et al., in review)).  Thus, it is critical to note that in a 
concurrent publication, we report reductions in cell size in the MGN of P7 HI but not P3 
HI rats as masured fron subjects in the current study (see Alexander et al., in review for 
further discussion of these findings).   
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 Learning/Memory deficits 
In addition, P7 HI injured animals showed significant deficits on both the spatial 
and non-spatial learning/memory tasks in adulthood as compared to P3 HI injured and 
sham animals. Furthermore, P7 HI injured animals also showed significant reductions in 
right striatal and right hippocampal volume.  These anatomic indices may be important 
given the extensive data showing that the hippocampus mediates both spatial navigation 
and memory (Packard et al., 1996; White et al., 2002).  It is possible that reductions in 
right hippocampal volume in the P7 HI injured animals contribute to deficits seen on the 
spatial memory maze.  In the same way, dorsal striatal structures, (such as nucleus 
accumbens) have been suggested to mediate non-spatial navigation and learning (Packard 
et al., 1996; White et al., 2002; Packard et al., 2002).  Thus anatomic disruptions of 
striatum might account in part for the non-spatial memory deficits seen in P7 HI rats.  In 
the clinical literature, term HIE infants with disruptions to the hippocampus and 
associated projections to cortex also showed disrupted memory function and spatial 
processing (Aylward et al., 2005).   
 Visual Attention deficits 
   Interestingly, in stark contrast to behavioral patterns on all other tasks, P3 HI 
animals showed robust deficits on the visual attention task as compared to both sham and 
P7 HI injured animals.  There are no other data that we are aware of demonstrating visual 
attention deficits following preterm neonatal HI injury in rodent models, nor comparing 
behavioral outcome as a function of timing of injury.  However, clinical data shows that 
children born prematurely are clearly at increased risk for ADHD (Aarnoudse-Moens et 
al., 2009; Lindstrom et al., 2011), and attention problems are believed to result from 
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underlying deficits in processing speed, working memory, and/or poor visuospatial 
abilities (de Kieviet et al., 2012; Mulder et al., 2011).  It has been proposed that damage 
to subplate neurons in premature infants with HI injury may results in disruptions to 
fronto-striato-thalamic circuitry, which could, in turn, result in functional deficits in 
attention, modulation of activity, and executive functioning (Aylward et al., 2005).  In 
fact, data show that adolescents born prematurely exhibit deficits on pre-attentive and 
attention tasks (Hall et al., 2008).  Additionally, participants showed dysfunction of the 
frontal cortex as measured by EEG (Hall et al., 2008).  In the current study, P3 HI 
animals did not show any significant volume loss in specific brain regions such as the 
striatum, but attention deficits might reflect specific cellular or circuitry dysfunction 
without global tissue loss.  Alternatively, our anatomic criteria for striatal measurements 
may not have captured specific and focal alterations.   
Timing differences in Neurodevelopment for P3 versus P7  
 In order to interpret the differing pattern of behavioral deficits following early 
versus late HI injury, it is important to review what is know about the neuroanatomical 
areas of susceptibility based on the timing of injury.  That is, the variety of behavioral 
deficits seen in the P7 HI injured animals might be explained by the timing in 
development of affected regions such as the cortex, hippocampus, and striatum. Research 
has demonstrated that at birth, rodent cortical development is in an “elementary” stage, 
and it is not until 6-12 days after birth that the six typical cortical layers become apparent 
(Eayers et al., 1959).  Additionally, rapid dendritic branching occurs around P12 and the 
density of axons increases markedly between P6-18 (Eayers et al., 1959).  In the striatum, 
cell death regulated by apoptosis (measured by TUNNEL) is apparent during the first 
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week of postnatal life - - between P3 and P7 (Maciejewsa et al., 1997).  Furthermore, 
maturation of hippocampal cells does not occur until P15-18 in the neonatal rodent 
(Bayer et al., 1974).  The timing of these developmental processes may contribute to the 
heightened vulnerability of these regions following late HI injury in the rodent.  
Additionally, the development of different cortical catecholimaine and other receptor 
subtypes (e.g., AMPA and NMDA) might also contribute to vulnerability to brain injury 
in cortical regions following late injury.  Specifically, increases in the NMDA receptor 
does not occur in the hippocampus and cortex until late in prenatal development (P7-P12) 
and also continues through postnatal development in the human infant (Rice et al., 2000). 
This is a key temporal event since the NMDA receptor has been implicated in the 
detrimental glutotoxicity effects of the apoptotic cascade following HI injury (Banasiak 
et al., 2000).  This may contribute to a lack of extensive tissue loss in P3 HI injured rats 
as compared to P7 HI rats in the current study.  
Interestingly, P3 HI injured animals showed robust deficits on the visual attention 
task despite a lack of volumetric alterations in key brain structures.  This dissociation is 
not altogether incongruent, since behavioral changes may also result from subtle changes 
in neural circuitry.  For example, a recent study has demonstrated wide spread decreases 
in connectivity strength of intracerebral connections during development in premature 
subjects (Pandit et al., 2013).  To the best of our knowledge, there are few studies 
specifically investigating visual attention ability and neural connectivity in premature 
children.  However other cognitive behaviors (such as language) have been associated 
with altered connectivity in adolescents born prematurely and with no diagnosis of IVH-
PVH.  Here, using both fRMI and DTI, preterm subjects were found to employ neural 
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systems for auditory language that were different from term controls  - - specifically, 
right hemisphere activation that differed from typical left hemisphere language 
processing (Gozzo et al., 2009; Meyers et al., 2010; Mullen et al., 2011).  Preterm 
subjects also showed alterations in resting state connections in executive control 
networks as measured by fMRI (Lubsen et al., 2011).  Although little is known about 
vulnerability of neural connectivity patterns to deleterious changes following preterm 
birth, disruptions here could reflect disruptions in formation or pruning of neural synaptic 
connections (Gozzo et al., 2009).   
Conclusions 
 In conclusion, the current study provides a direct comparison of anatomic and 
behavioral outcomes following comparable HI injury in a P3 (preterm equivalent) rodent 
model and a P7 (term equivalent) rodent model.  On a global level, evidence of 
substantially enhanced inflammatory responses to HI at older neonatal ages could explain 
in part the more severe anatomic and robust behavioral deficits seen in P7 HI subjects 
(Brochu et al., 2011).   However, the transient RAP deficits and robust attention deficits 
seen in P3 HI subjects indicate that some deleterious effects have occurred here as well, a 
finding consistent with clinical evidence of heightened risk for language and attention 
problems among preterm neonates (Aarnoudse –Moens et al., 2009; Lindstrom et al., 
2011).  Importantly, though clinical literature indicates elevated risk for 
cognitive/behavioral difficulties in both preterm HI and term HIE populations, it has been 
difficult to conduct any direct comparisons in outcomes due to the difficulties in 
matching other key variable across these diverse populations.  The current study, 
however, suggests that when all other factors are held constant, HI injury at term likely 
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has far greater long-term consequences than HI injury in preterm infants.  This finding 
heightens the urgency to continue a search for neuroprotective interventions such as 
whole body/head cooling or erythropoietin in term HIE infants (Juul, 2012; Shankaran et 
al., 2007).  However, our findings also show subtle but significant early RAP deficits and 
robust attention deficits in a preterm HI model, heightening the importance of developing 
interventions for this population as well – particularly so for interventions that might 
specifically protect attention systems.  Future studies should examine the specific regions 
and neural processes that are vulnerable following early and late neonatal HI injury, as 
well as further exploring changes in brain connectivity and resulting behavioral deficits 
following preterm birth.   
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Figure 1: A 5 (Day) x 3(Treatment) repeated measures ANOVA revealed a significant 
overall Treatment effect [F(2,37) = 5.247, p<.05] along with a significant Day x 
Treatment interaction [F(8,148) = 2,718, p<.05].  Specifically, significant overall 
Treatment effects were seen between P7 HI and shams [F(1,24) – 12.776, p<.01] with 
specific differences on Day 3 [t(24) = 2.461, p<.05] and Day 4 [t(24) = 3.199, p<.05] 
with P7 HI performing worse.  A significant Treatment effect was also seen between P3 
HI and P7 HI [F(1,26) = 7.261, p<.05] with specific differences on Day 2 [t(26) = 2.334, 
p<.05], Day 3 [t(26) = 2.132, p<.05], and Day 4 [t(26) = 2.985, p<.05] with P7 HI 
performing worse.  There were no difference between P3 HI and shams.  
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Figure 2: A - A 4 (Day) x (Gap) x 3 (Treatment) repeated measures ANOVA revealed a 
significant overall Treatment effect [F(2,14) = 7.482, p<.05} in the juvenile period.  
Specific differences were found between P3 HI and shams [F(1,9) = 3.935, p<.05] with 
P3 HI performing worse, and between P7 HI and shams [F(1,9) = 14.785, p<.05] with P7 
HI performing worse.  B – A 9 (Gap) x 3 (Treatment) repeated measures ANOVA 
revealed a significant overall difference in Treatment [F(2,36) = 5.799, p<.05].  There 
was a specific difference between P7 HI and shams, [F(1,23) = 3.699, p<.05, one tailed] 
and between P3 HI and P7 HI groups [F(1,25) = 10.085, p<.05] with P7 HI performing 
worse.  There was no difference between P3 HI and shams.   
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Figure 3: A – A 5 (Day) x 3 (Treatment) repeated measures ANOVA revealed a 
significant overall Treatment effect [F(2,37) = 9.959, p<.05].  Specific differences were 
seen between P7 HI and shams [F(1,24) = 0.098, p<.01] and P3 HI and P7 HI [F(1,26) = 
10.985, p<.05] with P7 HI performing worse.  There was no difference between P3 HI 
and shams.  B – A repeated measures ANOVA revealed a significant overall Treatment 
effect [F(2,37) = 12.048, p<.01).  Specific differences were seen between P7 HI and 
shams [F(1,24) = 9.232, p<.01] and between P3 HI and P7 HI [F(1,26) = 16.835, p<.01] 
with P7 HI performing worse.  There was no difference between P3 HI and shams.   
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Figure 4: A – A 6 (Day) x 3 (Treatment) repeated measures ANOVA revealed a 
significant overall Treatment effect [F(2,36) = 3.122, p<.05].  Specific differences were 
seen between P3 HI and shams, [F(1,23) = 5.845, p<.05] with P3 HI performing worse.  
There were no differences seen between P3 HI and P7 HI or between P7 HI and shams.  
B – A 4 (Day) x 3 (Treatment) repeated measures ANOVA revealed a trend for an overall 
Treatment effect [F(2,29) = 2.569, p=.09] and a significant Day x Treatment interaction 
[F(6,87) = 2.287, p<.05]. Differences were seen between P3 HI and shams [F(1,18) = 
5.49, p<.05] with specific differences on Day 1 [t(23) = -2.431, p<.05], Day 2 [t(23) = -
3.010, p<.01] and on Day 3 [t(23) = -2.431, p<.05] of testing with P3 HI performing 
worse.  A Day x Treatment interaction was also seen between P3 HI and P7 HI [F(3,66) = 
2.68, p<.05], with specific differences Day 1 [t(26) = -2.199, p<.05] and a trend on Day 2 
[t(22) = -1.780, p=.08] with P3 HI performing worse.  There was no significant 
difference between P7 HI and sham.   
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Figure 5: A – A Univariate ANOVA revealed a significant overall Treatment effect for 
right ventricular volume [F(2,39) = 18.77, p<.001] with specific differences between P7 
HI and shams [t(24) = -4.137, p<.001] and between P3 HI and P7 HI [t(26) = -4.529, 
p<.001] with P7 HI showing higher right ventricle volume.  There was no difference 
between P3 HI and shams, or in left ventricle volume. B – A Univariate ANOVA 
revealed a significant overall Treatment effect right for cortical volume [F(2,39) = 33.9, 
p<.001] with specific differences between P7 HI and shams [t(24) = 6.063, p<.001] and 
between P3 HI and P7 HI [t(26) = 6.089, p<.001] with P7 HI showing smaller right 
cortical volume.  There was no difference between P3 HI and shams, or in left cortical 
volume.  C - A Univariate ANOVA revealed a significant overall Treatment effect for 
right hippocampal volume [F(2,39) = 25.58, p<.001] with specific differences between 
P7 HI and shams [t(24) = 4.675, p<.001] and between P3 HI and P7 HI [t(26) = 6.531, 
p<.001] with P7 HI showing smaller right hippocampal volume.  There was no difference 
between P3 HI and shams, or in left hippocampal volume.  D - A Univariate ANOVA 
revealed a significant overall Treatment effect for right striatal volume [F(2,39) = 34.08, 
p<.001] with specific differences between P7 HI and shams [t(24) = 7.084, p<.001] and 
between P3 HI and P7 HI [t(26) = 6.021, p<.001] with P7 HI showing smaller right 
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striatal volume.  There was no difference between P3 HI and shams, or in left striatal 
volume.  E - A Univariate ANOVA revealed a significant overall Treatment effect for 
corpus callosum area [F(2,39) = 32.364, p<.001] with specific differences between P7 HI 
and shams [t(24) = 6.372, p<.001] and between P3 HI and P7 HI [t(26) = 6.357, p<.001] 
with P7 HI showing smaller callosum area.  There was no difference between P3 HI and 
shams. 
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Abstract 
 Children born prematurely (<37 weeks gestational age) or at very low birth 
(VLBW; <1500 grams) are at increased risk for hypoxic ischemic (HI) brain injuries.  
Additionally, infants born full term can suffer from HI injury resulting from birth 
complications.  In both populations, blood/oxygen delivery to the brain is compromised, 
often resulting in long-term brain damage and later cognitive delays such as deficits in 
language development.  Literature suggests that language delays in specifically language 
impaired (SLI) and also HI populations may be associated with underlying deficits in 
rapid auditory processing (RAP; i.e., the ability to process acoustic differences between 
phonemes in speech).  Notably, other developmental neuropathological populations (e.g., 
dyslexics) also show language-based impairments concurrent with RAP deficits.  Data 
from these populations supporting a relationship between RAP deficits and poor language 
outcomes has led to the formulation of the “magnocellular theory,” specifically 
suggesting that damage to or loss of large magnocellular (or “magno”) cells in thalamic 
nuclei could relate to disruptions in temporal processing of visual (lateral geniculate 
nucleus; LGN) and possibly auditory (medial geniculate nucleus; MGN) information 
(although an anatomically distinct magnocellular sub-division has not been identified in 
the MGN to date).  Moreover, it is purported that damage to this sub-population of cells 
from hypoxia ischemia might underlie or contribute to subsequent RAP deficits, with 
cascading effects on both language and reading development.  In animal models of HI, 
persistent RAP deficits are seen in late HI injured (postnatal (P)7 rodents (who exhibit 
neuropathology comparable to term birth injury)) but not in early HI injured rodents 
(such as P1 or P3 HI animals, who exhibit neuropathology comparable to human pre-term 
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injury).  The current study sought to investigate the average cell size, number of cells, 
and cumulative probability of cell size in the MGN of P3 HI and P7 HI injured male rats 
that previously demonstrated RAP deficits.  Pilot data from our lab (Alexander et al., 
2011) had demonstrated cell size abnormalities (a shift towards smaller cells) in P7 but 
not P1 HI injured animals as compared to shams, and the current finding support this 
result, with evidence of a shift to smaller cells in the right MGN of P7 HI but not P3 HI 
subjects.  Moreover, right cell number was found to correlate with gap detection (fewer 
cells = worse performance (higher attenuation scores)) in P7 HI injured subjects.  These 
findings could be applied to clinical populations, suggesting an anatomic marker that may 
index potential long-term language disabilities in HI injured infants and possibly other at-
risk populations as well.     
Introduction 
 Hypoxic Ischemic (HI) injures are commonly diagnosed in infants born 
prematurely (< 37 weeks gestational age) and/or at very low birth weight (VLBW; < 
1500 grams; Annibale & Hill, 2008; Volpe, 2001; Volpe, 2009).  Additionally, HI 
injuries can arise in term infants suffering from birth complications (e.g., cord prolapse, 
cord asphyxia, or fetal distress; de Vries & Cowan, 2009; Johnston, et al., 2001; Lai & 
Yang, 2011; Volpe, 2001).  In both populations, HI injury reflects a reduction in blood 
and/or oxygen delivery to the brain.  In premature infants, HI brain injuries are related to 
the presence of intraventricular (IVH) /periventricular hemorrhage (PVH), or 
periventricular leukomalacia (PVL; a non-hemorrhagic ischemic injury; Volpe, 2001).  
Injured premature populations predominantly show subsequent white matter (subcortical) 
damage, as well as disruptions of white matter fiber tracts (e.g., cortico-spinal tracts and 
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internal capsule; Nagy et al., 2010).  Conversely, among term infants suffering from HI, 
hypoxic ischemic encephalopathy (HIE) is more commonly diagnosed, characterized by 
global gray matter damage to the cortex, hippocampus, basal ganglia and/or thalamus 
(Jyoti et al., 2006; Huang & Castilla, 2008; Marinez-Biagant et al., 2012; Nosarti et al., 
2008).   
 Although the timing and location of brain injury differs between premature and 
term populations, both show a higher rate of later learning and language deficits as 
compared to healthy counterparts.  For example, children born prematurely required more 
support in spelling, reading and writing, and showed deficits in receptive and expressive 
language skills (Luu et al., 2009; Ortiz-Mantilla, et al., 2008; van Lierde et al., 2009).  At 
two years old, VLBW infants showed significantly lower scores on language 
comprehension tasks, and at four years old these behavioral scores correlated with 
performance on language comprehension, naming, and auditory discrimination tasks  
(Jansson-Verkassaio et al., 2004).  Furthermore, at age 6, these same subjects showed 
alterations on mismatched negativity during naming tasks as well as difficulty in 
preattentively discriminating changes in syllables (Jansson-Verkassaio et al., 2004).  
Similarly, full term injured infants diagnosed with moderate to severe HIE were found to 
show receptive language, reading and spelling deficits as compared to healthy controls 
(Badawi et al., 2001).  Furthermore, the degree of watershed brain injury was found to 
correlate significantly with verbal IQ scores later in life (Steinman et al., 2009).  
Previous research has suggested that deficits in rapid auditory processing (RAP; 
processing mechanisms that are required to distinguish the difference between speech 
phonemes) may underlie disruptions in subsequent development of complex language 
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and reading (Bradley et al, 1983; Farmer et al., 1985; Hari et al., 1996, 2001; Kraus et al, 
1996; McAnally et al., 1996; McCrosky et al., 1980; Stein 1993; Neville et al., 1993; 
Robin et al, 1989; Paterson et al., 2006; Tallal et al., 1980, 1985, 1993; Witton et al., 
1998; Wright et al., 1997; Benasich et al., 2002; Choudhury et al., 2007).  Specifically 
regarding HI injured populations, VLBW children diagnosed with severe PVL were 
found to score significantly lower on tasks requiring auditory temporal processing 
(Downie et al., 2002).  Furthermore, using path analysis , these authors showed a 
relationship between auditory temporal processing and reading ability suggesting these 
two variables are indirectly related through cascading events (Downie et al., 2002).   
 To date, among neonatal HI injured populations, no specific anatomical marker 
has been found to correlate with language delays.  However, in other populations of 
developmentally language disordered populations (such as dyslexics), post mortem 
studies have demonstrated significant reductions in the number of magnocellular cells in 
the lateral geniculate nucleus (LGN), which are known to process temporal components 
of visual information (Livingstone et al., 1991; Galaburda et al., 1985; Galaburda & 
Livingstone, 1993; Lehmkuhle et al., 1993; Lovegrove et al., 1990; Slaghuis et al., 1993; 
Stein 2001).  These anatomical abnormalities have been suggested to relate to behavioral 
deficits in magnocellular aspects of visual information processing (i.e., low contract 
motion but not high contract detail or color (which requires parvocellular processing); 
Livingstone et al., 1991; Lovegrove et al., 1990; Slaghuis et al., 1993, Lehmkuhle et al., 
1993)).  Recently, these findings have been extended to cell populations in the medial 
geniculate nucleus (MGN) from the same dyslexic brains.  Here, post mortem histological 
analysis again revealed reductions in the number of “large” cells in the MGN (Galaburda 
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& Livingstone et al., 1993).  It is hypothesized that the large cells in the MGN might 
preferentially process temporal aspects of acoustic information (much like functional 
divisions seen in the LGN), and disruptions to these cells might relate to behavioral 
impairments in RAP (Galaburda & Livingstone, 1993).  The latter results are consistent 
with the magnocellular theory, which hypothesizes that behavioral deficits in temporal 
processing across various sensory systems are associated with reductions in large or 
“magno” cells in underlying thalamic nuclei (Chase & Stein, 2003; Leonard, 1998; 
Livingstone et al., 1991; Stein 2001).  However, it should be noted that a magnoceullular 
sub-division of the MGN has not been anatomically identified (as is seen in the LGN). 
 Animal models can provide further insight into cellular abnormalities following 
early disruptions in brain development (e.g., see Fitch et al., 2004; Szalkowski & Fitch, 
2012).  For example, the Rice-Vannucci model can be used to study neonatal HI injury, 
and involves cauterization of the right common carotid artery followed by a period of 
time in a hypoxic chamber (8% oxygen; Vannucci & Vannucci, 2005).  When these 
injuries are induced early in life in rats (between postnatal (P) 1-5), resulting pathologies 
roughly correspond to pathologies as seen in preterm HI infants (Silbereis et al., 2010).  
Injuries induced later in life (P7-12) roughly correspond to those seen in full term infants 
with regards to brain development and HIE-like pathology (Vannucci & Vannucci 2005).  
Previous studies have demonstrated persistent RAP deficits in P7 HI injured rodents – 
similar to those identified in language-disabled populations (Alexander et al., 2013; 
Alexander et al., submitted; McClure et al., 2005; McClure et al., 2006; McClure et al., 
2006; McClure et al., 2007; Hill et al., 2011).  However, other studies found that when 
injuries were induced earlier in life (on P1 or P3) animals showed deficits on RAP tasks 
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only in juvenile periods but not adulthood (McClure et al., 2006; Alexander et al., 
submitted).  That is, by adulthood, these animals no longer showed deficits, with RAP 
scores compared to shams (McClure et al., 2006; Alexander et al., submitted).  Authors 
interpreted this as a “recovery of function” in the early but not late HI injured rodents 
(McClure et al., 2006; Alexander et al., submitted).  In addition, significantly smaller 
cells and abnormal cell size distributions were found in the MGN of the rats with a P7 HI 
injury, though P1 HI injured animals showed no changes in cell size or cell distribution 
compared to shams (Alexander et al., 2011).  Taken together, these data suggest that 
persistent RAP deficits as seen in a term HI model may be associated with permanent 
cellular abnormalities in the MGN.     
 Given the human behavioral evidence showing language delays in HI injured 
populations, along with the rodent behavioral data showing deficits on RAP scores in late 
but not early HI injured animals, as well as the cell size abnormalities in the MGN of P7 
but not P1 HI injured rodents, the current study sought to evaluate MGN neuronal size 
distribution in P3 and P7 HI injured rodents (see Alexander et al., submitted, for 
behavioral data from this study).  Based on the unilateral nature of the injury, we 
hypothesized that any abnormalities might be seen to a greater extent in the right MGN.    
Methods 
 Brain tissue from a prior study designed to evaluate behavioral outcomes in P3 
and P7 HI injured animals was used for the current study (Alexander et al., in review).  
Time mated pregnant dams were ordered from Charles River Laboratories and shipped to 
Bousfield Psychology Department at the University of Connecticut on embryonic day 5.  
Upon birth, litters were culled to 8 males and 2 females, and only male pups were used 
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based on data showing a sex difference on neuropathology and behavioral deficits 
following neonatal HI (Hill et al., 2013).  On P3 or P7, pups were anesthetized with 
isoflurane (2.5%) and received a mid-line incision longitudinally on the neck.  The right 
common carotid artery was located and permanently cauterized.  Sham animals received 
the same incision, but there was no manipulation of the artery.  Pups were marked with a 
footpad injection and returned to their dam for two hours to feed.  HI subjects were then 
placed in an air-tight container (sitting on top of a heating pad and under a warming 
lamp) with flowing 8% humidified oxygen, for a period of 120 minutes (temperatures 
monitored).  Sham animals were placed in a similar open container with normal air 
oxygen, flowing for the same amount of time.  At P145 (following a battery of behavioral 
testing), animals were anesthetized with ketamine (100 mg/kg) and xylazine (15 mg/kg) 
and then were transcardially perfused with .9% saline solution followed by 10% buffered 
formalin.  Brains were removed and placed in 10% buffered formalin.  Twenty-four 
hours prior to slicing, brains were placed in 30% sucrose solution for cryoprotection.  
They were sectioned at 60 µm on a cryostat, with every 3rd section saved and mounted.  
Cell bodies were stained using cresyl violet (CV) staining procedures.  
 Cells size in the left and right MGN was measured using Stereo Investigator 
MicrobrightField software on an Axio 2 Zeiss Microscope set using the 100X objective.  
With the optical fractionator and nucleator probes, the cell’s nucleus was marked, and the 
distance to six different rays bisecting the perimeter of the cell membrane were measured.  
On average, 5-6 brain sections included the MGN (per animal/ per hemisphere), and 
these were used for measurement.  A grid size of 250 µm x 250 µm and a counting frame 
of 25 µm x 25 µm were used.  The average cell size for the right and left MGN were 
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calculated for each subject, and then analyzed separately as a function of Treatment.  
Additionally, the cumulative probability for the MGN cells size (µm2) was analyzed for 
the right and left MGN separately.  For analysis, cell size values were ordered from 
smallest to largest within each Treatment group (for each side), and the cumulative 
probability was then calculated by dividing “1” by the total number of cells counted in 
each Treatment group.  Thus we were able to represent the frequency of data points equal 
to or smaller than a given point across the X-axis, ranging from 1 to about 400 µm2.  This 
cumulative frequency distribution was also generated separately for each Treatment 
group for each side.   Additionally, mean cell area and the number of cells per section 
(total number of cells divided by the number of sections counted) for the left and right 
MGN were calculated for each for animal.   
 Finally, bivariate correlations were used in order to analyze a possible relationship 
between average RAP behavioral scores and number of cells per section in the right 
MGN.  Given the lower than necessary n’s for each group to run a correlation analysis, 
average scores for juvenile RAP (across gap and across day), adult RAP (across gap) and 
number of cells per section in the right MGN were z-scored separately for each group.  In 
this way, group differences were controlled for and a bivariate correlation was run 
including all three groups.  To further investigate a possible relationship between RAP 
scores and number of cells per section in specific groups, bivariate correlations were run 
on raw behavioral and histological scores for each group individually.        
For mean cell size and number of cells per section, data was analyzed using a one-
way analysis of variance (ANOVA), and follow up comparisons were performed using 
independent samples t-tests.  Cumulative distribution of cells between all three groups 
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was analyzed using a non-parametric Kruskal-Wallis test.  Specific comparisons between 
groups were made using nonparametric Kolmogorov-Smirnov tests.   Finally, a paired 
measures correlation was run between: 1) right hemisphere mean MGN cell area, and 2) 
mean score on a Silent Gap 0-100 RAP task previously employed with these subjects at 
age P34-38 (juvenile) and also between cell area and 3) silent gap scores from P60 
(adulthood; see Alexander et al., in review for details on the task).  In brief, the Silent 
Gap 0-100 task tested animals RAP capabilities by using the animal’s basic pre-pulse 
inhibition reflex and requiring subjects to distinguish a “cue” prior to a startle eliciting 
stimulus, ranging from 2 to 100 ms in duration.  This task showed robust deficits in both 
P3 and P7 HI injured animals during the juvenile period, however, by adulthood only P7 
HI injured animals continued to show deficits (with P3 HI injured animals performing 
comparably to shams).  Correlations were performed against mean MGN cell size values 
using both the juvenile and adult gap data within P3 HI, P7 HI and sham groups 
separately, as well as using combined z-scores.     
Results 
 Cell measurements were taken from a total of 40 brains: P3 HI n=14; P7 HI n=14; 
P3 sham n=6; and P7 sham n=6.  There were no significant differences in average cell 
size, number of cells per section, cell distribution, nor in previously obtained behavioral 
RAP scores (Alexander et al., in review) between the two sham groups, thus they were 
combined to create a sham group of n=12.   
Average Cell Area 
 A one-way ANOVA revealed no significant overall Treatment effect on average 
cell area for the left [F(2,39) = .166, p>.05] nor right [F(2,39) = 1.766, p>.05] MGN.  
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Although this analysis failed to reach significance, scores were in the expected direction 
with P7 HI animals showing smaller average cell area in the right MGN (P3 HI= 81.45 
µm2, P7 HI = 65.58 µm2, and sham = 77.55 µm2).    
Number of Cells per Section 
 A one-way ANOVA revealed no significant Treatment effect in number of cells 
for the left MGN [F(2,39) = .421, p>.05].  However, analysis did reveal a significant 
Treatment effect for right MGN [F(2,39) = 14.423, p<.001] (Figure 1).  Specific follow-
up independent samples t-tests revealed a significant difference between P7 HI and sham 
animals (t(24) = 5.445, p<.001) and between P3 HI and P7 HI animals (t(26) = 4.540, 
p<.001), with P7 HI animals showing significantly fewer cells per section compared to 
both groups.  There was no significant difference between P3 HI and sham groups (t(24) 
= .104, p>.05).   
Cumulative Distribution   
 For the left MGN (Figure 2a), the results of the Kruskal Wallis non-parametric 
analysis revealed a significant overall Treatment effect (H(2) = 10.655, p<.005).  Specific 
follow-up comparisons using the two sample Kolmogorov-Smirnov test revealed a 
significant difference between P7 HI and sham groups (p<.001), with P7 HI animals 
showing a shift towards larger cells.  There was no difference between P3 HI and sham 
groups (p>.05), nor between P3 HI and P7 HI (p>.05).     
 For the right MGN (Figure 2b) the results of the Kruskal Wallis non-parametric 
analysis again revealed a significant overall Treatment effect (H(2) = 86.233, p<.001). 
Specific follow-up comparisons using the two sample Kolmogorov-Smirnov test revealed 
a significant difference between P3 HI and sham groups (p<.001), with P3 HI animals 
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showing a shift towards larger cells.  Additionally, results showed a significant difference 
between P7 HI and shams groups (p<.005), and between P3 HI and P7 HI (p<.001), with 
P7 HI animals showing a shift towards smaller cells compared to both groups.    
Behavioraland Cell Size/Number Correlation 
 In order to analyze a possible relationship between average RAP scores and size 
of cells/average number of cells per section, bivariate correlation analysis were run 
between Z-scored mean juvenile and adult gap Att scores, and Z-scored mean MGN cell 
size and number within each group.  These overall analyses did not yield significant 
correlations (although scores were in the expected direction (negative correlation, with 
fewer/smaller cells related to worse behavior (higher Att scores)).  Nonetheless, when 
analyzing individual groups, P7 HI animals did show a significant negative correlation 
between raw RAP scores in juvenile Day 3 and the number of cells per MGN section in 
the right MGN (r=-.577, p<.05).  Although correlations in P3 HI and sham animals were 
also in the expected direction, these correlations also failed to reach significance.  
Furthermore, there were no significant correlations in either group between cell measures 
and adult RAP, scores although correlations were again in the expected direction.  
Discussion 
 Using the HI rodent model, the current study demonstrated that the number of 
cells in the right MGN in P7 HI injured animals was significantly smaller compared to 
both P3 HI and sham animals. Furthermore, the current study also demonstrated that P7 
HI injured animals had a significant shift towards smaller cells in the right MGN 
compared to both P3 HI and sham animals.  Interestingly, there was also a difference in 
the right MGN for P3 HI versus sham animals, with P3 HI animals showing a significant 
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shift towards larger cells.  Furthermore, P7 HI animals also showed a significant shift 
towards larger cells compared to shams in the left MGN, another surprising finding.    
 Furthermore, bivariate correlation analysis revealed a significant relationship 
between Day 3 juvenile RAP scores and average number of cells per MGN section in the 
right MGN in P7 HI injured animals.  Correlations in P3 HI and sham animals, for both 
juvenile and adult RAP scores and number of cells per section in the right MGN, were in 
the expected direction but failed to reach significance. 
 The current findings are consistent with prior reports showing abnormal cell size 
distribution in the right MGN of late (P7) HI but not early (P1 or P3) HI animals 
(Alexander et al., 2011).  Furthermore, these results are consistent with a similar study 
where P1 focal ischemic lesions in male rats (resulting in the formation of cortical 
“microgyria,” an anomaly associated with behavioral deficits in RAP tasks) also showed 
a shift towards smaller cells in the MGN when compared to sham animals (Herman et al., 
1997).  As in the current study, these focal ischemic animals also showed deficits on RAP 
tasks (Herman et al., 1997).  These data are also consistent with human post mortem 
evidence demonstrating a shift towards smaller cells in the MGN in brains of dyslexics, 
coupled with behavioral evidence of RAP deficits in a wide range of language impaired 
populations (Galaburda et al., 1994; Bradley & Bryant, 1983; Downie et al., 2002; 
Farmer & Klein, 1985; Hari & Kiesla, 1996; Hari & Renvall, 2001; Kraus et al, 1996; 
McAnally & Stein, 1996; McCrosky & Kidder, 1980; Neville, et al., 1993; Robin et al., 
1989; Paterson, et al., 2006; Stein. 1993;  Tallal, 1980; Tallal et al., 1985, 1993; Witton, 
et al., 1998; Wright et al., 1997; Benasich et al., 2002; Choudhury et al., 2007). Finally, 
the current results support and extend the magnocellular theory, which proposes that 
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deficits in rapid auditory processing (or RAP) in a variety of language-impaired 
populations in part arise due to anomalies in large or “magno” thalamic MGN cells.  This 
theory originated through evidence of deficits in magnocellular processing of visual 
information and an overall reduction of neuronal cell size in the magnocellular division in 
the LGN of human dyslexic brains (Lehmkuhle et al., 1993; Livingstone et al., 1991; 
Lovegrove et al., 1990; Slaghuis et al., 1993).  However, since clear distinction of 
magnocellular/parvocellular division in the MGN of the thalamus have not been 
delineated, it can only be suggested that large cells may preferentially encode temporal 
components of acoustic information (Galaburda & Livingstone, 1993; Stein, 2001).   
 Interestingly and unexpectedly, the current study also showed alterations in cells 
in the right MGN of P3 HI animals, showing a significant shift towards larger cells 
compared to shams.  Furthermore, alterations in cell size were also seen in the left MGN 
(contralateral hemisphere to injury), where P7 HI animals showed a significant shift 
towards larger cells compared to shams.  These changes in part could be explained by the 
reorganization and plasticity effects following neonatal HI injury.  As for changes in the 
left hemisphere, this evidence suggests alterations might not be due to direct damage.  
Furthermore, a recently published paper showed a shift in cell size in the MGN of rats 
who received embryonic ventricular transfection of RNAi for the dyslexic candidate gene 
Dyx1c1 (Szlakowski et al., 2013), suggesting that alterations in MGN cells might not 
simply occur because of cortical atrophy (as typically seen following HI injury), but due 
to a variety of conditions characterized not only by early injury but also potentially by 
genetic factors.  Findings of pervasive (bilateral) reorganization following early unilateral 
HI injury are also generally consistent with the notion that, in direct contrast to adult 
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populations where focal brain damage can be clearly tied to specific and largely 
predictable functional deficits, disruption of the brain during early development does not 
lead to “focal” injury but rather, a subtle and pervasive reorganization (Thomas & 
Karmiloff-Smith, 2002; Van Den Tweel et al., 2006).  Early changes in the expression of 
multiple cell death mediators in both the ipsi-and contralateral hemisphere following a 
unilateral HI injury have also been demonstrated in six week old rats (when HI surgery 
was performed on P12).  Specifically, alterations in cytokines, hypoxia inducing factor-
1α, and phosphorylated-Akt levels in both the ipsi-and contralateral hemisphere were 
seen following HI injury, supporting bilateral reorganization following unilateral HI 
injury in neonatal rats (Van Den Tweel et al., 2006).  Although this phenomenon may 
explain the greater resiliency of neonates with regards to maintaining overall function 
following severe brain injury, it also explains the stark difficulties in identifying a neural 
signature for specific types of behavioral deficits in developmentally impaired 
populations. 
 The current study also found a decrease in number of cells per section in the right 
MGN of P7 HI injured rats with a non-significant reduction in average cell area.  The 
lack of significant results in average cell area might be explained by few large cells still 
present in the right MGN of P7 HI injured animals, which might have pulled up the 
average in the P7 HI group, or the need for a larger n (using a larger window on more 
sections).  A significant reduction in the number of cells per section in the right MGN of 
P7 HI animals compared to P3 HI animals, along with the shift towards smaller cells in 
P7 animals, suggest that large “magno” cells might selectively be dying.  Why this would 
happen in the P7 HI animals but not the P3 HI animals could be partially explained by the 
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differences in brain development at the point when HI injury was induced.  Post mortem 
human brain thalamic tissue showed by term age, nuclear groups are well formed but 
there is continued growth, maturation, and migration of LGN and MGN cells (Dekaban et 
al., 1954).  Furthermore, the development of glutamatergic receptor subtypes (AMPA and 
NMDA) might also contribute to the vulnerability of the MGN at P7.   Specifically, 
increases in the NMDA receptor do not occur in other areas such as the hippocampus and 
cortex until later in prenatal rodent development (P7-12), and these populations continue 
to rise through postnatal development in the human infant (Rice et al., 2000).  The 
NMDA receptor has also been implicated in the apoptotic cascade following neonatal HI, 
leading to glutotoxicity and cell death (Banasiak et al., 2000).  Additionally, it could be 
that larger MGN cells require more oxygen and nutritional support for development and 
survival following neonatal HI injury as opposed to smaller cells.  Taken together, the 
differential timing of thalamic maturation as well as maturation of the NMDA receptor 
populations might make these large “magno” cells of the MGN more vulnerable to late 
neonatal HI injury.    
 In closing, to our knowledge, this is the first study to demonstrate a shift in the 
cell size distribution in the right MGN (ipsilateral to HI injury) in P7 HI injured rodents 
that also showed persistent rapid auditory processing deficits at the behavioral level 
(Alexander et al., in review).  Furthermore, P3 HI injured rodents that previously showed 
a recovery of function on RAP tasks by adulthood did not show a shift towards smaller 
cells in the right MGN (Alexander et al., in review).  Additionally, P7 HI animals showed 
a reduction in number of cells in the MGN compared to sham and P3 HI animals.  Future 
studies are needed to make a stronger association between other cellular abnormalities in 
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the MGN of HI injured rodents and RAP deficits, perhaps by identifying a global pattern 
of altered circuitry.  Additionally, studies investigating the use of neuroprotectants 
following neonatal HI injury could be performed using MGN cell size at an outcome 
measure.  Previous studies have demonstrated the therapeutic benefit of erythropoietin 
(McClure et al., 2006; McClure et al., 2007; Alexander et al., 2013) on RAP deficits in 
P7 HI injured rodents.  It could be possible that these therapeutic benefits manifest in part 
through preserving cellular integrity in the MGN. Finally, an improved characterization 
of apoptotic markers and other cellular features characterizing early and late neonatal HI 
injury, starting at time-points immediately following injury induction (and throughout 
development), could help better characterize the pattern and nature of changes in large 
MGN cells. Overall, an improved understanding of how early injury -- such as that 
associated with term-birth incidents that cause HIE -- can in turn lead to anatomic 
changes that can be tied to functional deficits, will better serve the at-risk neonatal 
population through improved early screening, and a more delineated focus on specific 
“brain changes” that follow these early injuries and lead to the dramatic increases in 
cognitive disabilities (and language disabilities) evidenced in these vulnerable 
populations.   
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Figure  1: A one-way ANOVA revealed a significant Treatment effect in the right MGN 
for the number of cells per section [F(2,39) = 14.423, p<.001].  Follow-up independent 
samples t-test revealed a significant difference between P7 HI and shams (t(24) = 5.445, 
p<.001) and between P7 HI and P3 HI (t(26) = 4.540, p<.001).  There was no difference 
between P3 HI and sham (t(24) = .104, p>.05).  There was also no Treatment effect in the 
left MGN [F(2,39) = .421, p>.05].   
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Figure 2: A) For the left MGN, a Kruskal-Wallis non-parametric test revealed a 
significant Treatment effect between P3 HI, P7 HI and shams (H(2) = 10.655, p<.005).  
Follow up two-sample Kolmogorov-Smirnov analysis revealed significant differences 
between P7 HI and sham (p<.001) with P7 HI showing a shift towards larger cells.  There 
was no difference between P3 HI and shams (p>.05) or P3 HI and P7 HI (p>.05).  B) In 
the right MGN, a Kruskal-Wallis non-parametric test revealed a significant Treatment 
effect between P3 HI, P7 HI and shams (H(2) = 86.233, p<.001). Follow up two-sample 
Kolmogorov-Smirnov analysis revealed significant differences between P7 HI and sham 
(p<.003), and P3 HI and P7 HI (p<.001) with P7 HI showing a shift towards smaller cells 
compared to both groups.  There was also a significant difference between P3 HI and 
shams (p<.001) with P3 HI showing a shift towards larger cells compared to shams. 
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Abstract 
 Hypoxia Ischemia (HI) and associated brain injuries are seen in premature as well 
as term infants with birth complications.  Resulting impairments involve deficits in many 
cognitive domains, including language development.  Poor rapid auditory processing is 
hypothesized to be one possible underlying factor leading to subsequent language delays. 
Mild hypothermia treatment for HI injuries in term infants is widely used as an 
intervention, but can be costly and time consuming.  Data suggest that the effectiveness 
of hypothermia treatment following HI injury declines beyond six hours post injury.  
Thus, the availability of a therapeutic alternative without these limitations could allow 
doctors to treat HI injured infants more effectively, and thus reduce deleterious cognitive 
and language outcomes. Evidence from both human studies and animal models of 
neonatal HI suggests that erythropoietin (Epo), an endogenous cytokine hormone, may be 
a therapeutic agent that can ameliorate HI brain injury and preserve subsequent cognitive 
development and function..  The current study sought to investigate the therapeutic 
effectiveness of Epo when administered immediately after HI injury, or delayed at 
intervals following post injury, in neonatal rodents.  Rat pups received an induced HI 
injury on postnatal day 7, followed by an intraperitoneal injection of Epo (1,000 U/kg) 
either immediately, 60 minutes, or 180 minutes following induction of injury.  Subjects 
were tested on rapid auditory processing tasks in juvenile (P38-42) and adult periods 
(P80-85).  Ventricular and cortical size was also measured from post mortem tissue.  
Results from the current study show a therapeutic benefit of Epo when given immediately 
following induction of HI injury, with diminished benefit from a 60-minute delayed 
injection of Epo, and no protection following a 180 minute delayed injection.  The 
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current data thus show that the effectiveness of a single dose of Epo in ameliorating 
auditory processing deficits following HI injury decreases precipitously as treatment is 
delayed following injury.  These data may have important implications for experimental 
human neonatal intervention with Epo.     
 
Introduction 
 
 Hypoxia-Ischemia (HI) refers to a disruption in blood and oxygen delivery to the 
brain.  In neonates, incidents such as intraventricular-periventricular hemorrhage (IVH-
PVH) - an injury observed in very preterm infants (gestation age <32 weeks) or at very 
low birth weight (VLBW; < 1,500 grams; Volpe 2008, 2009) – can result in HI injury.  
Periventricular leukomalacia (PVL) is a related ischemic HI injury also seen in 
premature/VLBW infants (Volpe, 2001).  Hypoxic-ischemic encephalopathy (HIE) is 
diagnosed in full-term infants suffering from birth complications such as cord prolapse or 
placental abruption (Volpe, 2008). Despite varying etiologies for HI across pre-term and 
term populations, these early HI injuries uniformly lead to an increase in behavioral 
sequelae such as learning and language deficits at later ages (Aarnoudse-Moens et al., 
2009; Anderson et al., 2010; Badawi et al., 2001; de Vries et al., 2010; Ortiz-Mantilla et 
al., 2008).  VLBW children exhibit deficits on standardized language and cognitive tasks 
in early childhood (Ortiz-Mantilla et al., 2008) and sustained deficits in both language 
comprehension and language production at four years of age (Jansson-Verkasola et al., 
2004).  A meta-analysis revealed that premature/VLBW children also display poorer 
performance on spelling, reading, and verbal fluency tasks as compared to term control 
children (Aarnoudse-Moens et al., 2009).  Term infants diagnosed with HIE show verbal 
IQ deficits at four years of age, and lower scores are seen with increasing degree of injury 
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as reflected by MRI [9]. With specific regard to developmental language deficits, it has 
been suggested that disruptions in underlying rapid auditory processing (RAP) or the 
ability to discriminate between rapidly presented auditory cues (such as those that occur 
in speech) may be one factor leading to delayed and/or disordered language learning in 
HI injured children.  Specifically, studies of children diagnosed with an HI injury in 
infancy show RAP deficits later in childhood (Downie et al., 2002; see Ortiz-Mantilla et 
al., 2008), and other researchers have shown that deficits in RAP (measured in infancy) 
correlate with and are predictive of language outcomes in later years (Benasich et al., 
2002; Choudhury et al., 2007; Tallal et al., 1976).  Children diagnosed with a 
developmental language impairment concurrent to rapid auditory processing deficits also 
show abnormal oscillatory EEG activity during a RAP task (Heim et al., 2011). 
Furthermore, children with a family history of language impairment show abnormal 
maturation of long-latency auditory evoked potentials from six months to four years of 
age, as compared to children without a family history, and these scores correlate with 
subsequent language and cognitive abilities for both groups (Choudhury et al., 2011).   
 Studies using the neonatal rodent models of early HI allow for the experimental 
assessment of outcomes following early HI injury (i.e., short and long-term 
neuropathology, long-term behavior), as well as variables that may modulate these 
outcomes.  Using the Vannucci method, induction of HI injury on postnatal day 7 (P7) in 
rodents (roughly correlating to a 34-36 week old human in terms of brain development) 
produces a pattern of neuropathology that parallels injuries seen in term infants with HIE 
(Vannucci & Vannucci, 1997; Vannucci, 2000) and provides a model for the study of the 
developmental trajectory of a term-like HI injury (Vannucci & Vannucci, 1997; 
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Vannucci, 2000).  Moreover, male rats that receive an HI injury on P7 are found to show 
subsequent deficits on RAP tasks at both juvenile and adult ages -- possibly reflecting 
outcomes related to language deficits in human populations (McClure et al., 2005; 
McClure et al., 2005; McClure et al., 2006; Hill et al., 2012).  These P7 HI injured rats 
also show gray matter damage, particularly in the cortex and hippocampus, along with 
increased ventricular size as measured by post mortem histological analysis (all similar to 
the patterns of brain injury seen in term-HI injured children; (Volpe, 2008; Volpe, 2001; 
McClure et al., 2005; McClure et al., 2005; McClure et al., 2006; Hill et al., 2012).  
Using the neonatal rodent HI model as described here, studies have also examined 
possible therapeutic variables that could be employed to improve long-term outcomes.   
 Erythropoietin (Epo) has been proposed as an intervention to reduce deleterious 
outcomes following an HI injury.  Epo is a cytokine hormone expressed endogenously in 
the brain, kidney and liver (Buemi et al., 2002; Ghezzi et al., 2004).  Systemically, Epo 
regulates the production of new red blood cells, and has been shown to increase the 
number of erythrocytes in times of chronic hypoxia (thus improving the amount of 
oxygen delivery to affected tissues (Soliz, 2012).  It has also been administered to 
increase red blood cell production for the treatment of anemia.  However, this mechanism 
seems unlikely to underlie any protective effects of a single dose of Epo such as was used 
here.  Epo has been shown to readily cross the blood brain barrier, and binds to the Epo 
receptor (EpoR).  Epo and EpoR are highly expressed in gray matter, including the cortex 
and hippocampus, which are particularly vulnerable to hypoxic/ischemic insult (Buemi et 
al., 2002)  Furthermore, expression of endogenous Epo has been found to increase in the 
cortex within 24 hours following neonatal HI insult in rodent models (Spandou et al., 
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2004).  The endogenous expression of Epo in response to HI insult, coupled with the 
distribution of EpoR in grey matter, makes it a promising candidate for therapeutic 
intervention following HI injuries.   
 Historically, Epo has been successfully used to help treat anemia in premature 
infants.  Retrospective studies of outcomes among treated infants reveal that Epo may 
also have some neuroprotective properties (Buemi et al., 2002; Bierer et al., 2006; 
McPhearson & Juul, 2006; McAdams et al., 2010; Zhu et al., 2009).  In a study 
investigating the therapeutic effects of Epo in extremely low birth weight infants, infants 
treated with 400 U/kg three times per week and who later showed high Epo plasma 
concentrations had better Mental Development Index scores (18-22 months) than infants 
who were treated but showed lower Epo plasma concentrations (Bierer et al., 2006).  In 
another study (reviewed in McPhearson & Juul, 2010) where preterm infants were treated 
with multiple doses of Epo at birth, treated subjects showed improvements in gross 
motor, fine motor and language tasks at 6-12 months when compared to matched controls 
(McPhearson & Juul, 2010).  Furthermore, high dose of Epo administration in VLBW 
infants (25,000 U/kg the first three days of life), positively correlated with cognitive and 
motor scores at 4-36 months (McAdams et al., 2012). In term infants diagnosed with 
moderate HIE who were treated with repeated doses of Epo (300 U/kg or 500 U/kg), 
better Mental Development Index scores and lower incidence of disability were seen as 
compared to the control group at 18 months (Zhu et al., 2009).    Finally, when term 
infants diagnosed with HIE were treated with multiple doses of Epo at birth they showed 
fewer incidence of seizures at five days, improved EEG scores two weeks after birth, and 
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improved neurological scores as measured by the Denver Developmental Screening Test 
II at six months of age (Elmahdy et al., 2010).  
 The use of Epo as a neuroprotectant in neonatal rodent HI models has also 
revealed promising findings. For example, treatment with Epo immediately following HI 
injury in P7 rat pups has been shown to reduce infarct size in cortex (Aydin et al., 2003; 
Chang et al., 2005; Fan et al., 2011; Kumral et al., 2003; Kumral et al., 2004; McClure et 
al., 2007; McClure et al., 2007) and hippocampus (Aydin et al., 2003; McClure et al., 
2007) as well as to reduce the volume of the lateral ventricles (McClure et al., 2007;  
McClure et al., 2007).  Treatment with Epo immediately following HI injury was also 
found to reduce white matter damage by protecting developing pre-oligodendrocytes 
(Iwai et al., 2010; Mizuno et al., 2008) and preserving the volume of the sub-ventricular 
zone (Kim et al., 2008).  At the behavioral level, Epo has been shown to ameliorate later 
sensory/motor deficits (Fan et al., 2011; Kim et al., 2008), as well as spatial memory 
deficits (Kumral et al., 2004; McClure et al., 2007; McClure et al., 2006) in P7 HI injured 
rats.  Additionally, Epo has been shown to ameliorate RAP deficits in P7 HI injured rats 
as measured in both juvenile and adult periods (McClure et al., 2006; McClure et al., 
2007). This latter result suggests that Epo could possibly be used to help ameliorate later 
language deficits (which are correlated with RAP indices) in HI injured children. 
 Although other neuroprotective regiments are currently being used in clinical 
trails to reduce negative outcomes following HI injuries in children -- such as mild head 
or full-body hypothermia -- the delay time between injury and the initiation of treatment 
(as defined by target reduction in core body or head temperature) can frequently reduce 
the efficacy of treatment  (Gunn et al., 1999; Karlsson et al., 2008). Thus, the 
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implementation of a more widely available and speedy form of neuroprotective treatment 
(such as an injection) could improve intervention options and outcomes for HI injured 
infants. Given this background, the current study was designed to address two aims: 1) to 
replicate previously reported protective effects of Epo treatment immediately following 
P7 HI injury in rats; and 2) to examine whether Epo delivered at a clinically-relevant 
post-injury delay (60 or 180 minutes) could afford similar (or any) long-term protection. 
Thus we assessed the effectiveness of immediate and delayed administration of Epo on 
long-term behavioral and histological outcomes in a P7 rodent model of early HI injury.  
We hypothesized that HI-saline treated animals would show significantly worse RAP 
scores and higher pathology indices as compared to sham controls (as previously 
demonstrated; (McClure et al., 2005; McClure et al., 2005; McClure et al., 2006). Next 
we hypothesized that immediate post-injury treatment with Epo would significantly 
improve RAP scores and pathology outcomes, again replication previous data (McClure 
et al., 2007; McClure et al., 2006) and that HI animals treated with a comparable dose of 
Epo at 60 and 180 minute delays might demonstrate a partial therapeutic benefit.  
Methods  
Subjects 
 Subjects were male Wistar rats, born to time-mated dams (Charles River 
Laboratories, Wilmington, MA) at the University of Connecticut.  Males were used based 
on evidence that behavioral deficits following early HI injury may be less severe in 
females, making the assessment of neuroprotection in females more difficult (Hill et al., 
2012).  Pups were culled and cross-fostered as necessary on P1 to yield litters comprised 
of 8 males and 2 females (female pups were retained to maintain normal maternal 
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behavior).  Subjects were weaned at P21 and pair-housed with like-treated littermates.  At 
P55, animals were single housed for further testing.  All subjects were housed using a 12 
hour light/dark cycle with food and water available ad libitum.   
Induction of HI 
 Male pups were randomly assigned within-litter to each treatment group: HI 
vehicle (sterile saline); HI Epo immediate (1,000 U/kg); HI Epo 60 minute delay (1,000 
U/kg); Epo 180 minute delay (1,000 U/kg); or corresponding sham (no HI or ligation) 
saline-treated groups.  Within the sham and HI saline group, subsets of animals received 
saline injections at time points equivalent volume to each of the Epo groups to control for 
the possible effects of injection timing (however, no differences were found and these 
subsets were subsequently pooled). Pups receiving HI surgery on P7 were anesthetized 
with isoflurane (2.5%) and a midline incision was made longitudinally in the neck.  The 
right common carotid artery was located and separated from surrounding tissue, 
cauterized, and the incision was sutured.  Pups were marked with a footpad injection to 
identify their treatment condition at weaning.  Pups were placed under a warming lamp 
and allowed to recover from anesthesia, then were returned to their dams for two hours in 
order to feed.  Animals assigned to the sham condition were similarly placed under 
anesthesia, but only a mid-line incision was made with no manipulation of the carotid 
artery. After 2 hours with dams, HI pups were then placed in an air-tight container in 
which they were exposed to 8% humidified oxygen (balanced with nitrogen) for a period 
of 120 minutes.  Sham animals were placed in an open container with normal air 
exposure for the same period.  
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Erythropoietin Administration 
 Following removal from the hypoxic chamber, animals received either Epo 
(intraperitoneal (i.p.) injection; Protein Sciences Corporation, 1,000 U/kg in sterile saline; 
36,37) or vehicle only (sterile saline) according to predetermined assigned conditions (HI 
Saline, n=15); HI Epo immediate (HI Epo 0, n=15); HI Epo one hour delay (HI Epo 60, 
n=15); HI Epo three hour delay (HI Epo 180, n=15); or corresponding sham saline 
treatment (Sham, n=16). Saline treated animals (HI or sham) received a comparable 
volume i.p. injection of saline at the same designated time points (although immediate, 60 
min and 180 delay saline injections were not found to differ and were pooled within both 
saline treated shams and HI subjects for further analysis). All pups were then returned to 
their dams, and remained undisturbed until weaning on P21.  All behavioral testing was 
done blind to Treatment condition.  
Behavioral Testing: startle reduction 
 The startle reduction paradigm utilizes the natural acoustic startle reflex (ASR), or 
motor response, to a startle eliciting stimulus (SES).  When the SES is preceded by a pre-
stimulus, a reduction is seen in the ASR (startle reduction), also known as pre-pulse 
inhibition or PPI.  In this study, the SES was a 105 dB, 50 ms white noise burst for all 
auditory tasks. Comparisons between the ASR amplitude on trials with no pre-pulse 
(uncued trials), versus presence of a pre-pulse cue (cued trials), were made for each 
subject on each task to calculate attenuation score as an objective measure of sensory 
detection on that task (as previously described in Fitch et al., 2008).  The inter-trial 
interval between each SES ranged from 16 s-24 s, and averaged 20 s.   
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Behavioral Testing Apparatus 
 During startle reduction testing, each subject was placed on an individual load-
cell platform (Med Associated PHM-252B, Georgia, VT) in a black polypropylene cage.  
The output from the platforms was amplified (linear amp PHM-250-60 Med Associates) 
and acquired by a Biopac MP 100A-CE acquisition system.  This system was connected 
to a Power Macintosh G3, which displayed the output in a waveform with the computer 
program AcqKnowledge. Auditory stimuli were generated on a Pentium III Dell PC with 
custom programmed software and a Tucker Davis Technologies (RP2) real-time 
processor, amplified by a Niles SI-1260 System Integration Amplifier. Sound files were 
delivered via 10 Cambridge Soundworks MC100 loudspeakers placed 53 cm above the 
platforms. Each animal’s ASR amplitude was recorded (in mV) by extracting the 
maximum peak value from the 150 ms signal epoch following the SES.  Cued and uncued 
trials were coded and compared to assess the animal’s absolute and attenuated response 
amplitude across trials.  Scores were analyzed by calculating the attenuation (ATT) score 
as a function of the average cued trials divided by the average uncued trials and 
multiplied by 100 to get a percentage (cued trials/uncued trials *100).  
Single Tone procedure (P35) 
 The single tone task consisted of 103 cued or uncued trials.  Trials were presented 
in random order, and animals were tested for one session.  The single tone procedure was 
used to assess for underlying processing deficits or hearing deficits that might confound 
further testing results.  Uncued trials consisted of a silent background followed by the 
SES.  On cued trials, a 75 dB, 7 ms, 2300 Hz tone was presented.  On cued trials, the cue 
to burst interval (the time between when the cue was presented and when the SES was 
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presented) varied (25 ms, 50 ms, 75 ms, and 100 ms).  This was to ensure all animals 
could perform the pre-pulse inhibition task at differing difficulty levels.   
Silent Gap (SG) procedure (P38-P42; Juvenile) 
 The silent gap procedure consisted of 299 trials per session, and animals were 
tested on one session/day for four consecutive days. Testing occurred in the juvenile 
period (age P38 – P42). For all trials, a continuous background broad-band white noise 
(75 dB) was played.  Uncued trials consisted of the background white noise followed by 
the SES (a burst of white noise at 105 dB). On cued trials, a gap in the white noise 
varying in duration (between 2-100 ms) was provided as a cue 50 ms before the 
presentation of the SES.  In prior research we have found the silent gap task to provide a 
good evaluation of acoustic processing thresholds in young animals as compared to more 
difficult tasks that are effective in eliciting deficits from adults (41).    
FM Sweep procedure (P80-P85; Adult) 
 The FM sweep procedure consisted of 102 trials per session.  Animals were tested 
on one session/day for five consecutive days.  The background comprised a repeated 
presentation consisted of a 75 dB downward frequency sweep (2300-1900 Hz), which 
varied in duration (275ms, 225ms, 175ms, 125ms, 75ms) for each session on different 
days (one duration per session).  Sweeps were separated by a between stimulus ISI, 
always 200 ms greater than the sweep duration.  The uncued trials consisted of the same 
downward sweep presented 50 ms prior to the SES.  Cued trials consisted of a reversal of 
the previous sweep (or “oddball,” i.e., low to high instead of high to low) presented 50 
ms before the SES.  The FM Sweep task provides a more challenging task as compared to 
the SG task.  In fact, by adulthood most animals (including HI subjects) can successfully 
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perform SG 0-100, thus revealing no Treatment differences on this task.  Introducing a 
more difficult task in adulthood, such as the FM Sweep, thus allows us to investigate 
persistent HI effects.      
Histology  
At P100 animals were weighed, anesthetized with Ketamine (100 mg/kg) and 
Xylazine (15 mg/kg), and transcardially perfused with 0.09% saline and 10% buffered 
formalin phosphate.  Brains were removed and placed in formalin.  Before slicing, brains 
were placed in a 30% sucrose solution for cryoprotection and then were sliced on a 
coronal plane at 60µm using a cryostat.  Every third section was mounted on a slide and 
stained using cresyl violet.  Volumes of the lateral ventricles and right cortical volume 
were examined using a Zeiss Imager A.2 microscope and Micro Bright Field (MBF) 
Stereo Investigator computer software (Williston, VT).  Cavalieri’s estimator of volume 
was calculated using the MBF computer software.  All measurements were performed 
blind to Treatment group.   
 
Statistical Analyses 
 All statistical analyses were performed using SPSS 15.0 software, and an alpha 
criterion of .05. Two-tailed analyses were used unless otherwise stated. For initial 
analyses, for each task we compared behavioral scores of subsets of the sham saline and 
HI saline treated animals that received injections at the 3 different time points. No 
differences were found, and therefore these subsets were grouped into HI saline (n=15) 
and Sham saline (n=16) for further analyses. ANOVAs were performed for each task 
using multiple levels of Treatment. Based on specific a priori hypotheses as described 
above, planned comparisons were performed (as a function of Treatment) between paired 
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groups. Specific comparisons were made between HI saline vs Sham; HI Epo 0 delay vs 
Sham; HI Epo 60 minute delay vs Sham; and HI Epo 180 delay vs Sham. Additionally, a 
separate comparison of each of the 3 Epo groups to HI saline treated was performed.   
 Repeated measures analysis of variance (ANOVA) was used to analyze ATT 
scores for each of the RAP tasks.  Variables included Treatment (5 levels; Sham, HI 
Saline, HI Epo 0, HI Epo 60, and HI Epo 180), Day (4 levels for Silent Gap and 5 levels 
for FM sweep), and Gap (9 levels for SG 0-100 task only).  Univariate ANOVA was also 
used to analyze histology, specifically for right and left ventricular size and right cortical 
size, which we have previously shown to provide a reliable index of pathology [18, 19, 
21].  We note here that tissue from several brains could not be accurately measured as a 
result of histologic factors (loss of tissue integrity in severely damaged brains leading to 
inability to confidently identify tissue borders), and the final n used for anatomic analysis 
in each group was: HI Saline, n=12; HI Epo 0, n=13; HI Epo 60, n=13; HI Epo 180, 
n=12; Sham, n=14. Specific follow up independent samples t-tests were used to compare 
ventricular scores between each HI group relative to shams, as described above. Graphs 
presented in the results section show mean ATT scores for auditory tasks; note that a 
higher score indicates poorer performance (100% equals chance performance levels, with 
no difference between cued and uncued trials).   
Results 
 
Normal Single Tone 
 A 4 (Cue) x 5 (Treatment) repeated measure ANOVA revealed no main effect of 
Treatment, [F (4,71) = .945, p>.05], indicating no differences in subjects simple pre-pulse 
inhibition with a single tone (data not shown).  Additional paired analyses further failed 
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to reveal significant differences for any comparison. This confirms an absence of 
differences in basic startle reduction behavior or auditory processing abilities between 
groups, which is important in allowing attribution of Treatment effects on more complex 
tasks to a failure to process the stimulus, and not hearing or basic PPI deficits. 
Silent Gap 0-100 (P38 – P42) 
 A 4 (Day) x 9 (Gap) x 5 (Treatment) repeated measures ANOVA was performed, 
and this revealed a trend toward an overall main effect of Treatment [F (4,71) = 2.281, 
p=.06] though it did not reach significance, as well as a significant Gap x Day x 
Treatment interaction [F (4,71) = 1.495, p<.05].  The triple interaction likely reflects the 
fact that all scores improved over Days, and particularly so at the longer Gaps, but this 
improvement was more marked in the high-performing Treatment groups. A follow up 9 
(Gap) x 2 (Treatment) x 4 (Day) one-tailed repeated measures ANOVA was performed 
specifically between Sham and HI saline groups, and this also revealed a trend toward a 
Treatment effect [F (1,29) = 1.980, p=.085; one-tailed], though it did not each 
significance (see Figure 1), with HI saline subjects performing worse.  Further analysis 
did reveal significant HI effects at specific gaps including 40 ms, t(29) = 1.182, p<.05, 
and 75 ms, t(29) = 1.982, p<.05, on the third day of testing (data not shown).  A 9 (Gap) 
x 2 (Treatment) x 4 (Day) repeated measures ANOVA was performed between the Sham 
and Epo 0 groups, and this revealed no significant difference between groups [F (1,29) = 
.226, p>.05]. However, a significant Treatment effect was seen between Sham and HI 
Epo 60 [F (1,29) = 6.575, p<.05], as well as a significant Treatment effect between Sham 
and HI Epo 180 [F (1,29) =  6.974, p<.01] (see Figure 2).  Thus scores were significantly 
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worse in HI saline treated, HI Epo 60 delay, and HI Epo 180 delay groups as compared to 
the Sham and Epo 0 groups.  
FM Sweep (P80 – P85) 
 Based on a priori planned comparisons, a 5 (Day) x 2 (Treatment) one-tailed 
repeated measures ANOVA was performed with Sham and HI saline treated groups. This 
analysis revealed a significant main effect of Treatment [F (1,29) = 3.361, p<.05] (see 
Figure 3), with HI saline subjects performing worse than shams.  A similar 5 (Day) x 2 
(Treatment) repeated measures ANOVA comparing Sham treatment to Epo 0 was 
performed, and this revealed no significant difference between groups [F (1,29) = 2.879, 
p>.05].  However, a non-significant effect of Treatment was seen between Sham and HI 
Epo 60 groups [F (1,29) = 3.773, p=.06], as well as a significant effect of Treatment 
between Sham and HI Epo 180 groups [F (1,29) = 4.387, p<.05] (see Figure 4).  Thus 
ATT response scores for HI saline treated and HI 180 minute delay groups were again 
significantly worse than the Sham and Epo 0 treated groups, with an intermediate 
difference for Epo 60. 
Histological Results 
 Ventricular volumes (measured in mm3) were assessed for both left and right 
hemispheres in all subjects (data not shown). Paired Samples T-Tests were performed for 
each Treatment group individually and these revealed no difference between the left and 
right ventricle in HI saline animals, (t(11)=-1.582, p=.07; one-tail), with the right 
ventricular volume larger than the left.  There was no difference in the Sham group 
(t(13)=-0.297, p>.05), the HI Epo 0 group, (t(12)=-1.65, p>.05) or the HI Epo 60 group, 
(t(12)=-1.06, p>.05) when comparing left and right ventricular volume (all comparisons 
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were two-tail comparisons).  There was, however, a significant difference in the HI Epo 
180 group, (t(11)=-2.16, p<.05), with right ventricular volume larger than left ventricular 
volume.  These indices indicate ventriculomegaly of the right side in injured subjects (HI 
saline and HI Epo 180) with amelioration of this effect in the Epo 0 group.  The HI Epo 
60 group showed a similar trend as the HI Epo 0 and HI Epo 180 group, with the right 
ventricular volume larger than the left, but this did not reach significance.  We found 
right cortical volume to be significantly smaller in HI saline animals as compared to 
shams (t(14.7)=-1.827, p<.05 (one-tailed)). Right cortical volumes in HI Epo 0 animals 
did not differ from shams.  Comparisons for HI Epo 60 and 180 versus shams were in the 
expected direction (smaller than shams), these comparisons did not reach significance.  
Discussion  
 The current study evaluated the therapeutic effects of immediate and delayed Epo 
administration following a P7 HI injury in male rats, using performance outcomes on 
several RAP tasks (administered in juvenile and adult periods) with clinical relevance to 
language outcomes.  We hypothesized that HI saline animals would show worse 
performance on RAP tasks, as well as higher pathology (ventricular) indices, as 
compared to Sham treated animals (as previously reported; McClure et al., 2005; 
McClure et al., 2005; McClure et al., 2006).  Additionally, we hypothesized that HI Epo 
immediate subjects would show comparable RAP scores and pathology measures relative 
to sham groups, again based on prior findings (McClure et al., 2006; McClure et al., 
2007). The current study did in fact confirm deficits on RAP attenuation scores (using 
silent gap detection task in the juvenile period, as well as a more difficult FM Sweep task 
in adulthood) when HI saline treated subjects were compared to sham treated groups, thus 
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replicating previous research (McClure et al., 2005; McClure et al., 2005; McClure et al., 
2006). We note that although the overall effects on the SG 0-100 task were marginal 
between HI saline and sham animals, we did find a significant HI effect specifically at the 
40 and 75 msec gaps.  Additionally, the current study showed a therapeutic benefit of 
immediate Epo administration following HI injury in P7 rat pups on these same tasks, 
again replicating prior work (McClure et al., 2006; McClure et al., 2007).   
 However, the current study demonstrated little to no therapeutic benefit following 
a 60 or 180 minute delayed injection of Epo following P7 HI injury when treated subjects 
were compared to sham treated animals on rapid auditory processing tasks in juvenile and 
adulthood periods.  Additional studies are needed to evaluate the potential therapeutic 
effects of a single delayed injection of Epo on other behavioral tasks, including other 
cognitive domains or sensorimotor tasks.  Additionally, ventricular pathology scores 
revealed a trend in the difference between left and right ventricular volume in the HI 
saline group and a significant difference in the HI Epo 180 group.  For both groups the 
right ventricle was larger than the left, as expected (given unilateral HI injury), noting 
that in several cases, tissue with a high degree of ventriculomegaly and cortical atrophy 
was compromised and therefore dropped. We suggest that if these more severely 
damaged HI brains had been included, the ventricular differences between HI and sham 
subjects likely would have reached significance. In the sham and HI Epo 0, there was no 
significant difference found between left and right ventricular volume.  For the HI Epo 60 
group, although the right ventricular volume was larger than the left, this comparison did 
not reach significance. 
Mechanisms of Epo Action 
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 Previous research has shown therapeutic effects of Epo administration following 
neonatal brain injury specifically in the central nervous system for both human infants 
and animal models.  In the central nervous system, Epo appears to mediate protective 
effects via the endogenous Epo-receptor (Ghezzi et al., 2004; Dame et al., 2001).  
Moreover, Epo receptors are expressed in both neonatal and adult brains (Dame et al., 
2001), and are up-regulated in ischemic areas in a neonatal focal ischemic injury model 
in rodents. Specifically, EpoR expression increases on neurons, microglia, and 
endothelium of blood vessels in the ischemic areas within 24 hours post insult following 
focal cerebral ischemia in 7 day old rat pups (Wen et al., 2004).  Increased Epo 
expression is also found in the cerebral spinal fluid of infants diagnosed with IVH as 
compared to controls (Juul et al., 1999).   
Studies have further shown that cell death following neonatal HI injury in a 
rodent model seems to occur in two phases: necrosis (an early or immediate response to 
HI) and apoptosis (secondary or delayed response to HI; Northington et al., 2001). Once 
in the central nervous system, Epo seems to exert beneficial effects primarily by 
preventing the apoptotic cascade, although some early anti-inflammatory effects are also 
seen.  Specifically, when Epo binds to its receptor, Janus kinase 2 (Jak 2) is activated, 
leading to the phosphorylation of signal transducer and activator of signal transduction 
and transcription 5 (Stat 5; Ghezzi et al., 2004; Sola et al., 2005).  These events lead to 
the up-regulation of anti-apoptotic genes such as Bcl-xL, a part of the Bcl family (Ghezzi 
et al., 2004).  Additionally, Epo treatment following a P7 HI injury in rodents has been 
found to down-regulate pro-apoptotic genes Bax and DP5 [34] and to prevent DNA 
fragmentation associated with apoptosis (Spandou et al., 2004).  Lastly, Epo, when bound 
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to its receptor, modulates calcium influx into the cell, further preserving the cell’s 
integrity (Ghezzi et al., 2004).  
Timing of cell death cascades following HI injury 
 Further research has shown that apoptotic cell death markers are heightened at 
different time points regionally within the rat brain following injury.  Areas such as 
cortex, striatum, globus pallidus, and CA1 show a high density of apoptotic cells 
approximately 6-12 hours following a P7 HI injury in the rat, and these remain elevated 
for up to 7 days post injury (Nakajima et al., 2000). Other areas, however, such as CA3, 
dentate gyrus, subiculum, and thalamus show more of a bell-shaped expression of 
apoptotic cells over time, where peak density is seen between 24 and 72 hours, followed 
by a decline in expression (Sola et al., 2005). Following a 5,000 U/kg i.p. injection, 
rodent brains have shown a peak expression of Epo at ten hours, with concentrations 
elevated for about 24 hours post injection (Statler et al., 2007).  Thus an immediate post-
injury i.p. injection of Epo should be expressed in the brain 10 hours after injury -- 
around the same time apoptotic cells are first seen to be highly expressed.   
Based on the above, a 60 minute delayed injection of Epo would be expressed in 
the brain just 11 hours after HI injury (and 180 minute delayed injection expressed in the 
brain 13 hours post injection), which certainly falls in the spectrum of apoptotic cell 
expression following HI injury. However, it may be that once critical aspects of the 
apoptotic cell death cascade are initiated, the process becomes increasingly difficult to 
reverse.  Thus an immediate injection of Epo may reach the brain in time to interfere with 
the very early events of the cell death cascade following HI - specifically, the 
inflammatory response (a part of necrosis) as well as activation of N-Methyl-D-aspartic 
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acid (NMDA) glutamate receptors (Banasiak et al., 2000), and early phases of apoptosis.  
In fact, in vitro models reveal that neurons pretreated with Epo showed increased 
survival in hypoxic neuronal cultures as compared to cells with no Epo treatment, an 
effect that appears to be due to Epo inhibiting glutamate release stimulated by hypoxia 
(Xu et al., 2009).  In vivo, treatment with Epo prior to induction of P7 HI injury also was 
shown to attenuate brain injury and decrease the amount of inflammatory mediators (such 
as interleukin 1β and tumor necrosis factor –α; Sun et al., 2005).  Additionally, 
pretreatment with Epo (300 U/kg) prior to induction of hypoxia has been shown to inhibit 
apoptosis (with the use of DNA ladder and TUNNEL staining; Sun et al., 2004); to 
protect both astrocytes and glia (Epo at 100 U/kg; Yamada et al., 2004); decrease the 
expression of caspase-3 (Epo at 30,000 U/kg; Brissaud et al., 2010); and decrease the 
expression of pro-apoptotic genes Bax and DP5 (Epo at 1,000 U/kg; Kumral et al., 2006).  
Thus, although Epo has been shown to work on multiple facets of the apoptotic cascade, 
interference with the very early factors might also be necessary to a fully therapeutic 
benefit of immediate Epo treatment following HI injury.  
Given these findings, it remains difficult to ascertain a basis for a specific critical 
temporal deadline, after which therapeutic benefits can no longer be obtained. Our 
behavioral findings, however, suggest that if Epo levels do not “reach the brain” within 
10 hours following injury – the time frame seen with immediate injection, and 
corresponding to peak apoptosis in cortical tissues – then the activation of cellular 
apoptotic cascades may reach levels at which subsequent Epo intervention can no longer 
reverse the process. Notably, some data suggests that when subsequent injections are 
combined WITH an immediate injection, additional benefits from later administration 
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can be obtained. Although speculative, this may reflect the fact that once Epo effectively 
“blunts” critical neural apoptotic cascades, then additional Epo may provide a further 
ameliorative benefit. Alternately, multiple or higher doses of Epo (up to 30,000 U/Kg) at 
a delay following injury could provide therapeutic benefits where the single does of Epo 
provided here at 1,000 U/Kg was not effective. For example, clinical studies have used 
multiple injections of Epo over days in both preterm and HIE infants (Bierer et al., 2006; 
McPhearson & Juul et al., 2010; McAdams et al., 2012; Zhu et al., 2009; Elmahdy et al., 
2010), and have shown improvements in a variety of cognitive and motor tasks.  Animal 
studies have also shown an improvement with multiple Epo injections in neonatal brain 
injured rodent models.  One study investigating the therapeutic effect of multiple doses of 
Epo (1 U/g at 0h, 24h, and 7 days post injury) following a P10 medial cerebral artery 
occlusion revealed that animals treated with multiple doses scored better on a spatial 
learning and memory tasks, and also showed increased regional and hemispheric volumes 
compared to non-treated animals and animals treated with a single dose of Epo (Gonzalez 
et al., 2008).  Furthermore, when Epo (1,000 U/kg) was administered at multiple time 
points starting 48 hours post P7 HI injury, treated animals showed increased 
oligodendrogenesis and maturation of oligodendrocytes, enhanced neurogenesis, 
attenuated white matter injury and improvements on sensorimotor tasks as compared to 
non-treated animals (Iawi et al., 2010).  Clearly, future studies with repeated injections 
are needed to determine the full therapeutic window for Epo at multiple or higher doses.   
 Nonetheless, it is important to note that our results are consistent with a study by 
Keller et al., (2006).  Here, researchers used an intracranial injection of ibotenic acid in 
P5 mice to mimic the effects of PVL in preterm neonates.  Animals who received a single 
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injection of Epo (at 5,000 U/kg) showed attenuated lesion size when the drug was 
administered less than an hour after injury.  Delayed administration (4, 8, or 12 hours 
post injury), however, was found to have no therapeutic effect (Keller et al., 2006).  Our 
current study showed similar evidence of a therapeutic time window for efficacy of Epo 
following neonatal brain injury in rodent models.  Specifically, we showed beneficial 
effects of Epo when administered immediately following the induction of injury, with 
little to no benefit when administration was delayed for an hour or more post injury.  
Additional studies are needed to fully understand the effects of delayed administration of 
Epo following HI injury along with the possible importance of these finding to clinical 
populations.  Finally, future studies should include assessment of RAP in female HI 
injured animals treated with Epo, noting that prior studies have failed to show a robust 
RAP deficit as typically seen in males (Hill et al., 2012), thus providing little platform to 
identify any “improvements” following treatment.    
Conclusions 
The current study extends previous findings showing that immediate treatment 
with Epo following P7 HI injury in a rodent models yields positive therapeutic effects on 
rapid auditory processing tasks, as well as reducing gross brain injury as measured by 
ventricular indices.  We report here that delaying treatment with Epo for one to three 
hours hour results in no measurable benefits on RAP and histological measures.  Future 
studies will need to more carefully examine the effects of Epo administration during the 
time window under 60 minutes following injury. Future studies should also investigate 
the use of both multiple doses after a delay, higher doses (up to 30,000 U/kg) after a 
delay, and potential protective effects of Epo in females following neonatal HI. In 
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closing, these findings may have critical implications in suggesting that time is truly “of 
the essence” in providing clinical therapeutic interventions for neonates with HI, and this 
issue should be further studied in human clinical trials.  Further, while the results of the 
study presented here are specifically relevant to the clinical efficacy of delayed Epo 
treatment in term HIE populations, future work should explore the relevance of the 
findings for preterm and other neonatal HI populations as well. 
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Figure 1. A repeated measures ANOVA revealed a trend towards a Treatment effect 
(p=.085, one-tail) on silent gap detection, with HI saline animals performing worse than 
shams. Scores represent mean attenuated response (cued/uncued*100), and lower scores 
indicate better performance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 105 
 
 
 
 
Figure 2. A repeated measures ANOVA revealed no differences in Treatment between 
HI Epo immediate groups and Sham groups, but did show a significant Treatment effect 
between HI Epo 60 minute delay and shams (p<.05), as well as significant Treatment 
effect between HI Epo 180 minute delay and shams (p<.01) on silent gap detection. 
Scores represent mean attenuated response (cued/uncued*100), and lower scores indicate 
better performance. 
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Figure 3. A repeated measures ANOVA revealed a significant overall Treatment effect 
between HI saline and sham groups (p<.05, one-tail) on FM sweep detection. Scores 
represent mean attenuated response (cued/uncued*100), and lower scores indicate better 
performance. 
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Figure 4. A repeated measures ANOVA revealed no significant differences in Treatment 
between HI Epo immediate and sham groups, but did reveal a trend towards a Treatment 
effect (p =.062) between HI Epo 60 minute delay and sham groups, and a significant 
Treatment effect (p <.05) between HI Epo 180 minute delay and sham groups on FM 
sweep detection. Scores represent mean attenuated response (cued/uncued*100), and 
lower scores indicate better performance. 
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Addendum I 
 
Evaluation of the therapeutic benefit of delayed administration of erythropoietin 
following early hypoxia-ischemic injury in rodents 
 
Correlation Analysis 
 
 For further assessment of the relationship between rapid auditory processing 
deficits and neuropathology in HI injured rodents treated with Epo, we analyzed RAP 
scores and right ventricular volume within Epo treated groups only (HI Epo 0, HI Epo 60, 
and HI Epo 180).  In order to run a correlation analysis, we averaged Att scores across 
gaps for each day for the SG 0-100 task and across days for the FM Sweep task.  
Bivariate correlations were run between right ventricular volume and SG 0-100 averaged 
Att scores or FM Sweep averaged Att scores across all the three HI Epo treated groups. 
Results showed a trend for a significant correlation between averaged juvenile Att scores 
on Day 2 of SG 0-100 task and right ventricular volume (r=.281, p=.081) and a trend for 
a significant correlation between averaged FM Sweep Att scores and right ventricular 
volume (r=.306, p=.061).  In both cases, larger ventricles were associated with worse 
scores.  
 These results suggest that right ventriculomegaly following P7 HI injury is related 
to later deficits in rapid auditory processing.  However, given the numerous areas of the 
brain that are engaged in subserving auditory processing as well as the varied cellular 
neuropathology following neonatal HI, this might be more of an indirect relationship 
rather than right ventricular volume serving as a direct link to RAP deficits.  
Additionally, these analyses failed to reach significance.  However, brains with a high 
degree of damage were increasingly difficult to process and as a result tissue from 
animals with a high degree of ventriculomegaly were not sampled thoroughly due to 
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tissue loss.  If this tissue had been able to be processed and analyzed our correlational 
analysis may have reached significance. 
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Abstract 
Hypoxia Ischemia (HI) refers to the disruption of blood and/or oxygen delivery to 
the brain. Term infants suffering perinatal complications that result in decreased blood 
flow and/or oxygen delivery to the brain are at risk for HI. Among a variety of 
developmental delays in this population, HI injured infants demonstrate subsequent 
memory deficits. The Rice-Vannucci rodent HI model can be used to explore behavioral 
deficits following early HI events, as well as possible therapeutic agents to help reduce 
deleterious outcomes. Caffeine is an adenosine receptor antagonist that has recently 
shown promising results as a therapeutic agent following HI injury. The current study 
sought to investigate the therapeutic benefit of caffeine following early HI injury in male 
rats. On post-natal day (P) 7, HI injury was induced (cauterization of the right common 
carotid artery, followed by two hours of 8% oxygen). Male sham animals received only a 
midline incision with no manipulation of the artery followed by room air exposure for 
two hours. Subsets of HI and sham animals then received either an intraperitoneal (i.p.) 
injection of caffeine (10 mg/kg), or vehicle (sterile saline) immediately following 
hypoxia. All animals later underwent testing on the Morris Water Maze (MWM) from 
P90 to P95. Results show that HI injured animals (with no caffeine treatment) displayed 
significant deficits on the MWM task relative to shams. These deficits were attenuated by 
caffeine treatment when given immediately following the induction of HI. We also found 
a reduction in right cortical volume (ipsilateral to injury) in HI saline animals as 
compared to shams, while right cortical volume in the HI caffeine treated animals was 
intermediate. These findings suggest that caffeine is a potential therapeutic agent that 
could be used in HI injured infants to reduce brain injury and preserve subsequent 
cognitive function. 
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 Introduction 
Children born prematurely (less than 37 weeks gestational age) or at very low 
birth weight (VLBW; less than 1500 g) are at increased risk for hypoxic-ischemic (HI) 
injury, resulting from decreased blood and/or oxygen flow to brain tissue (Volpe, 2009). 
HI injury and encephalopathy (HIE) can also occur in full-term infants following birth 
complications (i.e., asphyxia, cord prolapse or placental disruption; de Vries et al., 2009; 
Vannucci, 2000; Volpe, 2008). Cognitive delays are seen later in life in both premature 
and full-term HI injured populations. For example, children born prematurely showed 
reduced memory quotient scores on the Weshler’s Memory Scale in childhood (Briscoe 
et al., 1998), as well as deficits on a spatial working memory task (Vicari et al., 2004). 
Children born very prematurely also showed later deficits on a visuospatial memory task 
when compared to healthy age-matched controls. Furthermore, the severity of their brain 
injury at birth negatively correlated with later test scores on verbal and visuospatial tasks 
(Luu et al., 2011). Neural structures associated with memory abilities are also known to 
be affected by HI injury. For example, hippocampal volume was positively correlated 
with visual working memory scores in two year old children born prematurely (i.e., 
smaller volumes/lower scores). Preterm infants with smaller hippocampal volumes also 
showed deficits on a visual working memory task when compared to non-injured infants 
(Beauchamp et al., 2008). Similar effects have been seen in full-term HI injured infants 
where severe injury (diagnosed at birth) was associated with later deficits in various 
memory tasks such as memory for names, narrative sentence repetition, and “everyday 
memory tasks”, when compared to scores from children with a mild-moderate injury 
(Marlow et al., 2005).  
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Rodent models can be used to further investigate the effects of neonatal HI brain 
injury on subsequent behavioral and cognitive outcomes. One well characterized 
technique involves cauterization of the right common carotid artery on postnatal day (P) 
7 rat (roughly corresponding 34–36 weeks gestational age in human infants), followed by 
a period of decreased oxygen exposure. This P7 HI model simulates both behavioral and 
pathophysiological outcomes as seen in term HI injured infants, including memory 
deficits (Vannucci & Vannucci, 1997; Vannucci & Vannucci 2005). For example, P7 HI 
animals performed worse on the Morris Water Maze (MWM; a test of spatial navigation 
and learning) compared to sham animals (Delcour et al., 2012; McClure et al., 2005; 
McClure et al., 2007; Arteni et al., 2003; Arteni et al., 2010; Ikeda et al., 2001). Along 
with spatial memory function, P7 HI injured animals also show deficits in choice reaction 
time tasks (Ideka et al., 2001), place learning tasks (Arteni et al., 2003), and spatial 
working memory tasks (Arteni et al., 2003; Arteni et al., 2010; Ikeda et al., 2001). In 
addition to behavioral deficits, HI injured animals show reductions in gray matter volume 
(e.g., cortex and hippocampus), along with increased ventricular volume in post-mortem 
histological analysis (Hill et al., 2011; McClure et al., 2005; McClure et al., 2006). 
Given deficits in behavior in the P7 HI rodent model, coupled with observed 
reductions in gray matter volume, we were interested in studying therapeutic agents that 
might attenuate injury and improve outcomes in this model. Caffeine is a promising agent 
that has recently gained attention as having potential to help mitigate some of the long-
term behavioral deficits and neuropathology evident in HI injured infants. Caffeine is a 
non-selective adenosine receptor (AR) antagonist clinically used to increase respiratory 
drive in order to wean premature infants off ventilation and provide treatment of apnea of 
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prematurity. Extensive research has characterized the regional distribution and function 
of adenosine receptor sub-types in the rodent brain, though much of this research derives 
from adult models and evidence suggests that AR function may differ in the neonatal 
brain (Cunha et al., 2005). The major adenosine receptor subtypes include adenosine (A) 
1 receptor (A1R), A2AR, A2BR and A3R (Rivkees et al., 2001; Fredholm et al., 2005). 
By adulthood, A1R mRNA is widespread in the brain, and is found at its highest levels in 
the hippocampus, cerebellum, and cerebral cortex (Fredholm et al. 2005). A2AR mRNA 
is highly enriched in the striatum, globus pallidus, and is also found in astrocytes, 
microglia, and blood vessels throughout the brain (Fredholm et al., 2005). A3Rs are 
present in nerve terminals of cortical and hippocampal cells, astrocytes, and microglial  
cells (Fredholm et al., 2005). In the adult rodent brain, caffeine shows a high affinity for 
the A1R, A2AR and A3R, and a low affinity for A2BR. Caffeine has also been found to 
inhibit phosphoidesterase, promote the release of calcium from intracellular stores, and 
interfere with GABA-A receptor function, although these effects are seen at caffeine 
doses well outside of therapeutic ranges and thus are not candidate mechanism for the 
current model (Fredholm et al., 2005; Ribeiro et al., 2010). More data is clearly needed to 
fully characterize caffeine/adenosine receptor interaction in the neonatal brain, but 
caffeine has nonetheless shown beneficial neuroprotective effects following neonatal HI 
injury. For example, in addition to improving respiration, caffeine has also been found to 
improve the rate of survival without disability in premature infants, as well as decrease 
the incidence of cerebral palsy and neurodevelopmental delay (Schmidt et al., 2006; 
Schmidt et al., 2007; Stevenson et al., 2007; Bentiz et al., 2008; Gray et al., 2011). 
Preterm infants treated with caffeine for two hours (via intravenous injection) also 
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showed increased cortical activity as measured by EEG (Supcun et al., 2010). Finally, 
when neonatal mice were reared in an hypoxic environment from P3 to P14 with a dam 
provided ad libitum caffeine in drinking water, treated pups showed increased 
myelination, more normally arranged axons, increased proportion of oligodendrocytes, and 
decreased ventricular volume as compared to hypoxic mice who were not exposed to 
caffeine (Back et al., 2006).  
To our knowledge no studies have directly investigated the therapeutic benefits of 
caffeine on behavioral outcomes following P7 HI injury in the rat. Although other 
neuroprotective methods such as whole body or head cooling have been used to treat HI 
injury in infants, the development of a more widely available (i.e., injectable) 
intervention might help improve infant outcomes following HI injury. Thus, the current 
study sought to investigate the effectiveness of caffeine treatment following HI injury in 
P7 rat pups. We hypothesized that rat pups treated with caffeine would show improved 
scores on the MWM and attenuated grey matter loss when compared to vehicle treated HI 
animals.  
Methods 
 Subjects  
Subjects were male Wistar rats born to time mated dams (Charles River 
Laboratories, Wilmington, MA, USA). Dams were shipped to the University of 
Connecticut on embryonic day 4 (E4), and were housed in tubs in an approved animal 
facility. Upon birth (P1), litters were culled to 10 pups (8 males and 2 females per litter). 
Only male pups were used in the current study, based on established sex differences 
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between males and females following HI injury (with males showing a more robust 
pattern of deficits than females; Hill et al., 2012). Two female pups were retained in each 
liter to maintain normal maternal behavior. Subjects were weaned on P21 and pair housed 
with like-treated littermates until P55, when they were single housed for the duration of 
the study. All subjects were housed in a 12-h light/dark cycle with food and water 
available ad libitum.  
Induction of Hypoxia Ischemia 
On P7, each pup was randomly assigned one of four treatment groups: HI vehicle 
(sterile saline), HI caffeine, sham vehicle, or sham caffeine. All treatment conditions 
were balanced across litters. For the HI procedure, pups were anesthetized with isoflurane 
(2.5%) and a midline incision was made longitudinally on the neck on the ventral side. 
The right common carotid artery was located and separated from surrounding tissue, 
cauterized, and the incision was sutured. Pups were marked with a footpad injection to 
indicate treatment group at weaning. Pups were then allowed to recover from the 
anesthesia under a warming lamp, and were returned to their dam for two hours to feed. 
Animals who were assigned to the sham condition were placed under anesthesia, but only 
had a midline incision with no manipulation of the carotid artery. Sham treated pups were 
allowed to recover and were also returned to the dam. Two hours after all pups had 
received the surgery, HI subjects were placed in an airtight oxygen container flowing 8% 
humidified oxygen (balanced with nitrogen) for a period of  
120 min. Sham animals were placed in an open container with room air exposure for the 
same duration.  
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Caffeine Administration 
Immediately following the 120 min chamber exposure, animals received an 
intraperitoneal (i.p.) injection of either caffeine (10 mg/kg) or vehicle (sterile saline in 
comparable volume), and all pups were then returned to their dam. On P21, subjects were 
weaned and paired housed with like-treated littermates for later behavioral testing 
 Behavioral Testing 
Water Escape (P87) 
A one-day water escape task was performed to assess for general motor deficits 
that might confound results. The water escape task involved the use of an oval tub (40.5 
inches x 21.5 inches) filled with room temperature water and a visible platform at one 
end of the tub. Subjects were placed at the end of the tub opposite to the visible platform 
and were timed until they swam to and climbed on top of the platform. Latency to escape 
was recorded for each animal. 
Morris Water Maze (MWM; P90–P95) 
MWM testing lasted for five consecutive days, and was performed in a 48 inch 
diameter hard plastic tub, with a 6 inch diameter platform submerged below the water 
line (so that is was not visible to the subjects). For each trial, the escape platform was 
located in the same quadrant (southeast) in the tub. Water was maintained at room 
temperature. The tub was surrounded by various extra-maze cues in the room (painted 
shapes on the walls, the experimenter, lights), and there were no intra-maze cues. Each 
testing day consisted of four trials in which the start position (north, south, east, west) 
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varied. The start position never repeated in one day and the order varied randomly 
between testing days. Animals were given 45 s to locate and summit the submerged 
platform, and the latency to reach the platform was recorded for each subject for each 
trial. If an animal failed to reach the platform in 45 s, it was gently guided to the platform 
and allowed to sit for 5 s before being removed from the maze. 
Histology 
Upon the completion of behavioral testing, animals were anesthetized with 
Ketamine (100 mg/kg) and Xylazine (15 mg/kg) and transcardially perfused with 0.9% 
saline and 10% buffered formalin phosphate. Brains were removed and placed in the 10% 
buffered formalin phosphate. Prior to slicing, brains were placed in a 30% sucrose 
solution for cryoprotection for 24 h, and were then sliced in a coronal plane at 60 µm on a 
cryostat. Every third section was mounted on a slide and stained using cresyl violet. With 
the use of a Zeiss Imagine A.2 microscope and Micro Bright Field (MBF) Stereo 
Investigator computer software (Willinston, VT, USA) cortical volume was measured 
and calculated using Cavalier’s estimator. Due to complications with the slicing and/or 
staining procedures, some tissue sections were lost, so that there were not enough 
sections to create an accurate representation of total cortical volume in nine rat brains (5 
HI saline and 4 HI caffeine). All measurements were performed blind to treatment group.  
Statistical Analysis 
For all measures we employed planned paired comparisons among HI saline, HI 
caffeine, sham saline, and sham caffeine groups. Specific comparisons based on a priori 
hypotheses were made between: HI saline vs. sham (to confirm replication of HI effects); 
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HI saline vs. HI caffeine (to assess any beneficial effects of caffeine); and HI caffeine vs. 
sham (to determine whether caffeine-treated subjects were equivalent to shams). In 
addition, we compared caffeine versus saline treated shams to ascertain any effects of 
caffeine on normal subjects, and/or to pool shams.  
Repeated Measure Multiple Analysis of Variance (ANOVA) was used to analyze 
MWM scores. Unless stated otherwise, all analyses were two-tailed. In comparing the HI 
saline to sham groups on behavioral and volumetric measurement outcomes, our lab has 
previously shown significant deleterious effects, and thus one-tailed analyses were used 
for these specific comparisons (McClure et al., 2005; McClure et al., 2006; McClure et 
al., 2006). Variables analyzed and presented in the results section for the MWM task 
include Treatment (3 levels; sham [pooled sham saline and sham caffeine], HI saline, and 
HI caffeine) and Day (5 levels). For the MWM task, total latency (in seconds) to reach 
the platform for the four trials each day was the dependant variable. A “Learning Index 
(LI)” score was calculated to assess possible learning differences between groups (i.e., an 
index of slope for each animal). The equation LI = (Day1 latency - Day2) + (Day 2 - Day 
3) + (Day 3 - Day 4) + (Day 4 - Day 5) was applied to each animal, and scores were 
analyzed using a one-way ANOVA. Finally, a non-parametric Kruskal-Wallis ANOVA 
was used to analyze right cortical volumes (i.e., the side of injury) by Treatment, using 
the same paired comparisons delineated above. SPSS 15.0 with a criterion of alpha 0.05 
was used for all analyses.  
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Results 
In preliminary analysis we found no significant difference between sham saline 
and sham caffeine groups for MWM latencies [F(1,6) = 0.673, p > 0.05], and thus for 
further analysis these animals were pooled as “shams”. 
Water Escape (P87) 
A Univariate ANOVA revealed no significant effect of Treatment groups [F(2,35) 
= 0.87, p > 0.05] on water escape latencies indicating comparability in each group’s 
ability to see the platform, and to swim to it.  
Morris Water Maze (P90–P95) 
An initial 5 (Day) x 3 (Treatment) repeated measures ANOVA revealed a 
significant between groups effect of Treatment for the three groups: HI saline, HI 
caffeine and sham [F(2,33) = 4.697,  p < 0.05]. There was also a significant within 
subjects effect of Day [F(4,144) = 6.445, p < 0.01], reflecting decreasing latencies with 
learning. Additional ANOVAs were used to compare specific paired groups. We did not 
see a Treatment x Day interaction.  
A 5 (Day) x 2 (Treatment) repeated measures ANOVA revealed a significant 
Treatment difference between HI saline and sham treated animals [F(1,21) = 3.274, p < 
0.05, one-tailed], with the HI saline group taking longer to reach the platform than shams 
(Figure 1a). A further 5 (Day) x 2 (Treatment) repeated measures ANOVA also revealed 
a significant Treatment difference between HI saline and HI caffeine treated animals 
[F(1,28) = 8.477, p < 0.01], with the HI saline group taking longer to reach the platform 
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compared to the HI caffeine group (Figure 1b). Finally a 5 (Day) x 2 (Treatment) 
repeated measures ANOVA revealed no significant differences between HI caffeine and 
sham animals  [F(1,21) = 0.363, p > 0.05] (Figure 1c). The within variable Day showed a 
trend for the HI saline and sham comparison [F(4,84) = 1.599, p = 0.09, one tailed], but 
was significant for the HI saline vs. HI caffeine comparison [F(4,112) = 2.7, p < 0.05] as 
well as for the HI caffeine and sham comparison [F(4,84) = 2.824, p < 0.05]. As above, 
these Day effects reflect learning. 
Finally, to assess putative learning effects, a “Learning Index” was calculated for 
each animal. The results of a one-way ANOVA revealed no significant difference 
between groups on this measure [F(2,35) = 0.083, p > 0.05], however, scores were in the 
expected direction (shams > HI saline).  
In addition we performed a paired samples t-test between Day 1 versus Day 5 
within each Treatment group. For the HI saline group this effect was non-significant 
[t(14) = 1.22, p > 0.05, one tailed], indicating there was no learning effect over Days. In 
the HI caffeine group, a paired samples  
t-test revealed a significant difference between Day 1 and Day 5 [t(14) = 1.88, p < 0.05, 
one-tailed]. Additionally, in the sham group, a paired samples t-test revealed a significant 
difference for learning as well, [t(7)=1.513, p < 0.05, one tailed].  
Histology 
Volumetric Analysis 
Although the results of a Kruskal Wallis ANOVA did not yield any significant 
results for right cortical volume analysis, scores were in the expected direction (HI saline 
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animals showing the smallest right cortical volume and sham animals showing the 
largest). It should be noted that a lower n was used for analysis in both the HI saline (n = 
11) and HI caffeine (n = 10) groups, due to the fact that brain tissue showing severe 
injury or a high degree of ventriculomegaly became increasingly difficult to process. 
These technical confounds weakened the power of this analysis although again, the 
expected differences in means (HI saline < sham) were seen [for HI saline, M = 68.2 
mm3 SD = 9.2 and for sham, M = 75.2 mm3 SD = 5.9]. 
Discussion 
The current study provides evidence for protective effects of caffeine following a 
P7 HI injury in a rodent model. Outcomes include behavioral measures on the MWM and 
histological measures of right cortical volume. HI saline animals had significantly longer 
latencies to reach the platform on the MWM as compared to shams, replicating prior data 
(declour et al., 2012; McClure et al., 2005; McClure et al., 2007; Arteni et al., 2003; 
Arteni et al., 2010; Ikeda et al., 2001). Caffeine treatment immediately following HI 
injury preserved spatial memory function, with HI caffeine animals showing significantly 
shorter latencies to reach the platform than HI saline. Additionally, Learning Index scores 
were calculated for each animal across days, and analysis revealed no differences 
between the three groups. This suggests all animals could learn the task, but that HI 
saline animals performed worse overall.  
Adenosine in Neonatal HI 
The cognitive deficits as well as neuropathological changes evident following 
neonatal HI injury are thought to be mediated in part by elevated adenosine levels 
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following HI. Typically in neonatal rodents, interstitial adenosine levels (basal) are 
around 50 nM, but are believed to increase to upwards of 1000 nM during ischemic 
events (Cunha et al., 2005; Rivkees et al., 2001). Additionally, adenosine deaminase 
(ADA), a key enzyme to deaminate adenosine and thus maintain levels of adenosine, is 
also increased following neonatal HI in the cortex (Pimentel et al., 2009) and 
hippocampus (Pimentel et al., 2011). This dramatic increase in adenosine may promote 
accelerated expression of apoptotic activity, leading to a rise in free radical and caspase 
formation (Rivkees et al., 2001). During typical development in rodents, adenosine A1R 
increases in density between P9 and P15. Moreover, although receptors are found 
throughout the brain, highest levels are specifically seen in the cortex and hippocampus 
by adulthood (Cunha et al., 2005). Studies have shown that rodents treated with an A1 
receptor agonist from P9 to P14 exhibit increased ventricular volume, reduced 
periventricular white matter volume, and a reduced number of neurons in the cortex and 
hippocampus (Turner et al., 2002) as well as decreased expression of myelin (Rivkees et 
al., 2001). Theses changes are thought to reflect the fact that excess adenosine binding to 
the A1 receptor leads to the activation of hypoxia-inducing factor (HIF)-α, which in turn 
promotes the apoptotic cascade leading to cell death (Rivkees et al., 2001; Ryzhov et al., 
2007). Additionally, adenosine accumulation following hypoxia is thought to be 
responsible for electrical suppression in the brain. For example, the release of adenosine 
was directly related to the depression of excitatory synaptic transmissions in hippocampal 
slices of P10–24 rats (Dale et al., 2000; Frenguelli et al., 2003) and increased adenosine 
levels following hypoxia as measured in vivo in adult animals led to suppressed 
electrically evoked synaptic transmission (Ilie et al., 2006). Again these latter deleterious 
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effects are thought to be mediated via activation of A1Rs. Consistent with the negative 
effects of A1 receptor activation in the neonatal brain, blockade of the A1 receptor has 
been found to exert protective effects in HI injured mice (Turner et al., 2003). For 
example, knock-out mice deficient in the A1 receptor and reared in a hypoxic chamber 
from P3 to P14 showed decreased ventricular volume and increased white matter density 
as compared to wild-type HI mice that did express the A1 receptor (Dale et al., 2000).  
Although the effects of adenosine expression and resulting brain damage following 
early HI injury appears to be primarily mediated through the A1 receptor, activation of 
the A2A receptor has also been implicated. For example, knock-out mice for the A2A 
(A2A -/-) receptor that had HI injury induced on P7 were evaluated three weeks to three 
months later, and brain injury was found to be exacerbated in the A2A -/- animals as 
compared to wild types. Furthermore, A2A -/- animals also showed impairments on rota-
rod and beam walking tasks (Aden et al., 2003). Since A2A receptors are located on the 
capillaries, an over-activation resulting from adenosine increases after HI injury could 
contribute to intraventricular hemorrhage via rupture of these vessels (although this has 
not been empirically demonstrated) (Rivkees et al., 2001). In sum, A2A receptor 
activation is not well understood in development but may play a role in HI pathology.  
 Caffeine Treatment Following Neonatal HI 
In the adult brain, the effects of caffeine are primarily mediated through 
antagonism of A1Rs and A2ARs (Fredholm et al., 2005; Fredholm et al., 1999), where 
antagonism of A1 affects transmitter release and neuronal firing, and antagonism of 
A2As seems to affect dopaminergic transmission (Fredholm et al., 1999(. Additionally, 
caffeine has been shown to attenuate long-term potentiation in hippocampal slices 
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(Costenla et al., 2010). The neuroprotective effects of caffeine following neonatal HI, 
however, are primarily via antagonism of the A1 receptor (Rivkees et al., 2011), 
consistent with evidence that AR antagonism appears to be mediated differently in the 
adult brain as compared to the embryonic fetal and neonatal brain (Stevenson et al., 
2007). Importantly, in the neonatal brain, A1R activation offers no protection in 
ischemia-induced damage but instead is associated with brain injury (Cunha et al., 2005). 
Studies have shown deleterious effects of caffeine (not seen in adults) during normal fetal 
brain development, including a wide array of behavior, neurochemical, and 
electrophysiologic changes (Aden et al., 2011; da Silva et al., 2008; Yazdani et al., 1988; 
Guillet et al., 1991; Silva et al., 2012). However, serum caffeine levels in caffeine treated 
premature infants were found to be correlated with a change in pro-inflammatory and 
anti-inflammatory cytokine levels in the peripheral blood, with a greater concentration of 
anti-inflammatory molecules correlated with higher levels of caffeine (between 10 and 20 
µg/mL). Additionally, reductions in interleukin (IL)-6 and tumor necrosis factor (TNF)-α 
(both pro-inflammatory) and increases in IL-10 (anti-inflammatory) were seen in these 
subjects (Chavez-Valdez et al., 2011). Finally, activation of A2ARs and A2BRs (located 
on capillaries; Fredholm et al., 2005) could induce capillary leakage, which might 
contribute to hemorrhages and HI. Thus antagonism of A2ARs and A2BRs may explain 
in part why caffeine treated infants show lower incidence of intra-ventricular hemorrhage 
(IVH; Rivkees et al., 2001). Caffeine treatment also down-regulates TNF-α and the 
release of cytokines in response to lipopolysaccharides (an endotoxin that elicits a large 
inflammatory response from the immune system; LPS) in term injured infants (Chavez-
Valdez et al., 2009). There are likely to be additional cellular factors involved in 
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cognitive protection based on the work of others. For example, in cultured developing 
cortical neurons, caffeine enhanced CREB dependant gene expression and mediated the 
activity-dependant BDNF and TrkB expression (Connolly et al., 2010). Neonatal mice 
reared in hypoxia treated with caffeine also showed more normally arranged axon 
orientation and increased the proportion of immature oligodendrocytes (Back et al., 2006). 
Premature baboons treated with caffeine also showed improved myelination (Rivkees et al., 
2011). Similarly, a study investigating the effects of induced early life convulsions in P7 
rodents, injured animals showed deficits in selective memory in adulthood and a loss of 
presynaptic glutamate terminals. Caffeine prevented these memory deficits and prevented 
the loss of nerve terminal markers in the hippocampus (Cognato et al., 2010). Although 
loss of gross brain volume is a significant complication following neonatal HI injury, it 
could be that the protective effects of caffeine allow in part for cellular reorganization 
and plasticity effects contributing to the rescue of behaviors. Additional studies are 
needed to confirm this hypothesis and to characterize how different cell types might 
reorganize themselves in order to prevent brain injury and resulting behavioral deficits 
following early HI injury.  
Central versus Peripheral Effects of Caffeine Treatment 
As stated above, caffeine was originally used in premature infants to improve 
respiratory drive and treat apnea of prematurity by decreasing the threshold for sensitivity 
of hypercapnia, and increasing contractility of the diaphragm (Charles et al., 2008). 
Caffeine has also been shown to lead to a decreased rate of bronchopulmonary dysplasia 
in treated compared to non-treated premature children (Schmidt et al., 2006) as well as 
improved cognition at 18 months. Due to improved and more consistent adequate blood 
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oxygenation in these treated infants, it is not possible to conclude definitely that the 
neuroprotective effects of caffeine in this population are mediated exclusively by central 
brain related changes versus the elimination of intermittent hypoxia. Animal models 
expressing the A1 receptor show suppression of respiratory drive with adenosine, and 
stimulation of respiratory drive with caffeine, while in A1R knock-out mice for A1Rs, 
adenosine showed no suppressive effects on respiratory drive, and no stimulatory effects 
with caffeine (Rivkees et al., 2001). Blockade of A2A receptors are also implicated in the 
neuroprotective role of caffeine. Specifically, in the medulla of the brainstem (an area 
implicated in cardiac function and respiratory drive), about half of the GABAergic 
neurons (measured by in situ hybridization and retrograde tracing) express mRNA for 
A2A receptors in the developing mouse brain. This suggests that A2A receptors might 
play an important role in respiration early in life as well (Zaidi et al., 2006). While brain 
injury in premature infants are typically associated with repetitive respiratory-induced 
mild to moderate drops in brain oxygenation over a period of weeks, hypoxia brain injury 
in term infant are generally perinatal acute events, much like the acute injury used in our 
rodent model. Thus we hypothesize the neuroprotective effects of caffeine in our model 
are due to the direct effect of caffeine via the interaction with the adenosine receptor and 
not due to changes in breathing and long term improved oxygenation.  
Conclusions 
Here, we replicated prior reports that HI injury in a P7 rodent leads to behavioral 
deficits on the MWM task, and provide new evidence that these deficits can be 
ameliorated with the use of caffeine treatment immediately following the induction of 
injury. Evidence suggests that these effects may be largely mediated via caffeine 
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antagonism of A1 receptors, although this hypothesis must be empirically tested. In 
closing, additional studies are needed to determine the possible neuroprotective role of 
caffeine for other behavioral modalities, and neuroanatomical alterations, in both rodent 
models and human trials. Future studies could investigate the effects of delayed and/or 
multiple injections of caffeine, varied caffeine dosage, caffeine coupled with other 
therapeutic agents, or in combination with hypothermia treatment.  
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Figure 1. (a–c) Total latencies (in seconds) across 4 trials/day are shown. (a) A 
significant difference between HI saline and sham was seen [F(1,21) = 3.274, p < 0.05, 
one tailed], with HI saline performing significantly worse than shams. (b) A significant 
difference between HI saline and HI caffeine treated animals was seen [F(1,28) = 8.477, 
p < 0.01], with HI saline animals performing significantly worse than HI caffeine. (c) No 
significant differences in treatment were seen between HI caffeine and sham animals 
[F(1,21) = 0.363, p > 0.05]. For all graphs, error bars represent standard error. 
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Abstract 
 Hypoxic ischemic (HI) injuries can occur in neonates due to compromised blood 
and/or oxygen flow to the brain.  Infants born prematurely (<37 weeks gestational age) or 
at very low birth weight (VLBW; <1500 grams) - - along with term born children 
suffering from birth complications - - are at increased risk for HI injury.  Cognitive 
deficits are common in both populations, and these include delays in language 
development and memory processes.  Caffeine is one promising neuroprotectant found to 
reduce deleterious outcomes following neonatal HI injury.  These possible therapeutic 
effects of caffeine can be further explored using neonatal rodent HI models.  The current 
study explored the effects of both immediate and delayed caffeine administration 
following induced neonatal HI injury in rats.  Specifically, on postnatal day (P) 7, an 
insult was implemented by cauterization of the right carotid artery followed by two hours 
of 8% oxygen, while sham animals received a midline incision but no cauterization of the 
artery and exposure to room air.  Following treatment, a subset of HI and sham animals 
received an intraperitoneal injection of caffeine (10 mg/kg) or vehicle (sterile saline) 
immediately following the induction of injury, while the other subset of HI and sham 
subjects received a comparable injection at a 60-minute delay.  Beginning on P25, 
animals were tested on a variety of behavioral auditory processing and memory tasks.  
We found that caffeine treatment immediately following neonatal HI injury appeared to 
protect against learning/memory deficits, but not auditory processing deficits.  We also 
demonstrated that delaying caffeine treatment by an hour compromised the therapeutic 
effectiveness of treatment on the learning/memory tasks.  The current findings suggest 
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task-specific benefits of this agent, as well as reduced efficacy at delay, and thus our 
finding are relevant to the treatment of neonatal HI injuries in human populations.   
Introduction 
 Children born prematurely (<37 week gestational age) or at very low birth weight 
(VLBW; <1500 grams) are at increased risk for hypoxic ischemic (HI) injury (Annibale 
& Hill, 2008; Volpe, 2001; Volpe, 2009). Term infants suffering from birth 
complications (e.g., asphyxiation, placental disruption/failure, cord prolapse) are also at 
risk for HI injury (de Vries & Cowan, 2009; Johnston, et al., 2001; Lai & Yang, 2011; 
Volpe, 2001).  In premature/VLBW infants, HI injury can arise due to the fragile vascular 
system and poor cerebral autoregulation, with pressure fluctuations leading to ruptures 
resulting in interventricular hemorrhage/periventricular hemorrhage (IVH/PVH; Volpe, 
1997; Volpe, 2009).  Drops in pressure can also lead to ischemic reperfusion failure, 
leading in turn to non-hemorrhagic ischemic injuries such as periventricular leukomalacia 
(PVL; Volpe, 2001).  Premature HI injury is commonly associated with damage to white 
matter fiber tracts, and some gray matter (Volpe, 2009).  Full term HI infants are more 
commonly diagnosed with hypoxic ischemic encephalopathy (HIE), which is a more 
global form of injury affecting predominantly gray matter areas such as the cortex, 
hippocampus, basal ganglia, and thalamus (Huang & Castillo, 2008; Martinez-Biarge, et 
al., 2011).      
 Although the cause and location of HI injuries can differ between these two 
populations, both exhibit later cognitive delays, including deficits in language (Jansson-
Verkasalo et al., 2003; Steinman et al., 2009), as well as learning/memory processes 
(Briscoe et al., 2001; Gimenez et al., 2004; Luu et al., 2011; Luu, et al., 2011; Vicari, et 
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al., 2004).  With regard to language deficits, children born prematurely were found to 
require more support in spelling, reading and writing skills, and to exhibit deficits in 
receptive and expressive language skills (Luu et al., 2009; Ortiz-Mantilla, et al., 2008; 
Van Lierde et al., 2009).  Furthermore, at two years of age, VLBW infants showed 
significantly lower scores on language comprehension tasks, and at four years these 
scores correlated with language performance (Jansson-Verkassaio et al., 2003).  At age 6, 
these same subjects showed alterations in mismatched negativity during a naming task, as 
well as difficulty in preattentively discriminating changes in syllables (Jansson-
Verkassaio et al., 2004).  Full term injured infants diagnosed with moderate to severe 
HIE also showed receptive language, reading, and spelling scores that were significantly 
lower than healthy full term controls (as measured in childhood; Badawi et al., 2001).  
Furthermore, another study showed that in term HI injured infants, the degree of global 
brain injury (as measured at birth) correlated significantly with verbal IQ scores at 4 
years (Steinman et al., 2009).  Rapid auditory processing (RAP; the ability to 
discriminate differences between rapidly presented auditory cues), is one proposed 
mechanism crucial to proper language development.  In fact, studies have demonstrated 
that children diagnosed with moderate to severe PVL at birth showed deficits on RAP 
tasks later in childhood (Downie et al., 2002).  Furthermore, deficits in RAP early in life 
correlated significantly with and were predictive of later language impairments in both at-
risk and typically developing populations (Benasich & Tallal, 2002; Choudhury et al., 
2007). 
 With regard to memory deficits, children born extremely prematurely showed 
deficits on a short-term non-word working memory task as well as a sentence 
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comprehension task (Briscoe et al., 1998).  Using the Wechsler Memory Scale in 
childhood, children born prematurely also showed lower than expected memory quotient 
scores based on verbal IQ (Gadian et al., 2000).  Decreased activation of the caudate 
nucleus (measured by fMRI), as well as poorer performance on a spatial memory task, 
were also seen in children born prematurely (Curtis et al., 2006).  Term injured infants 
with severe HI (diagnosed at birth) that were tested at 7 years of age showed deficits on 
various memory tasks, including memory for names, narrative memory sentence 
repetition, and “everyday memory tasks,” as compared to children with a mild to 
moderate insults (Marlow et al., 2005).   
 Animal models can be used to further explore the negative effects of neonatal HI 
injury.  One common model used is the Rice-Vannucci model. Here, the right common 
carotid artery is cauterized, followed by exposure to decreased oxygen levels for a period 
of time (typically 90 –150 minutes; Vannucci & Vannucci, 2005).  When this type of 
injury is induced on postnatal day (P) 7-10, subsequent neural anomalies are seen 
predominantly in gray matter areas (corresponding to term birth HI injury; Vannucci & 
Vannucci, 2005).  Animals who received an HI injury on P7 also showed subsequent 
deficits on RAP tasks during both juvenile and adult periods (Alexander et al., 2013; Hill 
et al., 2013; McClure et al., 2005; McClure et al., 2005; McClure et al., 2006).  These 
deficits could possibly reflect outcomes related to language deficits in human HI 
populations.  Furthermore, these P7 HI rats also showed gray matter damage in the cortex 
and hippocampus, as well as enlarged lateral ventricular volume, when measured in post 
mortem histological analysis (McClure et al., 2005; McClure et al., 2005; McClure et al., 
2006; Alexander et al., 2013).  Rodents with a neonatal HI injury also exhibited memory 
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deficits, specifically with P7 HI injured animals showing poorer performance on a spatial 
navigation task as compared to sham animals (Arteni et al., 2003; Delcour et al., 2012; 
Ikeda et al., 2001; McClure et al., 2005; McClure, et al., 2007; Alexander et al., 2013).  
P7 HI injured animals also showed deficits on choice reaction tasks (Ikeda et al., 2001), 
place learning tasks (Arteni et al., 2003), and spatial working memory tasks (Arteni et al., 
2003; Ikeda et al., 2001).  Subjects from these studies further showed reductions in 
hippocampal volume in post mortem histology (McClure et al., 2006; McClure et al., 
2007).   
 Given the various deficits observed following neonatal HI injury in both human 
and rodent models, various neuroprotectants have been explored in order to prevent brain 
injury.  Caffeine is a promising and novel candidate for neuroprotection following 
neonatal HI injuries.  Caffeine is a non-selective adenosine antagonist originally used to 
increase respiratory drive and thus help wean premature infants off ventilation.  However, 
caffeine was also shown to have surprising therapeutic effects following HI.  For 
example, premature infants treated with caffeine showed an increased rate of survival 
without long-term disability, along with decreased incidence of cerebral palsy or 
neurodevelopmental delay (Benitz, 2008; Gray et al., 2011; Schmidt et al., 2006; Schmidt 
et al., 2007; Stevenson, 2007).  Additionally, premature infants treated with caffeine for 
respiratory stimulation subsequently showed increased cortical activity measured by EEG 
(Supcun et al., 2010).  In animal models of HI, neonatal mice reared in hypoxic 
environments from P3-P14 (with a dam provided caffeine in the drinking water ad lib), 
caffeine treated hypoxic pups showed increased myelination, more normally arranged 
axons, increased proportions of oligodendrocytes, and decreased ventricular volumes as 
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compared to non-treated hypoxic pups (Back et al., 2006).  In a related study, premature 
baboons treated with caffeine also showed increased myelination (Rivkees & Wendler, 
2011).  Finally, we previously found that P7 HI injured pups treated with caffeine (10 
mg/kg) immediately following the induction of injury performed significantly better on a 
spatial learning/memory task as compared to non-treated HI pups (Alexander et al., 
2013).      
 Although several neuroprotective strategies have been investigated to treat HI 
injury in infants (e.g., whole body cooling or erythropoietin), both of these have shown 
decreased therapeutic effectiveness as the time to initiate treatment is increased (i.e., with 
increasing delay; Alexander et al., 2013; Gunn & Gunn, 1998; Karlsson et al., 2008).  
Given these findings, we sought to characterize the therapeutic effectiveness of caffeine 
when initiation of treatment was similarly delayed following HI injury.  On P7 animals 
were treated with caffeine immediately or 60 minutes after HI injury (or sham treatment).  
We hypothesized that P7 HI animals treated with caffeine immediately following injury 
would show neuroprotective effects on RAP and memory/learning tasks, as well as on 
post mortem histology. However, we hypothesized that when treatment was delayed, 
caffeine might provide little to no therapeutic effectiveness on both behavioral measures 
and post mortem histology.   
Methods 
 Time-mated Wistar dams were ordered from Charles River Laboratories, and 
were shipped to Bousfield Psychology Building at the University of Connecticut on 
embryonic day 6.  Dams were housed in the Bousfield Psychology vivarium on a 12-hour 
light/dark cycle, where they gave birth.  Upon birth, pups were culled to litters of eight 
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males and two females (P1).  Only males were used in the current study, based on sex-
specific differences in both behavioral and neuroanatomical anomalies following early HI 
injury (Hill et al., 2012).  Female pups were retained to normalize maternal behavioral, 
and were used for other research at weaning.     
 On P7, pups within each liter were randomly selected for sham or HI procedures,  
(treatments were balanced within litters).  HI selected pups were anesthetized with 2.5% 
isoflurane, and a longitudinal midline incision was made in the neck.  The right common 
carotid artery was located, separated from surrounding tissue, and completely cauterized.  
The incision was sutured and animals were given a footpad injection indicating their 
specific treatment condition.  Sham animals were treated in a similar manner except there 
was no manipulation of the carotid artery.  All pups were allowed to recover under a 
warming lamp, and were returned to their mother for approximately two hours for 
feeding.  For hypoxia, HI assigned pups were placed in an air-tight chamber (placed on a 
warming pad and under a heat lamp in order to maintain nest temperature) containing 8% 
humidified oxygen (balanced with nitrogen) for 120 minutes.  Sham animals were placed 
in a similar warmed container, but exposed to room air for the same amount of time.  
Following hypoxia, subsets of HI and sham animals were given an intraperitoneal (i.p.) 
injection of either caffeine base (10 mg/kg) immediately, or at a 60 minute delay, or a 
vehicle (sterile saline) i.p. injection in a comparable dose, at the same time points.  Final 
groups were: a) HI saline immediately (0 min), n=7; b) HI saline delayed (60 min), n=7; 
c) HI Caffeine immediately (0 min), n=12; d) HI Caffeine delayed (60 min), n=9; e) 
Sham saline immediately (0 min), n=7; f) Sham saline delayed (60 min), n=3; g) sham 
caffeine immediatley (0 min) n=7; h) and sham caffeine delayed (60 min), n=3.  All pups 
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were returned to their dams and allowed to grow up normally until weaning (P21).  Upon 
weaning, pups were double-housed with like-treated subjects, and then later were single 
housed at P60 for testing.   
Behavioral Testing 
Rapid Auditory Processing (P35-38; P61-62) 
 The rapid auditory processing procedure capitalizes on an animal’s natural pre-
pulse inhibition reflex.  When a startle-eliciting stimulus (SES) is coupled with a benign 
acoustic stimulus just prior to an acoustic burst, the animal exhibits a pre-pulse inhibition 
(or a startle reduction).  The acoustic startle reflex (ASR) is a relatively large motor reflex 
response to a SES.  The procedure allows for an indirect measure of the animal’s ability 
to detect a cue, based on the magnitude of the startle attenuation (reduction) elicited by 
the prepulse cue (see Fitch et al., 2008 for review).  In this way, the magnitude of the 
animal’s startle response in cued versus uncued trials can be evaluated as a function of 
cue property (e.g., duration), and thus can provide a direct measure of detection of the 
pre-SES cue.  During testing, animals were placed on a Med Associates PHM-252B load 
cell platform in a black polypropylene cage, in a quiet testing room.  Output voltages 
from each platform were sent through a PHM-205-60 linear load cell amplifier and into a 
Biopac MP100A-CE Acquisition system.  This was connected to a Power Macintosh G3 
computer, which recorded the amplitude of each subject’s startle response (using 
Acknowledge Software), starting with the onset of the SES.  Auditory stimuli were 
generated on a Pentium III Dell PC with custom programmed software, and a Tucker 
Davis Technologies RP2 real time processor.  Stimuli were amplified using a Niles SI-
1260 Systems Integration Amplifier.  The sound program was delivered through 10 
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Cambridge Soundworks MC 100 loudspeakers placed 53 cm above the load cell 
platforms.  The SES was always 105 dB, for a 50 ms burst.  For each animal, the 
attenuation (Att) score was calculated by taking the mean cued startle score divided by 
the mean uncued startle score within a session, and multiplied by 100 to turn it into a 
percentage (cued/uncued * 100).  These Att scores were used for further statistical 
analysis.    
Normal Single Tone: 
 The single tone task consisted of 103 cued and uncued trials.  Trials were 
presented in random order, and all animals were tested for one session (1 day).  The 
single tone procedure was used to assess any possible underlying processing deficits or 
hearing deficits that might confound further testing results.  Uncued trials consisted of a 
silent background followed by the SES.  On cued trials, a 75-dB, 7-ms 2300-Hz tone was 
presented 50 ms prior to the SES.  Analysis by Treatment group was performed to insure 
that all animals could perform the basic prepulse inhibition tasks.   
Silent Gap (SG) 0-100 and 0-10 procedure: 
   The silent gap (SG) procedure consisted of 299 trials per session.  All animals 
were tested on one session/day for 4 days (SG 0-100) in the juvenile period, and for one 
session/day for 2 days (SG 0-10) in adulthood.  For all trials, a continuous background 
broad-band white noise (75 dB) was played.  Uncued trials consisted of continued 
background white noise followed by the SES.  On cued trials, a silent gap in the white 
noise (varying in duration from 2-100 ms in the SG 0-100 task to 2-10 ms in the SG 0-10 
task) was presented 50 ms prior to the SES.   
Learning and Memory (P88-100): 
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  Prior to memory testing, animals were tested on a one day water escape task to 
assess general motor swimming deficits that might confound results.  The water escape 
task involved the use of an oval tub (40.5 in x 21.5 in) filled with room temperature water 
and a visible platform at one end of the tub.  Subjects were placed at the opposite end of 
the tub from the visible platform, and were timed until they swam to and climbed onto 
the platform.  Latency to escape was recorded for each animal.  All maze testing was 
performed in adulthood.   
Morris Water Maze (MWM): 
 Morris Water Maze (MWM; a task of spatial memory navigation) testing used a 
48-inch diameter hard plastic tub, with a six-inch diameter escape platform submerged 
right below the water line and out of direct sight of the animal.  Animals had to rely on 
extra-maze cues to locate the hidden platform.  For each trial, the escape platform was 
located in the same quadrant and the start position for each subject for each trial varied 
(N, S, E, W).  The animal’s trajectory was recorded with a Sony Digital 8 video camera, 
which was connected to a Dell Dimensions E521 computer.  Installed on the computer 
was SMART version 2.5 tracking software, which recorded the animal’s velocity 
(measured in cm/sec) and latency to platform (measured in seconds).  For each trial, 
animals were given 45 seconds to locate and reach the submerged platform.  If the animal 
failed to reach the platform in 45 seconds, it was gently guided to the platform and 
allowed to sit for 5 seconds before being removed from the maze.  The average total 
latency across four trials (per testing day) was used for analysis. 
Non-Spatial Maze (NSM):  
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Non-Spatial memory (NSM) testing used a 48-inch diameter hard plastic tub, with 
a six-inch diameter escape platform submerged right below the water line and out of 
direct sight of the animal.  There were four different intra-maze cues (black and white 
vertical lines, horizontal lines, diagonal lines sloping to the left, and diagonal lines 
sloping to the right) that were placed in four different quadrants in the tub.  The 
orientation of the intra-maze cues was changed on each trial, and this order was randomly 
selected at the beginning of each testing day.  For each trial, the escape platform was 
located in a different quadrant but corresponding to the same single intra-maze cue 
(always the vertical white and black lines).  The escape platform was associated with this 
same cue for the whole duration of testing.  The start position for each subject for each 
trial remained constant.  The animal’s trajectory was recorded with a Sony Digital 8 
video camera, which was connected to a Dell Dimensions E521 computer.  Installed on 
the computer was SMART version 2.5 tracking software, which recorded the animal’s 
velocity (measured in cm/sec) and latency to platform (measured in seconds).  For each 
trial, animals were given 45 seconds to locate and reach the submerged platform.  If the 
animal failed to reach the platform in 45 seconds, it was gently guided to the platform 
and allowed to sit for 5 seconds before being removed from the maze.  The average total 
latency across four trials (per testing day) was used for analysis.    
Histological Analysis: 
 For all histological procedures, animals were weighed and deeply anesthetized 
with an i.p. injection of ketamine (100 mg/kg) and xylaine (15 mg/kg).  Animals were 
then transcardially perfused with .9% saline followed by 10% buffered formalin.  Brains 
were removed from the skull and post-fixed in 10% buffered formalin.  Prior to slicing, 
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brains were transferred to a 30% sucrose solution for 24 hours for cryoprotection.  
Sections of 60 µm were obtained by the cryostat, and every third slice was saved and 
mounted on slides in a consecutive coronal series through the whole brain.  Tissue was 
stained using cresyl violet procedures.   
Cavaleri’s Estimator: 
 Using StereoInvestigator Software, brain damage was quantified using Cavaleri’s 
Estimator. Specifically, this involved drawing a contour around the perimeter of a brain 
structure and counting the number of cross sections on an overlaying grid within the 
contour.  The volume of the left and right lateral ventricles, cortex, hippocampus, and 
striatum (caudate and putamen) was measured.  Every other mounted section was 
counted, resulting in 10-12 representative sections per subject.   
Statistical Analysis: 
 All statistical analysis was performed using SPSS 16.0 software and an alpha 
level criterion of 0.05.  Two-tailed analysis was used, unless otherwise stated.  For each 
behavioral task, groups were compared using analysis of variance (ANOVA) with 
multiple levels of Treatment. Repeated measures ANOVAs were used to analyze each 
behavioral task.  For the RAP task, variables included Treatment, Day and Gap 
(duration).  For learning/memory testing, variables included Treatment and Day.  One-
way ANOVA was used to analyze volume of histological structures for both left and right 
separately.   Additionally, based on a priori hypotheses, planned comparisons were also 
performed as a function of Treatment between paired groups.   
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Results 
 Preliminarily analysis compared scores across the four sham groups (Sham 
Caffeine 0; Sham Caffeine 60; Sham saline 0; sham saline 60) on a variety of measures, 
and no significant differences were seen.  Therefore these groups were pooled for all 
analyses to create a sham group of n=20.  Additionally, no differences were seen between 
the two HI saline groups (HI Saline 0, HI Saline 60), therefore these groups were pooled 
for analysis, to create an HI saline group of n=14 
Rapid Auditory Processing: 
 Normal Single Tone (P34): On the normal single tone task, a one-way ANOVA 
revealed no significant Treatment effect [F(3,51) = .436, p>.05].  This indicated there 
was no difference in basic auditory processing abilities or pre-pulse inhibition between 
groups.  
 Silent Gap 0-100 (P35-38):  On the SG 0-100 task, a 4 (Day) x 9 (Gap) x 4 
(Treatment) repeated measures ANOVA revealed a significant overall Treatment effect 
[F(3,51) = 2.937, p<.05].  Follow-up repeated measures ANOVA revealed a significant 
difference between HI saline and sham animals [F(1,31) = 5.456, p<.05] (Figure 1a), with 
HI saline animals performing worse than shams.  Additionally, a follow up repeated 
measures ANOVA revealed significant difference between HI caffeine 0 and shams 
[F(1,30) = 5.094, p<05], with HI caffeine 0 animals performing worse than shams (Figure 
1b).  A significant Gap x Treatment interaction was also found between HI caffeine 60 
and sham groups [F(8,624) = 3.500, p<.001], with HI caffeine 60 animals performing 
worse than shams (Figure 1b).  Specifically, in the HI caffeine 60 versus sham 
comparison, differences were found at the 10 ms [F(1,27) = 4.355, p<.05], 20 ms [F(1,27) 
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= 5.085, p<.05], 40 ms [F(1,27) = 6.162, p<.05], and 100 ms [F(1,27) = 13.302, p<.001] 
gaps.    
 Silent Gap 0-10 (P61-62): On the SG 0-10 RAP task, a 2 (Day) x 9 (Gap) x 4 
(Treatment) repeated measures ANOVA revealed a significant overall Treatment effect 
[F(3,41) = 3.99, p<.01]5.  Follow up repeated measures ANOVAs revealed a significant 
difference between HI saline and sham groups [F(1,26) = 9.777, p<.005] (Figure 2a), 
with HI saline performing worse.  Additionally, repeated measures ANOVA revealed a 
significant difference between HI caffeine 0 and sham groups [F(1,24) = 6.839, p<.01], 
and between HI caffeine 60 and sham groups [F(1,21) = 5.822, p<.05], with HI caffeine 
groups performing worse.   
Learning and Memory  
 No significant Treatment effects were found for the water escape task [F(3,51) = 
2.495, p>.05].  This indicated a lack of differences in motor or visual ability as needed to 
locate a visible platform that might confound results.   
 Morris Water Maze (P 89-93): For MWM, a 5 (Day) x 4 (Treatment) repeated 
measures ANOVA showed no significant differences in swim speed [F(3,52) = 1.697, 
p>.05], confirming a lack of underlying swimming deficits in any group that might 
confound results.  For totally latency to reach the platform, a 5 (Day) x 4 (Treatment) 
repeated measures ANOVA failed to show a significant overall Treatment effect [F(3,51) 
= .822, p>.05], although scores were in the expected direction.  In fact, there was a trend 
for a Treatment effect between HI saline and sham animals [F(1,32) = 1.903, p=.08] and 
a trend for the Day x Treatment interaction [F(4,128) = 2.331, p=.05] with HI saline 
                                                
5 It should be noted that differences in degrees of freedom reflect computer malfunction 
that resulted in a loss of data for a few subjects on one day of testing.   
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animals performing worse.  Although there was no significant difference seen between 
HI caffeine 0 [F(1,30] = .975, p>.05] or HI caffeine 60 [F(1,27) = 1.346, p>.05] 
compared to shams, HI caffeine 0 animals performed more closely to shams than HI 
caffeine 60 animals.   
 Non-Spatial Maze (P 97-100):  For NSM, a 4 (Day) x 4 (Treatment) repeated 
measures ANOVA showed no significant differences in swim speed [F(3,51) = 2.614, 
p>.05], confirming a lack of underlying swimming deficits in any group that might 
confound results.  For total latency to reach the platform, a 4 (Day) x 4 (Treatment) 
repeated measures ANOVA revealed an overall trend [F(3,51) = 2.52, p=.06].  Follow-up 
repeated measures ANOVA revealed a significant difference between HI saline and sham 
groups [F(1,32) = 8.58, p<.01], with HI saline animals taking significantly longer to 
locate the platform (Figure 3a). Additionally, repeated measures ANOVAs revealed no 
significant difference between HI caffeine 0 and sham animals [F(1,30) = 3.58, p>.05] 
(Figure 3b).  However, there was a significant difference between HI caffeine 60 and 
shams [F(1,27) = 7.68, p<.01], wherein HI caffeine 60 animals took significantly longer 
to locate the escape platform (Figure 3b).   
Histology 
 Ventricular Volume: A one-way ANOVA revealed a significant Treatment effect 
for right ventricular volume [F(3,54) = 6.804, p<.001] (Figure 4a).  Follow-up 
independent samples t-tests revealed significant differences between HI saline and sham 
groups (t(32) = 5.232, p<.001), between HI caffeine 0 and sham groups (t(30) = 3.108, 
p<.005), and between HI caffeine 60 and sham groups (t(27) = 3.866, p<.001), with all 
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HI groups showing a higher rate of right ventriculomegaly compared to shams.  There 
was no significant Treatment effect in left ventricular volume [F(3,54) = .617, p>.05].   
 Cortical Volume: A one way ANOVA revealed a significant Treatment effect for 
right cortical volume [F(3,54) = 5.903, p<.005].  Follow up independent samples t-test 
revealed specific differences between HI saline and sham groups (t(32) = 4.670, p<.001), 
between HI caffeine 0 and sham groups (t(30) = 3.352, p<.005) and between HI saline 60 
and sham groups (t(27) = 3.072, p<.005), with all HI groups showing smaller right 
cortical volumes compared to shams.  There were no differences in left cortical volume 
[F(3,54) = .792, p>.05].   
Hippocampal Volume: A one-way ANOVA revealed a significant Treatment 
effect for right hippocampal volume [F(3,54) = 23.08, p<.001].  Follow-up independent 
samples t-tests revealed specific differences between HI saline and sham groups (t(32) = 
8.938, p<.001), between HI caffeine 0 and sham groups (t(30) = 5.545, p<.001) and 
between HI caffeine 60 and sham groups (t(27) = 4.822, p<.001), with all three HI groups 
showing significantly smaller right hippocampal volume compared to shams.  There were 
no differences in left hippocampal volume [F(3,54) = .785, p>.05].   
Striatal Volume: A one-way ANOVA revealed a significant Treatment effect for 
right striatal volume [F(3,54) = 13.826, p<.001].  Follow-up independent samples t-tests 
revealed specific differences between HI saline and sham groups (t(32) = 6.26, p<.001), 
between HI caffeine 0 and sham groups (t(30) = 4.673, p<.001) and between HI caffeine 
60 and sham groups (t(27) = 3.980, p<.001), with all three HI groups showing 
significantly smaller right striatal volume compared to shams.  There were no differences 
in left striatal volume [F(3,54) = .011, p>.05]. 
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Discussion  
 In the current study, we found that immediate caffeine treatment following P7 HI 
injury in rodents preferentially protected against behavioral deficits, showing 
amelioration of learning/memory (using a non-spatial learning/memory maze) but not 
RAP deficits (a novel finding). This first finding extends previously published evidence 
showing a preservation of learning/memory scores in HI injured animals treated 
immediately with caffeine following P7 HI injury, but using a spatial learning/memory 
maze paradigm (Alexander et al., 2013).  The current study failed to replicate this 
previous spatial learning/memory finding although scores on the Morris Water Maze 
were trending in the expected direction (HI saline animals performing worse than shams, 
HI caffeine 0 animals performing comparable to shams, and HI caffeine 60 animals 
performing close to HI saline).  Additionally, in the previous Alexander et al (2013) 
study, caffeine treatment immediately P7 HI animals also failed to show a protective 
effect on RAP tasks, although these results were not reported (unpublished data from 
Alexander et al., 2013).  Another novel finding, to our knowledge, is the lack of a 
therapeutic effect when caffeine treatment was delayed 60 minutes after the induction of 
P7 HI injury.  Specifically, HI animals with delayed caffeine treatment showed persistent 
deficits on RAP tasks in both juvenile and adult periods, as well as non-spatial learning 
and memory deficits, when compared to shams.  Furthermore, HI caffeine treated animals 
(both immediately and 60 minute delayed) showed significant ventriculomegaly as well 
as significant reductions in right cortical, hippocampal, and striatal volume.  Finally, non-
treated HI animals (HI saline) showed robust deficits on both RAP and learning/memory 
tasks as has been previously reported (Alexander et al., 2013; Hill et al., 2013; McClure 
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et al., 2005; McClure et al., 2005; McClure et al., 2006; Arteni et al., 2003; Delcour et al., 
2012; Ikeda et al., 2001; McClure et al., 2005; McClure, et al., 2007; Alexander et al., 
2013). Non-treated HI injured animals also showed significant right ventriculomegaly 
along with significant reductions in right cortical, hippocampal, and striatal volume, 
again replicating previous work (Alexander et al., 2013; McClure et al., 2005; McClure et 
al., 2005; McClure et al., 2006). 
Mechanisms of Caffeine Action 
 
Following neonatal HI, dramatic increases in adenosine are seen in the brain 
(from about 50 nM (basal conditions) to upwards of about 1000 nM; Rivkees et al., 2001; 
Rivkees & Wendler, 2011).  This rise is believed to promote accelerated expression of 
apoptotic activity, leading in turn to a rise in free radical and caspase formation (Rivkees 
et al., 2001).  Although caffeine is a non-selective adenosine antagonist, the 
neuroprotective effects following neonatal HI are believed to be primarily mediated via 
antagonism of the A1 receptor present throughout the brain but in highest density in the 
cortex and hippocampus by adulthood; (Rivkees & Wendler, 2011), specifically 
preventing various inflammatory mediators of cell death. In clinical studies, caffeine has 
been found to reduce inflammatory cytokine levels in the peripheral blood of premature 
infants, with reported reductions in IL-6, TNF-α, and IL-10 (Chavez Valdez et al., 2011).  
In term-injured infants, caffeine treatment also down-regulates tumor necrosis factor 
TNF-α, as well as the release of cytokines in response to lipoplysaccharides (Chavez-
Valdez et al., 2009).  However, the location of A1 and A2A receptors might play an 
important role in distinguishing what types of behaviors are later preserved.  A1 receptor 
density increases dramatically between P9 and P15 in the rodent brain, with the highest 
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levels being expressed in the cortex and hippocampus by adulthood (Cunha, 2005).  
Conversely, A2a receptors show highest density in the basal ganglia with a lower density 
throughout the whole brain (Cunha, 2005).  In specific regards to neural regions that 
might underlie rapid auditory processing impairments, there is some evidence suggesting 
that RAP deficits might in part be mediated by cellular abnormalities in the medial 
geniculate nucleus (MGN) of the thalamus (Galaburda et al., 1994; Stein, 2001; Herman 
et al., 1997; Alexander et al., in review).  Although there is some evidence suggesting the 
presence of A1 receptor gene expression in fetal rodents on gestational age 20 in the 
MGN (Weaver et al., 1996), A1 receptors are believed to be the most abundant in cortical 
and limbic systems at this time (Cunha, 2005).  It remains unknown as to the degree the 
A1 cell type in the MGN is functional at P7, and the role it might play following neonatal 
HI.  It could be that caffeine is not able to preferentially protect areas such as the MGN, 
thus failing to ameliorate deficits in RAP.  However, A1 and A2A receptors are widely 
expressed in areas that are believed to mediate learning/memory processes, such as 
cortical, limbic, and basal ganglia systems.  In fact, adult rodent lesion studies have 
demonstrated that the striatum plays an important role in non - spatial navigation and 
memory (Packard & McGaugh, 1996; Packard & Knowlton, 2002; White & McDonald, 
2002).  However, the current study failed to show preserved volume of the right striatum 
in HI caffeine 0 animals, suggesting the protective effects of caffeine may be more 
evident in preserved circuitry.  Additionally, more longitudinal behavioral studies are 
needed to characterize the therapeutic effects of caffeine following HI injury in both 
premature and term injured populations.  Previous studies have demonstrated that 
premature infants treated with caffeine performed better on both mental development and 
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psychomotor incidences at 18 months (Schmidt et al., 2007).  However, these are general 
cognitive measures and do not focus on specific behavioral modalities.  In fact, thalamic 
structures are critically involved in RAP, but if they lack functional A1 receptors (as 
compared to areas in the cortex or hippocampus) at P7, this could explain why HI 
animals treated immediately with caffeine would still show deficits on RAP tasks dispite 
preservation of learning and memory performance following injury.    
Impact of Therapeutic Delay   
 The current study also demonstrated a lack of therapeutic benefits following P7 
HI injury when caffeine treatment was delayed 60 minutes following HI injury.  It could 
be that the mechanisms of effective action of caffeine at the adenosine receptor following 
HI require immediate activation, and are ineffective with delay.  In fact, the activation of 
adenosine receptors is believed to mediate more immediate markers of the apoptotic 
cascade, suggesting these processes are critically implicated immediately after injury.  
Immediately after HI, excessive adenosine binding to A1 receptors leads directly to the 
activation of hypoxia-inducing factor (HIF), which in turn promotes apoptotic cell death 
(Rivkees et al., 2001; Ryzhov et al., 2007).  The notion that caffeine may antagonize 
these immediate deleterious events is supported by evidence demonstrating serum 
caffeine levels in treated premature infants are correlated with changes in pro-
inflammatory and anti-inflammatory cytokine levels in peripheral blood (Chavez-Valdez 
etl a., 2011).  Since cytokine and other inflammatory markers are believed to index 
immediate effects of the apoptotic cascade following neonatal HI, and appear in upwards 
of minutes following injury (Gill & Perez-Polo, 2008; J. J. Volpe, 2001), this suggests 
that antagonism of adenosine receptors must occur quickly in order to be effective.  
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Moreover, once this detrimental cascade is activated, it may be very difficult to stop or 
reverse, thus making delayed treatment less successful than treatment initiated 
immediately.  In fact, other studies investigating other therapeutic strategies for neonatal 
HI also show compromised effectiveness when treatment is delayed (Alexander et al., 
2013; Gunn & Gunn, 1998).  This study, along with other studies investigating the 
therapeutic effectiveness of delayed therapeutic intervention following neonatal HI 
injury, suggest that treatment needs to be initiated as soon as possible for optimal 
outcome.   
Task Specific Benefits of Caffeine Treatment 
 To our knowledge, this is the first study to demonstrate a preferential therapeutic 
effect of immediate caffeine treatment following neonatal HI, with immediate caffeine 
treatment preventing learning/memory but not RAP deficits.  As noted earlier, these task 
specific benefits could reflect regional differences in A1 receptor distribution and 
functionality, with lesser beneficial consequences in structures critical to RAP (such as 
the MGN).  Moreover, although we found significant protective effects of immediate 
caffeine treatment on our learning/memory task, we did not show any preservation of 
ventricular, cortical, hippocampal or cortical volume in HI animals treated immediately 
with caffeine (although we did see mean differences in the expected direction for right 
ventricular and cortical volume in the HI caffeine 0 group, these were not significant).  It 
could be the protective effects of caffeine allow for cellular reorganization and plasticity 
effects rather than preservation of gross volume of brain structures.  For example, in 
cultured developing cortical neurons, caffeine was found to enhanced CREB dependant 
gene expression and mediate activity-dependant BDNF and trkB expression (Connolly et 
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al., 2010).  Furthermore, neonatal mice reared in hypoxic environments treated with 
caffeine showed more normally arranged axons and increased proportions of 
oligodendrocytes (Back et al., 2006).  Finally, P7 rodents with induced early life 
convulsions showed selective memory deficits in adulthood (Cognato et al., 2010), but  
caffeine treatment prevented these memory deficits, and also prevented a loss of nerve 
terminals specifically in the hippocampus (Cognato et al., 2010).  However, there are no 
studies we are aware of empirically investigating this hypothesis.  Additional studies are 
needed to confirm this hypothesis and to characterize how different cell types might 
reorganize in response to caffeine treatment in order to prevent brain injury as well as to 
determine whether a larger n could reveal anatomic amelioration in the HI caffeine 0 
group.   
Conclusions: 
 The current study demonstrated: 1) a preferential therapeutic effect with 
immediate caffeine treatment following P7 HI injury in rodents, with caffeine 
treatment protecting against learning/memory deficits but not RAP deficits; 2) a 
lack of therapeutic effect on both RAP and learning/memory tasks when caffeine 
treatment was delayed by 60 minutes; and 3) a lack of evidence of preserved 
cortical of hippocampal volume following either treatment condition.  We interpret 
these findings to suggest that caffeine may act to antagonize adenosine A1 
receptors and thus block immediate events in the HI induced apoptotic cascade, and 
moreover that these receptor-mediated benefits may be regionally specific, leading 
to amelioration in some domains (learning/memory) but not others.  The 
mechanisms through which beneficial effects of caffeine treatment on 
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learning/memory tasks are seen despite a lack of preservation of cortical, 
hippocampal and striatal tissue remains to be explained, although it is notable that a 
non-significant trend towards smaller right ventricles and preserved right cortex 
was seen in the HI caffeine 0 groups (possible indicating a small effect that will 
require larger n to confirm).  Future studies should continue to examine these task-
specific and temporally specific effects of caffeine given its continued use in at risk 
neonates. 
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Figure 1: A) A 4 (Day) x 9 (Gap) x 4 (Treatment) repeated measures ANOVA revealed a 
significant overall Treatment effect [F(3,51) = 2.937, p<.05].  A) Follow up repeated 
measures ANOVA revealed a significant difference between HI saline and sham animals 
[F(,131) = 5.456, p<.05]. B) Follow up repeated measures ANOVA revealed a significant 
differences between HI caffeine 0 and shams [F(1,30) = 5.094, p<05].  A significant Gap 
x Treatment effect was also found between HI caffeine 60 and sham groups [F(8,624) = 
3.500, p<.001).  Specific differences were found at the 10 ms [F(1,27) = 4.355, p<.05], 
20 ms [F(1,27) = 5.085, p<.05], 40 ms [F(1,27) = 6.162, p<.05], and 100 ms [F(1,27) = 
13.302, p<.001] gaps. 
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Figure 2 : A) A 2 (Day) x 9 (Gap) x 4 (Treatment) repeated measures ANOVA revealed a 
significant overall Treatment effect [F(3,41) = 3.99, p<.01].  A) Follow up repeated 
measures ANOVAs revealed a significant differences between HI saline and sham groups 
[F(1,26) = 9.777, p<.005].  B) Repeated measures ANOVA revealed a significant 
difference between HI caffeine 0 and sham groups [F(1,24) = 6.839, p<.01] and between 
HI caffeine 60 and sham groups [F(1,21) = 5.822, p<.05]. 
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Figure 3: A) A 4 (Day) x 4 (Treatment) repeated measures ANOVA revealed a overall 
trend [F(3,51) = 2.52, p=.06].  A) Follow-up repeated measures ANOVA revealed a 
significant difference between HI saline and sham groups [F(1,32) = 8.58, p<.01].  B) 
Repeated measures ANOVAs revealed no significant difference between HI caffeine 0 
and sham animals [F(1,30) = 3.58, p>.05]. There was a significant difference between HI 
caffeine 60 and shams [F(1,27) = 7.68, p<.01]. 
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Figure 4: A) Ventricular Volume: A one-way ANOVA revealed a significant Treatment 
effect for right ventricular volume [F(3,54) = 6.804, p<.001].  Follow-up independent 
samples t-tests revealed a significant differences between HI saline and sham (t(32) = 
5.232, p<.001), between HI caffeine 0 and sham (t(30) = 3.108, p<.005), and between HI 
caffeine 60 and sham groups (t(27) = 3.866, p<.001). B) Cortical Volume: A one way 
ANOVA revealed a significant Treatment effect for right cortical volume [F(3,54) = 
5.903, p<.005].  Follow up independent samples t-test revealed specific differences 
between HI saline and sham groups (t(32) = 4.670, p<.0010, between HI caffeine 0 and 
sham groups (t(30) = 3.352, p<.005) and between HI saline 60 and sham groups (t(27) = 
3.072, p<.005). C) Hippocampal Volume: A one-way ANOVA revealed a significant 
Treatment effect for right hippocampal volume [F(3,54) = 23.08, p<.001].  Follow-up 
independent samples t-tests revealed specific differences between HI saline and sham 
groups (t(32) = 8.938, p<.001], between HI caffeine 0 and sham groups (t(30) = 5.545, 
p<.001) and between HI caffeine 60 and sham groups (t(27) = 4.822, p<.001). D) Striatal 
Volume: A one-way ANOVA revealed a significant Treatment effect for right striatal 
volume [F(3,54) = 13.826, p<.001].  Follow-up independent samples t-tests revealed 
specific differences between HI saline and sham groups (t(32) = 6.26, p<.001], between 
HI caffeine 0 and sham groups (t(30) = 4.673, p<.001) and between HI caffeine 60 and 
sham groups (t(27) = 3.98, p<.001). 
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Addendum II 
A combination therapeutic treatment of erythropoietin and caffeine following 
neonatal HI injury in a rodent model 
 
Unpublished Data  
 Although several studies have investigated the use of neuroprotectants in HI 
injured human populations as well as the neonatal HI rodent model, few have tested the 
therapeutic effectiveness when treatment regimens were combined.  It has been 
demonstrated in both human HI neonates as well as HI injured rodent models that these 
injuries lead to a variety of subsequent behavioral/cognitive deficits.  It could be feasible 
that optimal treatment interventions could include a combination of strategies, with 
compounds preventing different levels of the necrotic/apoptotic cell death cascade.  As 
far as we are aware there are only two studies that have investigated the use of multiple 
neuroprotective agents simultaneously in HI injured rodents.  In a recent study, P7 HI 
injured rodents were given three injections of Epo (1000 U/kg immediately, 24 hours and 
1 week following HI) in combination with whole body cooling (8 hours immediately 
following HI).  Results showed no significant differnces between combination therapy 
and non-treated animals on neuropathological scores, but animals only treated with Epo 
did show better neuropathological scores (Fang et al., 2012).  There were no significant 
Treatment effects in the combination therapy group.  In another study, P7 HI injured 
animals were treated with three hours of hypothermia immediately following hypoxia as 
well as Epo (5000 U/kg immediately following hypothermia, with two additional 
treatments at 24 and 48 hours).  Results showed mild improvement on sensorimotor tasks 
with the Epo only treated groups and a “borderline” improvement when Epo was 
combined with hypothermia (Fan et al., 2013).  Furthermore, the hypothermia treatment 
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alone provided extensive neuroprotection in female rodents with modest effects in male 
rodents (Fan et al., 2013).  Provided the limited and inconclusive results on combination 
therapy following neonatal HI, we sought to investigated a combination regimen of both 
Epo and caffeine in P7 HI injured rodents.  
 Briefly, animals underwent the HI surgery on P7 (cauterization of the right 
common carotid artery followed by 2 hours of 8% oxygen (balanced with nitrogen) 
exposure).  Sham animals received no manipulation of the carotid artery and were 
exposed to normal air for the same duration.  Only male animals were used given the sex-
specific difference following HI injury (Hill et al., 2012).  A subset of HI animals 
received either one injection of Epo (1000 U/kg), caffeine (10 mg/kg), or Epo+caffeine 
immediately following HI.  Control HI animals received comparable doses of the vehicle 
(sterile saline).  Sham animals were given the same dosing treatment as HI animals.  
After weaning, animals were tested on a variety of behavioral tasks. 
 Unfortunately, we were unable to obtain any meaningful results from this study.  
In fact, behavioral scores for sham animals were deviant from prior studies, as well as 
those of treated animals. We believe that the dam mothers were placed under significant 
stress because of building and vivarium construction (noise, vibration, smells) that might 
have negatively affected the pups in utero.  Furthermore, stressors in the neonatal period 
might have affected the mother’s behavior towards the pups, corticosterone levels in 
milk, and/or general brain development of the pups.  All of these factors could have led to 
aberrant behaviors in the sham animals, which made it difficult to draw any meaningful 
conclusions of neonatal HI injury or the use of combination therapeutic strategies.   
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 However, it is important to continue to study the use of combine therapeutic 
strategies following neonatal HI injury in order to better understand and employ optimal 
treatment for HI injured human neonates.   
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Chapter 7:    
 
Discussion 
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Summary of Findings: Hypoxic ischemic brain injury in neonates -- both preterm and 
term represents a major cause of infant mortality or long-term neurological morbidity 
(Annibale & Hill, 2008; Volpe, 2001; Volpe, 2009, Fatemi et al., 2009; Volpe, 2001).  
Deficits in motor, language, learning/memory and visual attention tasks are among the 
variety of long-term cognitive impairments seen in HI injured infants (Jansson-Verkasalo 
et al., 2004; Steinman et al., 2009; Briscoe et al., 2001; Gimenez et al., 2004; Luu et al., 
2011; Luu, et al., 2011; Vicari, et al., 2004; Fazzi et al., 2009; Cho et al., 2012; Martinez-
Biarge et al., 2011; Mercuri & Barnett, 2003; Mercuri et al., 2004; Kono et al., 2011; van 
Haastert et al., 2008).  Given this wide range of deficits seen in neonatal HI populations, 
various neuroprotectants are beginning to be explored as a means to prevent some or all 
of the long-term cognitive impairments.  Two promising neuroprotectants are 
erythropoietin, an endogenous cytokine hormone (Ghezzi et al., 2004); and caffeine, a 
non-selective adenosine receptor antagonist (Rivkees et al., 2011).  For the studies 
presented here, these two drugs were investigated specifically based on a their differing 
underlying mechanisms of action, pilot evidence of efficacy in human and/or animal 
models, and the fact that both drugs are among the small handful approved for use by the 
FDA in neonates.  Epo is believed to protect against HI injury by blunting the initial 
apoptotic cascade following HI, specifically by decreasing glutotoxicity, promoting anti-
apoptotic proteins (e.g., Bcl-xL), decreasing pro-apoptotic proteins (e.g., Bad), and 
mitigating the excess influx of intracellular Ca2+ that can occur with oxygen failure 
(Ghezzi et al., 2004; Kumal et al., 2003; Spandou et al., 2004).  Caffeine, conversely, is 
thought to act by preventing sharply elevated levels of adenosine (induced by HI) from 
binding to receptors, thus reducing or down-regulating the expression of apoptotic 
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compounds such as hypoxia inducing factor (HIF), and decreasing downstream necrotic 
inflammation associated with neonatal HI (Rivkees et al., 2011; Ryzhov et al., 2001).  
Previous studies have demonstrated, in both human and rodent models of HI, 
preservation of function on cognitive behavioral tasks and amelioration of associated 
neuropathology with each of these agents.  However, more research is needed to fully 
understand the therapeutic benefit of these compounds and their relationship to cognitive 
behavioral outcomes and neuropathology.  Initially, the work presented here was 
performed to investigate the differential effects of preterm versus term HI injury on 
behavioral tasks and neuropathology, and to provide an effective baseline of “injury” for 
the investigation of neuroprotection.  Subsequently, we investigated the use of Epo or 
caffeine immediately following P7 HI injury in a rodent model, and also the therapeutic 
effectiveness of each drug when time of treatment was delayed (which provides a 
clinically relevant variable, since delays can occur under real-world conditions).         
 Although numerous studies have been performed to investigate preterm and term 
HI injury in both human neonates and rodent models, few studies have directly compared 
and contrasted the differences in outcomes between each injury, and particularly so for 
injuries of comparable magnitude or degree but incurred at different ages. In part, this 
reflects the much lower incidence of HIE injuries (estimated at .1-.2% of all births) as 
compared to the much larger preterm/VLBW population (estimated at closer to 14% of 
all births, though preterm births with HI injuries represent a further subset of these), 
making the populations quite disproportionate and leading to a far larger number of 
outcome studies in preterms. The lack of comparative human data also reflects the 
difficult in relating degree of injury, since the mechansisms of focal ischemic or 
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hemorrhagic/ischemic injuries in preterms are very different from the global HI events 
that occur during birth.  One very interesting prior study has demonstrated a difference in 
the neuroinflammatory profile following P1 versus P12 HI in rat pups, with P12 HI 
animals showing a much greater expression of inflammatory markers as compared to P1 
animals (Brochu et al., 2011).  In another study directly comparing P1 (preterm) versus 
P7 (term) HI rodent models, P1 HI injured animals showed a recovery of function on 
RAP tasks, with functional deficits seen in juvenile but not adult periods (McClure et al., 
2006).  However, P7 HI injured animals showed persistent deficits on the same RAP 
tasks in both juvenile and adult periods, along with extensive injury in various brain 
regions (McClure et al., 2006).  Current results (Chapter 2) replicate and extend these 
prior data, specifically demonstrating a recovery of function in P3 HI injured animals on 
RAP tasks but persistent deficits in P7 HI injury animals.  Furthermore, P7 HI injured 
animals showed deficits on motor learning and learning/memory tasks compared to 
shams, whereas P3 HI animals showed no such deficits on these same tasks.   
Interestingly, P3 HI injured animals did show robust deficits on two different visual 
attention tasks as compared to shams in adulthood, while P7 HI injured animals 
demonstrated more subtle deficits on these same tasks.  Finally, P7 HI injured showed 
extensive volume loss in a variety of brain areas including the cortex, hippocampus, 
striatum and a reduction of cross-sectional area in the corpus callosum.  Notably, despite 
the functional deficits in juvenile RAP and visual attention tasks seen in P3 HI animals, 
this group showed no significant reduction of brain area or volume in regions assessed.  
Furthermore, we also report a shift towards smaller cells in the right medial geniculate 
nucleus (MGN) of these same P7 HI injured animals as compared to shams, with P3 HI 
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animals evidencing no apparent shift towards smaller cells (Chapter 3).  This measure 
might provide a cellular index of later RAP deficits, and could potentially provide a 
useful marker of language outcomes in a variety of populations at risk for later language 
disabilities (including neonates with HI injury, but other populations as well).  
Specifically, large cells in the MGN have been proposed to mediate temporal aspects of 
auditory information, much like magnocellular cells in the LGN mediate temporal aspects 
of visual information (although it must be noted that an anatomically distinct 
magnocellular sub-division of the MGN has not been identified; Stein 2001). As such, 
abnormalities in large cells of the MGN might underlie later deficits in RAP in HI injured 
rodents. Given this wide range of behavioral deficits and neuropathology following P7 HI 
injury, we chose to focus on the P7 HI model for further studies of neuroprotection, 
although possible amelioration of the attention deficits seen in P3 HI models represents a 
clinically interesting issue and should be investigated further in future studies.       
 Using the P7 HI rodent model, we then sought to explore the therapeutic potential 
of Epo and caffeine.  Specifically for Epo, previous studies have demonstrated a 
therapeutic effect following P7 HI injury on sensory/motor tasks (Fan et al., 2011; Kim et 
al., 2008), spatial/memory tasks (Kumral et al., 2004, McClure et al., 2006; McClure et 
al., 2007) and RAP tasks (McClure et al., 2006; McClure et al., 2007).  We extended 
these findings, and report novel evidence that delaying the initiation of treatment 
following HI injury by 60 or 180 minutes post hypoxia significantly compromises the 
therapeutic effectiveness of Epo in both juvenile and adult periods (Chapter 4).  
Specifically, we replicated previous findings showing no RAP deficits in HI animals 
treated with Epo immediately following hypoxia compared to shams.  However, when 
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treatment was delayed 60 or 180 minutes, the therapeutic effectiveness of Epo was 
significantly compromised as measured by RAP deficits.  Furthermore, P7 HI animals 
with delayed Epo treatment showed marked increases in the volume of the right lateral 
ventricle compared to left ventricular volume, which is a general index of 
neuropathology.  These results suggest that for optimal therapeutic effectiveness of Epo 
following neonatal HI injury, treatment should be initiated as soon as possible following 
the insult.   
 We then sought to investigate the therapeutic potential of caffeine following P7 
HI injury (Chapter 5).  Previous studies have shown caffeine to reduce the 
neuroinflammatory profile for injured preterm (Chaves-Valdez et al., 2011) and term 
(Chaves-Valdez et al., 2011) infants, as well as showing better neuropathological 
outcomes in a rodent model of HI. Studies have also reported increased myelination, 
more normally arranged axons, increased proportion of axons and decreased ventricular 
volume (Back et al., 2006).   Furthermore, caffeine treatment following HI injury in 
preterm infants improved Mental Development Index and Psychomotor Development 
Index measures later in life (Schmidt et al., 2007).  We extended this previous research, 
and showed that P7 HI injured animals treated immediately with caffeine had improved 
scores on a spatial learning/memory task as compared to non-treated HI rodents.  
Although there was no significant preservation of cortical volume in caffeine treated 
animals, scores were in the expected direction.  However, in Chapter 6 we report 
preliminary evidence that the therapeutic effectiveness of caffeine might be task specific.  
Here we found that animals with P7 HI injury treated immediately with caffeine showed 
improved behavior on learning/memory tasks, but not on RAP tasks, in both juvenile and 
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adult periods when compared to shams. We note that there is some variability within our 
own findings for these assessments, since our first study showed that caffeine remediated 
performance on the spatial Morris maze with immediate caffeine treatment, and yet our 
second study showed beneficial effects on the non-spatial water maze. It could be that the 
therapeutic effect of caffeine is more variable as compared to other therapeutic 
interventions following neonatal HI.  Thus, studies using a larger “n” in treated groups 
should probably be used in future research to better understand caffeine therapy, and it is 
likely that such a study would reveal positive effects on both MWM and NSM for 
immediate caffeine treatment, though the consistent lack of benefit for RAP tasks would 
likely replicate. Data from Chapter 6 also demonstrated that when caffeine treatment was 
delayed for 60 minutes post hypoxia, the therapeutic potential was compromised.  
Specifically, animals with P7 HI injury with delayed caffeine treatment showed no 
significant improvement on RAP or learning/memory tasks compared to sham animals.  
Again, these findings should be replicated to draw any definitive conclusions.   Notably, 
in Chapter 6, although we found no significant preservation of neuranatomical volumes 
in caffeine-treated HI subjects, scores were in the expected direction, with immediate HI 
caffeine treated animals showing greater volume of the cortex and decreased volume in 
the ventricles as compared to non-treated animals.  Again, these findings suggest that the 
use of a larger “n” would be optimal. 
 From the work presented here, we can draw some conclusions regarding HI injury 
and therapeutic treatments.  First, we show there is a significant difference in behavioral 
and neuroanatomical outcomes following P3 versus P7 HI in rodents.  Differences in 
behavioral outcomes may reflect regions of vulnerability in the brain at the timepoint 
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when the injury occurs.  We have also extended previous data showing significant 
protection with immediate treatment of Epo following P7 HI injury, but a compromised 
effectiveness when treatment is delayed.  Additionally, we show that immediate caffeine 
treatment might provide task-specific benefits (preventing learning/memory deficits but 
not RAP deficits), and that delaying treatment again compromises therapeutic 
effectiveness on these tasks.  However, these results need to be replicated.   
 Cumulative findings reported here have numerous potential clinical implications, 
including an emphasis on the need to better understand mechanistic differences in HI 
injury as a function of timing (and in particular, the more deleterious effects seen in term 
injury and the task-specific attention deficits seen in preterm injury), as well as 
highlighting the need to further explore various therapeutic agents in both populations. 
 
Future Research: Expanding upon the data presented here could contribute to our 
understanding of neonatal HI injury and optimal therapeutic interventions.  In regards to 
the differential effects in early (preterm) versus late (term) HI injury -- even though 
robust differences between outcomes for these two models were found on behavioral and 
neuropthalogical measures, the extent that the brain is able reorganize and compensate 
following HI injury in each model (or population) has yet to be fully understood.  The 
behavioral data presented here suggests that when injury is induced earlier in life, the 
brain is able to compensate better than following later (term) injuries.  For this reason, 
future research should focus on brain adaptations following both early and late HI injury 
in rodents. This would result in better understanding of the differing mechanisms of 
neuronal plasticity involved following injury, as well as insight into how these changes 
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might relate to later behavioral measures.  Interestingly, we have also demonstrated a 
shift in cell size in P7 HI animals that showed RAP deficits.  It has only been 
hypothesized that larger cells in the MGN might play a role in RAP processing (Stein 
2001).  Continued investigation into the magnocellular theory, as well as how it relates to 
RAP deficits seen in HI injured populations, is needed.  Long-term studies using rodent 
models of HI could employ immuno-histochemisty or MRI procedures to gain early 
morphological data documenting the brain changes immediately following injury, which 
would provide information about brain plasticity that we are not able to obtain with adult 
histological analysis.  Additionally, the deficits in juvenile RAP and adult visual attention 
tasks in the early (P3) HI injury should also be further explored.  Rather than a global loss 
in volume, these deficits might be related to more subtle changes in brain connectivity.  
Future research could investigate these findings in both human and rodent models of HI.      
 With regards to neuroprotective strategies following neonatal HI injury, future 
research should investigate the effects of multiple (sequential) immediate and delayed 
treatments for both Epo and caffeine following injury.  In the current studies, we chose to 
investigate the effects of a single injection of either drug. However, previous studies have 
shown promising effects with multiple-treatment regimens. For example, previous studies 
have demonstrated a therapeutic effect of Epo when treatment was delayed but given at 
multiple time points post injury.  For example, when administration was delayed 48 hours 
following P7 HI injury in rodents and followed up at multiple time points (up to 13 days 
post injury), treated animals showed increased oligodendrogenesis, attenuation of white 
matter injury, and improved sensory motor function (Iwai et al., 2010).  In the work 
presented here the lack of a therapeutic effect in the 60 or 180 minute delayed injection 
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could be attributed to the advanced point in the apoptotic cascade when therapeutic 
agents are able to reach target regions, with the cascade potentially be too far along to be 
blunted by a single intervention after a threshhold point.  In fact, previous research has 
shown a prolonged and delayed (up to a week) increase in apoptotic activity following 
neonatal HI injury (Nakajima et al., 2000), as well as a delay in the time required before 
Epo reaches the brain post i.p. injection (Statler et al., 2007).  It could be that once the 
apoptotic cascade reaches a spcific point, it is difficult to reduce or stop. Yet multiple 
treatments of Epo at varying later time points might produce a better therapeutic effect, 
and suggest continued maintenance doses may be needed to adequately protect the brain.  
Furthermore, Epo seems to be most effective in a dose dependant manner, where low 
doses were the most effective with three injections spread out over several days, although 
larger doses (30,000 U/kg) were found to be effective at a single dose immediately 
following injury (Keller et al., 2007).  However, data in the Keller (2007) study was 
collected only up to a week post injury, and future studies could investigate this dose 
dependant effect on long-term adult cognitive behaviors following neonatal HI injury.  
Regarding caffeine, to the best of our knowledge there are no studies that have 
investigated the effects of multiple, delayed, or dose-dependant treatments of caffeine 
following neonatal HI injury.  Future studies should investigate the use of multiple 
treatments of caffeine at various time points, both immediately after injury and/or at a 
delay.  Additionally, for the research presented here, dosing was selected based on adult 
rodent literature showing a therapeutic effect at 10 mg/kg (Salamone, Randall & Nunes, 
personal communication).  As far as we are aware, there are no studies investigating a 
dose dependant assessment of caffeine efficacy in a neonatal HI model.  Results from 
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such studies could better inform researchers about optimal dosing and timing of caffeine 
treatment in a neonatal HI injury model.  Clinically, it might not always be possible to 
initiate treatment immediately following HI injury, thus data demonstrating a therapeutic 
effect of multiple delayed treatments could improve the treatment options for HI injured 
infants.  Furthermore, both Epo and caffeine have both central and peripheral effects that 
might lead to therapeutic outcomes.  Epo also helps red blood cells carry oxygen to 
different organs throughout the body (Ghezzi et al., 2004) and caffeine increases 
respiratory drive (Charles et al., 2008), both of which could increase brain oxygenation 
following HI.  There are no studies we are aware of that delineate the central versus 
peripheral therapeutic effects of either drug.  Future studies could characterize the central 
versus peripheral effects of Epo and/or caffeine’s interaction with the necrotic/apoptotic 
cascade following neonatal HI injury, for example with the use of immunohistochemistry 
procedures.   Understanding the most beneficial therapeutic treatment strategies for both 
Epo and caffeine would again optimize treatment options for HI injured infants.   
 Finally, there is known sex specific difference in behavioral deficits and 
neuropathology following neonatal HI injury (Hill et al., 2013), which might also suggest 
a need for gender specific treatment.    Few studies have investigated this difference 
between males and females following neonatal HI, nor possible gender based 
neuroprotective strategies.  Briefly, the differing levels of gonadal hormonal 
concentrations, as well as possible sex differences in the apoptotic cascade (with males 
showing increased expression of a caspase- independent cascade, and females showing a 
more caspase-dependant cascade; see Hill et al., 2013 for review), might lead to better 
preservation of behavior and neuropathology in female models of neonatal HI.  In fact, 
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one study has shown an increased benefit of Epo treatment in female over male P7 HI 
injured rodents on sensorimotor tasks and cerebral infarct volume (Wen et al., 2006).  
Specific and different treatment regimens could be needed for males and females in order 
to provide best therapeutic outcomes.  That is, given the differences in expression of the 
apoptotic cascade following neonatal HI between males and females, it could be that 
different certain treatment strategies are more beneficial for one sex over the other.   
 In closing, future studies evaluating optimal treatment options for both Epo and 
caffeine following neonatal HI injury could lead to more informative application and 
options for clinical protection in human neonates.  For example, characterizing dose 
response curves, evaluating multiple treatment regimens, delineating central versus 
peripheral effects, and examining sex specific treatment options could all lead to a greater 
variety of optimal therapeutic options for HI injured human neonates. 
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